Pyridazinone compounds active as pesticides

Abstract

Compounds of formula (I) where Q is Qa or Qb; and R4 is R4a or R4b, and where the substituents are as defined in claim 1, and the agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of those compounds, may be used as insecticides.

Description

Pyridazinone compounds active as pesticides The present invention relates to pyridazinone compounds active as pesticides, for example, as active ingredients, having pesticidal activity. The invention also relates to the preparation of these pyridazinone compounds, to intermediate products useful in the preparation of these pyridazinone compounds, to the preparation of these intermediate products, to agrochemical compositions comprising at least one of these pyridazinone compounds, to the preparation of these compositions, and to the use of these pyridazinone compounds or compositions in agriculture or horticulture for controlling animal pests, including arthropods and, in particular, insects or members of the order Acarina. In particular, pyridazin-3-one compounds active as pesticides are disclosed. The scope of the invention, and therefore of protection, is defined by the appended claims. Any object described below, not covered by the scope as defined by the claims, is not intended to form part of the invention. In particular, any object relating to methods of treating the human or animal body by surgery, therapy, or for diagnostic purposes is explicitly excluded from the scope of protection. Documents WO 2021 / 083936, WO 2021 / 148639 and WO 2021 / 177160 describe certain quinazoline, quinazolinone and quinoline compounds. Surprisingly, certain novel pyridazinone compounds, particularly pyridazin-3-one compounds, have now been found to have pesticidal activity. Therefore, the present invention provides, in a first aspect, compounds of formula (I), as well as agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides thereof: where: A1, A2, and A3 are, independently of each other, N or CRY; or A1=A2-A3, taken together, are NR-C (=X0) -N; where X0 is O or S; A4 and A5 are, independently of each other, N or CRY; What is , where the dashed line represents the connection of Q to the rest of the compound of formula (I); R is hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, or C1-C3 haloalkoxy; R1 is hydrogen, C1-C6 alkyl, C1-C6 cyanoalkyl, C1-C6 aminocarbonylalkyl, C1-C6 hydroxycarbonylalkyl, C1-C6 nitroalkyl, C1-C6 trimethylsilanealkyl, C1-C3 alkoxy-C1-C6 alkoxy, C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C3-C4 cycloalkyl-C1-C2 alkyl or C3-C4 cycloalkyl-C1-C2 alkyl, wherein the C3-C4 cycloalkyl group is substituted with 1 or 2 halogen atoms, oxethan-3-yl-CH2-, C1-C6 alkyl carbonyl, C1-C6 alkoxy carbonyl, phenyloxycarbonyl, benzyloxycarbonyl, benzyl or benzyl substituted with 1 to 3 substituents independently selected from halogen, C1-C6 alkoxy and C1-C6 haloalkyl; R2a and R2b are each independently selected from hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkylsulfanyl, C1-C3 alkoxy, C1-C3 haloalkoxy, halogen, NO2, SF5, CN, C(O)NH2, C(O)OH, C(S)NH2, C3-C6 cycloalkyl, C3-C6 cycloalkyl substituted with one to three substituents independently selected from Rx, C3-C6 cycloalkylcarbonyl, phenyl, phenyl substituted with one to three substituents independently selected from Rx, heteroaryl, heteroaryl substituted with one to three substituents independently selected from Rx; OR6;piperidin-2-one-1-yl, piperidin-2-one-1-yl substituted with one to two substituents selected independently of Rx, pyridin-2-one-1-yl, pyridin-2-one-1-yl substituted with one to two substituents selected independently of Rx, azetidin-1-yl, azetidin-1-yl substituted with one to two substituents selected independently of Rx, pyrrolidin-1-yl, pyrrolidin-1-yl substituted with one to two substituents selected independently of Rx, C3-C6-C1-C4 cycloalkyl, C3-C6-C1-C4 cycloalkyl substituted with one to two substituents selected independently of Rz;C3-C6 cycloalkyl-C1-C3 alkoxy, C3-C6 cycloalkyl-C1-C3 alkoxy substituted with one to two substituents selected independently of Rx, C1-C5 cyanoalkyl, C1-C5 cyanoalkoxy, C1-C4 alkylsulfanyl, C1-C4 alkylsulfanyl substituted with one to three substituents selected independently of Rx, C1-C4 alkylsulfonyl, C1-C4 alkylsulfonyl substituted with one to three substituents selected independently of Rx, C1-C4 alkylsulfinyl, and C1-C4 alkylsulfinyl substituted with one to three substituents selected independently of Rx; R3 is C1-C3 alkyl or C1-C3 haloalkyl; R4 is , where the dashed line represents the connection of R4 to Qa or Qb; A14, A24, and A34 are, independently of each other, N or CH; R4c is C1-C3 alkyl, C1-C3 haloalkyl, allyl, propargyl, or C3-C6 cycloalkyl-C1-C4 alkyl; R5 is hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, C1-C3 alkoxy, C3-C4 alkoxy-C(O)-, (C1-C3 alkoxy)2CH-, halogen, -CN, NH2C(O)-, amino (i.e., -NH2), (C1-C3 alkyl)amino, di(C1-C3 alkyl)amino, hydroxyl, C3-C4 halocycloalkyl, C3-C4 cyanocycloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C1-C4 haloalkylsulfanyl, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylsulfanyl, alkylsulfinyl C1-C4, C1-C4 alkylsulfonyl, C1-C3 alkoxy-C1-C3 alkyl, C1-C3 alkoxy-C1-C3 alkoxy-C1-C3 alkyl, (C1-C3 alkyl)sulfonylamino, (C1-C3 alkyl)sulfonyl (C1-C3 alkyl)amino, (C1-C3 alkyl) NHC (O) -, (C1-C3 alkyl) 2NC (O) -, (C1-C3 cycloalkyl) NHC (O) -, (C1-C3 cycloalkyl) (C1-C3 alkyl) NC (O) -, (C1-C3 alkyl) C (O) (C1-C3 alkyl) N-, (C1-C3 alkyl) C (O) NH-, (C1-C3 alkyl) C (O) -, (C1-C3 alkoxy) C (O) -, HC (O) -, diphenylmethanimine, C1-C3 haloalkoxy, phenyl, or a 5-membered heteroaromatic ring;or R5 is phenyl substituted with one to three substituents selected from C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C3-C4 cycloalkyl, halogen, -CN and hydroxyl; or; R5 is a 5-membered heteroaromatic ring substituted with one to three substituents selected from C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C3-C4 cycloalkyl, halogen, -CN and hydroxyl; R5a and R5b are selected, independently of each other, from hydrogen, halogen, -CN, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, C1-C3 alkoxy, and C1-C3 haloalkoxy; R6 is phenyl, benzyl, heteroaryl, or C3-C6 cycloalkyl; or R6 is phenyl, benzyl, heteroaryl or C3-C6 cycloalkyl, each of which, independently of each other, is substituted with one to three substituents selected independently of RX; RX is independently selected from halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy, NO2, SF5, CN, -C(O)NH2, -C(S)NH2, C1-C4 haloalkylsulfanyl, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylsulfanyl, C1-C4 alkylsulfinyl, and C1-C4 alkylsulfonyl; RY is selected from hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, hydroxy, C1-C3 alkoxy, C1-C3 haloalkoxy, halogen, -CN and cyclopropyl; and RZ is selected from oxo, halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy and CN. The present invention also provides a method for preparing compounds of formula (I) as well as intermediate compounds useful in the preparation of compounds of formula (I). In a second aspect, the present invention provides a composition comprising a compound of formula (I), one or more auxiliaries and a diluent, and optionally one or more other active ingredients. In a third aspect, the present invention provides a method for combating and controlling insects, mites, nematodes, or molluscs, the method comprising applying to a pest, a pest site, or a plant susceptible to pest attack, an insecticidal, acaricidal, nematicidal, or molluscicidal effective quantity of a compound of formula (I) or a composition comprising such a compound. In a fourth aspect, the present invention provides a method for protecting plant propagation material from attack by insects, mites, nematodes, or molluscs, comprising treating the propagation material or the site where the propagation material is planted with an effective amount of a compound of formula (I) or a composition comprising such a compound. In a fifth aspect, the present invention provides a plant propagation material, such as a seed, comprising, or treated with or attached to, a compound of formula (I) or a composition comprising such a compound. This disclosure provides, in an additional aspect, a method for parasite control in or on an animal in need, comprising administering an effective amount of a compound of the first aspect. This disclosure further provides a method for ectoparasite control on an animal in need, comprising administering an effective amount of a compound of formula I as defined in the first aspect. This disclosure further provides a method for preventing and / or treating ectoparasite-borne diseases, comprising administering an effective amount of a compound of formula (I) as defined in the first aspect to an animal in need. Compounds of formula (I) having at least one basic center can form, for example, salts by the addition of acids, for example, with strong inorganic acids such as mineral acids, for example, perchloric acid, sulfuric acid, nitric acid, nitrous acid, a phosphorous acid or a hydrohalic acid, with strong organic carboxylic acids, such as C1-C4 alkanecarboxylic acids that are unsubstituted or substituted, for example, with halogen, for example, acetic acid, such as saturated or unsaturated dicarboxylic acids, for example, oxalic acid, malonic acid, succinic acid, maleic acid, fumaric acid or phthalic acid, such as hydroxycarboxylic acids, for example, ascorbic acid, lactic acid, malic acid, tartaric acid or citric acid, or such as benzoic acid, or with organic sulfonic acids, such as C1-C4 alkanes or acids arylsulfonic acids that are unsubstituted or substituted, for example, with halogen, for example,methane or p-toluenesulfonic acid. Compounds of formula (I) having at least one acid group can form, for example, salts with bases, for example, mineral salts such as salts with an alkali metal or an alkaline earth metal, for example, salts of sodium, potassium, or magnesium, or salts with ammonia or an organic amine such as morpholine, piperidine, pyrrolidine, a lower monoalkylamine, dialkylamine, or trialalkylamine, for example, ethyl-, diethyl-, triethyl-, or dimethylpropylamine, or a lower monohydroxyalkylamine, dihydroxyalkylamine, or trihydroxyalkylamine, for example, monoethanolamine, diethanolamine, or triethanolamine. In each case, the compounds of formula (I) according to the invention are in free form, in oxidized form as an N-oxide, or in salt form, for example, an agronomically usable salt form. N-oxides are oxidized forms of tertiary amines or oxidized forms of nitrogen-containing heteroaromatic compounds. They are described, for example, in the book "Heterocyclic N-oxides" by A. Albini and S. Pietra, CRC Press, Boca Raton 1991. The compounds of formula (I) according to the invention also include hydrates that can be formed during the formation of salts. The term "C1-Cn alkyl", as used herein, refers to a saturated hydrocarbon radical, linear or branched chain, attached through any of the carbon atoms having 1 to 2 carbon atoms, for example, any one of the radicals methyl, ethyl, n-propyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, n-hexyl, n-pentyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3, 3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl, or 1-ethyl-2-methylpropyl. The term "C1-Cn haloalkyl," as used herein, refers to a saturated alkyl radical, linear or branched chain,attached through any of the carbon atoms having 1 to 2 carbon atoms (as mentioned above), where some or all of the hydrogen atoms in these radicals may be replaced by fluorine, chlorine, bromine and / or iodine, i.e., for example, any one of chloromethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 2-fluoroethyl, 2-chloroethyl, 2-bromoethyl, 2-iodoethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, pentafluoroethyl, 2-fluoropropyl, 3-fluoropropyl, 2, 2-difluoropropyl, 2, 3-difluoropropyl, 2-chloropropyl, 3-chloropropyl, 2, 3-dichloropropyl, 2-bromopropyl, 3-bromopropyl, 3, 3, 3-trifluoropropyl, 3, 3, 3-trichloropropyl, 2, 2, 3, 3, 3-pentafluoropropyl, heptafluoropropyl, 1- (fluoromethyl) -2-fluoroethyl, 1- (chloromethyl) -2-chloroethyl,1-(bromomethyl)-2-bromoethyl, 4-fluorobutyl, 4-chlorobutyl, 4-bromobutyl or nonafluorobutyl., Accordingly, a term "C1-C2 fluoroalkyl" will refer to a C1-C2 alkyl radical bearing 1, 2, 3, 4 or 5 fluorine atoms, e.g., any one of difluoromethyl, trifluoromethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1,1,2,2-tetrafluoroethyl or pentafluoroethyl. The term "C1-Cn alkoxy," as used herein, refers to a saturated, linear-chain or branched alkyl radical having one or more carbon atoms (as mentioned above) bonded through an oxygen atom; for example, any one of the radicals methoxy, ethoxy, n-propoxy, 1-methylethoxy, n-butoxy, 1-methylpropoxy, 2-methylpropoxy, or 1,1-dimethylethoxy. The term "C1-Cn haloalkoxy," as used herein, refers to a C1-Cn alkoxy radical in which one or more hydrogen atoms in the alkyl radical are replaced by the same or different halo atom(s); examples include trifluoromethoxy, 2-fluoroethoxy, 3-fluoropropoxy, 3,3,3-trifluoropropoxy, and 4-chlorobutoxy. The term "C1-Cn-C1-Cm alkoxy" as used herein refers to an alkoxy radical having 1 an carbon atoms (as mentioned above) that is linked through the oxygen atom to an alkyl radical having 1 am carbon atoms (as mentioned above), the alkyl radical being connected to the rest of the molecule. The term "C1-Cn cyanoalkyl", as used herein, refers to a saturated linear or branched chain C1-Cn alkyl radical having 1 to n carbon atoms (as mentioned above), wherein one of the hydrogen atoms of these radicals has been substituted by a cyano group: for example, cyanomethyl, 2-cyanoethyl, 2-cyanopropyl, 3-cyanopropyl, 1-(cyanomethyl)-2-ethyl, 1-(methyl)-2-cyanoethyl, 4-cyanobutyl, and the like. The term "C1-Cn nitroalkyl" as used herein refers to a saturated linear or branched chain C1-Cn alkyl radical having 1 to n carbon atoms (as mentioned above), wherein one of the hydrogen atoms in these radicals is replaced by a nitro group -NO2: e.g., nitromethyl, 2-nitroethyl, 2-nitropropyl, 3-nitropropyl, 1-(nitromethyl)-2-ethyl, 1-(methyl)-2-nitroethyl, 4-nitrobutyl, and the like. The term "C3-Cn cycloalkyl", as used herein, refers to 3-n membered cycloalkyl groups such as cyclopropane, cyclobutane, cyclopentane, and cyclohexane. The term "C3-Cn cycloalkylcarbonyl", as used herein, refers to a 3-n-membered cycloalkyl group attached to a carbonyl (C=O) group, the carbonyl group being connected to the rest of the molecule. Similarly, the terms "C1-Cn alkylcarbonyl", "C1-Cn alkoxycarbonyl", "phenyloxycarbonyl", and "benzyloxycarbonyl", as used herein, refer to an alkyl, alkoxy, phenyloxy, and benzyloxyl group attached to a carbonyl (C=O) group, the carbonyl group being connected to the rest of the molecule. The term "C3-C4-C1-C2 cycloalkyl," as used herein, refers to a 3- or 4-membered cycloalkyl group with a methylene or ethylene group attached to the rest of the molecule. If the C3-C4-C1-C2 cycloalkyl group is substituted, the substituent(s) may be on the cycloalkyl group and / or the alkyl group. The term "C3-C6 cycloalkyl-C1-C4 haloalkoxy", as used herein, refers to a 3- to 6-membered cycloalkyl group connected to a 1- to 4-membered haloalkoxy group, the haloalkoxy group being connected to the rest of the molecule. The term "C1-Cn aminocarbonylalkyl", as used herein, refers to an alkyl radical in which one of the hydrogen atoms of the radical is replaced by a CONH2 group. The term "C1-Cn hydroxycarbonylalkyl", as used herein, refers to an alkyl radical in which one of the hydrogen atoms of the radical is replaced by a COOH group. The term "C1-Cn alkylsulfanyl," as used herein, refers to a C1-Cn alkyl moiety linked through a sulfur atom. Similarly, the term "C1-Cn haloalkylthio" or "C1-Cn haloalkylsulfanyl," as used herein, refers to a C1-Cn haloalkyl moiety linked through a sulfur atom. Likewise, the term "C3-Cn cycloalkylsulfanyl" refers to a 3-n-membered cycloalkyl moiety linked through a sulfur atom. The term "C1-Cn alkylsulfinyl," as used herein, refers to a C1-Cn alkyl moiety linked through the sulfur atom of the S(=O) group. Similarly, the term "C1-Cn haloalkylsulfinyl," as used herein, refers to a C1-Cn haloalkyl moiety linked through the sulfur atom of the S(=O) group. Likewise, the term "C3-Cn cycloalkylsulfinyl" refers to a 3-n-membered cycloalkyl moiety linked through the sulfur atom of the S(=O) group. The term "C1-Cn alkylsulfonyl", as used herein, refers to a C1-Cn alkyl moiety linked through the sulfur atom of the S(=O)2 group. Similarly, the term "C1-Cn haloalkylsulfonyl", as used herein, refers to a C1-Cn haloalkyl moiety linked through the sulfur atom of the S(=O)2 group. Likewise, the term "C3-Cn cycloalkylsulfonyl", refers to a 3-n-membered cycloalkyl moiety linked through the sulfur atom of the S(=O)2 group. The term "C1-Cn trimethylsilanealkyl", as used herein, refers to an alkyl radical in which one of the hydrogen atoms of the radical is replaced by a -Si(CH3)3 group. The term "C2-Cn alkenyl," as used herein, refers to a linear or branched alkenyl chain having two or more carbon atoms and one or two double bonds, for example, ethenyl, prop-1-enyl, but-2-enyl. The term "C2-Cn haloalkenyl," as used herein, refers to a C2-Cn alkenyl moiety substituted with one or more halogen atoms, which may be the same or different. The term "C2-Cn alkynyl", as used herein, refers to a linear or branched alkynyl chain having two or more carbon atoms and a triple bond, e.g., ethynyl, prop-2-ynyl, but-3-ynyl. The term "C2-Cn haloalkynyl", as used herein, refers to a C2-Cn alkynyl moiety substituted with one or more halogen atoms that may be the same or different. Halogen or "halo" generally refers to fluorine, chlorine, bromine, or iodine. This also applies, therefore, to halogen in combination with other meanings such as haloalkyl. The term "heteroaryl" as used herein refers to a 5- or 6-membered aromatic monocyclic ring having 1 to 3 independently selected heteroatoms of N, O, and S. Examples are heteroaryls J-1 to J-39 shown in Scheme J below. The preferred heteroaryls are pyridyl, pyrimidinyl, and pyrazolyl. Table J: Heteroaryl J-1 to J-39: The arrow on heteroaryls J-1 to J-39 represents the point of attachment to the rest of the compound. The expression "optionally substituted", as used herein, means that the group referred to is either unsubstituted or substituted by a specified substituent, e.g., "C3-C4 cycloalkyl is optionally substituted with 1 or 2 halogen atoms" means C3-C4 cycloalkyl, C3-C4 cycloalkyl substituted with 1 halogen atom and C3-C4 cycloalkyl substituted with 2 halogen atoms. The dashed line, as used herein, for example, in Qa, Qb, R4a, R4b and T, represents the connection / joining point to the rest of the compound. As used herein, the term "control" refers to reducing the number of pests, eliminating pests and / or preventing further damage by the pest in such a way as to reduce damage to a plant or a plant-derived product. As used herein, the term "pest" refers to insects and molluscs found in agriculture, horticulture, forestry, the storage of plant products (such as fruit, grain, and wood); and those pests associated with damage to man-made structures. The term pest encompasses all stages in the pest's life cycle. As used herein, the expression "effective amount" refers to the amount of the compound, or a salt thereof, which, after single or multiple applications, provides the desired effect. An expert in the field will readily determine an effective amount by using known techniques and observing the results obtained under similar circumstances. In determining the effective amount, several factors are considered, including but not limited to: the type of plant or derived product to be applied; the pest to be controlled and its life cycle; the specific compound applied; the type of application; and other relevant circumstances. As an expert in the field will appreciate, compounds of formula I contain a stereogenic center, which is indicated by an asterisk in the formula (I*) below: where A1, A2, A3, A4, A5, Q, R1, R2a, R2b, and R3 are as defined in the first aspect. The present invention covers both racemates and individual enantiomers. Compounds having a preferred stereochemistry are set out below. Particularly preferred compounds of the present invention are compounds of formula (I'): where A1, A2, A3, A4, A5, Q, R1, R2a, R2b, and R3 are as defined in the first aspect, as well as stereoisomers, enantiomers, and tautomers of compounds of formula (I), as well as agrochemically acceptable N-oxides and salts thereof. Embodiments according to the invention are provided as set forth below. In an embodiment of each aspect of the invention, A1, A2 and A3 are as defined below: A. A1, A2 and A3 are, independently of each other, N or CRY; or A1=A2-A3, taken together, are NR-C (=X0) -N; where X0 is O or S; B. A1, A2, and A3 are, independently of each other, N or CRY, with the condition that no more than two of the three are N; or A1=A2-A3, taken together, are NR-C (=X0) -N; or C. A1 and A3 are N, and A2 is CRY; or A1=A2-A3, taken together, are NR-C (=O) -N; or D. A1, A2 and A3 are, independently of each other, N or CH; or A1=A2-A3, taken together, are NR-C (=O) -N; either E. A1, A2, and A3 are, independently of each other, N or CH, provided that no more than two of the three are N; or A1=A2-A3, taken together, are NH-C (=O) -N; or F. A1 is N, and A2 and A3 are CH; or A1=A2-A3, taken together, are NH-C (=O)-N; either G. A1 and A2 are CH, and A3 is N; or A1=A2-A3, taken together, are NR-C (=O)-N; either H. A1 and A3 are N, and A2 is CH; or A1=A2-A3, taken together, are NH-C (=O)-N; either I. A1, A2 and A3 are, independently of each other, N or CRY, on the condition that no more than two of the three are N; or J. A1 and A3 are N, and A2 is CRY; or K. A1, A2 and A3 are, independently of each other, N or CH; or L. A1, A2 and A3 are, independently of each other, N or CH, on the condition that no more than two of the three are N; or M. A1 is N, and A2 and A3 are CH; or N. A1 and A2 are CH, and A3 is N; or O. A1 and A3 are N, and A2 is CH; or Q. A1=A2-A3, taken together, are NR-C (=X0)-N; either Q. A1=A2-A3, taken together, are N (CH3) -C (=X0) -N; either A. A1=A2-A3, taken together, are NH-C (=X0) -N; either S. A1=A2-A3, taken together, are NR-C (=O)-N; either T. A1=A2-A3, taken together, are N (CH3) -C (=O) -N; either U. A1=A2-A3, taken together, are NH-C (=O)-N; either V. A1=A2-A3, taken together, are NR-C (=S)-N; either W. A1=A2-A3, taken together, are NH-C (=S)-N; either X.A1=A2-A3, taken together, are N (CH3) -C (=S) -N. In an implementation of each aspect of the invention, A: X0 is O or S; or B. X0 is O; or C. X0 is S. In an implementation of each aspect of the invention, A. A4 is CRY, and A5 is N; or B. A4 is CRY, and A5 is CH; or C. A4 is CH, and A5 is N; or D. A4 is N, and A5 is CH; or E. A4 and A5 are both CH. In an implementation of each aspect of the invention, A. is N, A2 and A3 are CH, and A4 and A5 are both CH; or B. A1 and A2 are CH, A3 is N, and A4 and A5 are both CH; or C. A1 and A3 are N, A2 is CH, and A4 is CRY and A5 is CH; or D. A1 and A3 are N, A2 is CH, and A4 is CH and A5 is N; or E. A1 and A3 are N, A2 is CH, and A4 is N and A5 is CH; or F. A1 and A3 are N, A2 is CH, and A4 is N or CH and A5 is CH; or G. A1 and A3 are N, A2 is CH, and A4 is CH and A5 is N or CH; or H. A1 and A3 are N, A2 is CH, and A4 and A5 are both N; or I. A1 and A3 are N, A2 is CH, and A4 and A5 are both CH; or J. A1=A2-A3, taken together, are NR-C (=O) -N and A4 and A5 are both CH; or K. A1=A2-A3, taken together, are N (CH3) -C (=O) -N and A4 and A5 are both CH; either L. A1=A2-A3, taken together, are NH-C (=O)-N and A4 and A5 are both CH. In an embodiment of each aspect of the invention, R is A. hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, or C1-C3 haloalkoxy; or B. hydrogen, methyl, ethyl, difluoroethyl or trifluoroethyl; or C. hydrogen; methyl, ethyl, 2,2-difluoroethyl or 2,2,2,-trifluoroethyl or D. hydrogen; or E. methyl, or 2, 2, 2, -trifluoroethyl; either F. methyl; or G. methyl or hydrogen. In an embodiment of each aspect of the invention, R1 is A. hydrogen, C1-C6 alkyl, C1-C6 cyanoalkyl, C1-C6 aminocarbonyl alkyl, C1-C6 hydroxycarbonyl alkyl, C1-C6 nitroalkyl, C1-C6 trimethylsilane alkyl, C1-C3 alkoxy C1-C6 alkoxy, C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C3-C4 cycloalkyl C1-C2-alkyl or C3-C4 cycloalkyl C1-C2-alkyl where the C3-C4 cycloalkyl group is substituted with 1 or 2 halogen atoms, oxethan-3-yl-CH2-, C1-C6 alkylcarbonyl, C1-C6 alkoxycarbonyl, phenyloxycarbonyl, benzyloxycarbonyl, benzyl or benzyl substituted with 1 to 3 substituents independently selected from halogen, C1-C6 alkoxy and C1-C6 haloalkyl; or B. hydrogen, C1-C6 alkyl, C1-C6 cyanoalkyl, C1-C6 aminocarbonylalkyl, C1-C6 hydroxycarbonylalkyl, C1-C6 nitroalkyl, C1-C6 trimethylsilane-alkyl, C1-C3 alkoxy-C1-C6 alkoxy, C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C3-C4 cycloalkyl-C1-C2 alkyl, C3-C4 cycloalkyl-C1-C2 alkyl- where the C3-C4 cycloalkyl group is substituted with 1 or 2 halogen atoms, oxethan-3-yl-CH2-, phenyloxycarbonyl, benzyloxycarbonyl, or benzyl; or C. hydrogen, C1-C6 alkyl, C1-C6 cyanoalkyl, C1-C6 aminocarbonylalkyl, C1-C6 hydroxycarbonylalkyl, C1-C6 nitroalkyl, C1-C6 trimethylsilanealkyl, C1-C3 alkoxy-C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C3-C4 cycloalkyl-C1-C2 alkyl, benzyloxycarbonyl, or benzyl; or D. hydrogen, C1-C6 alkyl, C1-C6 cyanoalkyl, C1-C6 aminocarbonyl-alkyl, C1-C6 hydroxycarbonyl-alkyl, C1-C3 alkoxy-C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C3-C4 cycloalkyl-C1-C2 alkyl, benzyloxycarbonyl, or benzyl; or E. hydrogen, C1-C6 alkyl, C1-C6 cyanoalkyl, C1-C3 alkoxy-C1-C6 alkyl, C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C3-C4 cycloalkyl-C1-C2 alkyl, benzyloxycarbonyl, or benzyl; or F. hydrogen, C1-C3 alkyl, C1-C3 cyanoalkyl, C1-C3 alkoxy-C1-C3 alkyl, C1-C3 haloalkyl, C2-C4 alkenyl, C2-C4 haloalkenyl, C2-C4 alkynyl, C2-C4 haloalkynyl, C3-C4 cycloalkyl-C1-C2 alkyl, benzyloxycarbonyl, or benzyl; or G. hydrogen, C1-C3 alkyl, C1-C3 cyanoalkyl, C1-C3 alkoxy-C1-C3 alkyl, C1-C3 haloalkyl, C2-C4 alkenyl, C2-C4 haloalkenyl, C2-C4 alkynyl, C2-C4 haloalkynyl, C3-C4 cycloalkyl-C1-C2 alkyl, benzyloxycarbonyl, or benzyl; or H. hydrogen, methyl, ethyl, cyanomethyl, methoxymethyl, cyclopropylmethyl, allyl, propargyl, benzyloxycarbonyl, or benzyl; or I. hydrogen, methyl or cyclopropyl-methyl; J. hydrogen; or K. hydrogen. In an embodiment of each aspect of the invention, R2a is A. hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkylsulfanyl, C1-C3 alkoxy, C1-C3 haloalkoxy, halogen, NO2, SF5, CN, C(O)NH2, C(O)OH, C(S)NH2, C3-C6 cycloalkyl, C3-C6 cycloalkyl substituted with one to three substituents selected independently of Rx, C3-C6 cycloalkylcarbonyl, phenyl, phenyl substituted with one to three substituents selected independently of Rx, heteroaryl, heteroaryl substituted with one to three substituents selected independently of Rx, OR6, piperidin-2-one-1-yl, piperidin-2-one-1-yl substituted with one to two substituents selected independently of Rx, pyridin-2-one-1-yl, pyridin-2-one-1-yl substituted with one to two substituents selected independently of Rx, azetidin-1-yl, azetidin-1-yl substituted with one to two substituents selected independently of Rx, pyrrolidin-1-yl,pyrrolidin-1-yl substituted with one to two substituents selected independently of Rx, C3-C6 cycloalkyl-C1-C4 alkyl, C3-C6 cycloalkyl-C1-C4 alkyl substituted with one to two substituents selected independently of Rx, C3-C6 cycloalkyl-C1-C3 alkoxy, C3-C6 cycloalkyl-C1-C3 alkoxy substituted with one to two substituents selected independently of Rx, C1-C5 cyanoalkyl, C1-C5 cyanoalkoxy, C1-C4 alkylsulfanyl, C1-C4 alkylsulfanyl substituted with one to three substituents selected independently of Rx, C1-C4 alkylsulfonyl, C1-C4 alkylsulfonyl substituted with one to three substituents selected independently of Rx, C1-C4 alkylsulfinyl, and C1-C4 alkylsulfinyl substituted with one to three substituents selected independently of Rx; or, B. halogen, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, phenyl, heteroaryl selected from J-1 to J-39, each of C3-C4 cycloalkyl, phenyl or heteroaryl, independently of each other, is substituted with one to three RX substituents; OR6, piperidin-2-one-1-yl, pyridin-2-one-1-yl, azetidin-1-yl optionally substituted with RX, pyrrolidin-1-yl, C3-C6 cycloalkyl-C1-C4 alkyl optionally substituted with RX, C3-C6 cycloalkyl-C1-C3 alkoxy optionally substituted with RX, C1-C5 cyanoalkyl, C1-C5 cyanoalkoxy, C1-C4 alkylsulfonyl optionally substituted with RX, or C1-C4 alkylsulfinyl optionally substituted with RX; or C. halogen, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, phenyl, heteroaryl selected from J-1 and J-25, each independent of the other, being substituted with one to three RX substituents; OR6, piperidin-2-one-1-yl, pyridin-2-one-1-yl, azetidin-1-yl optionally substituted with RX, pyrrolidin-1-yl, C3-C6 cycloalkyl-C1-C4 alkyl optionally substituted with RX, C3-C6 cycloalkyl-C1-C3 alkoxy optionally substituted with RX, C1-C5 cyanoalkyl, C1-C5 cyanoalkoxy, C1-C4 alkylsulfonyl optionally substituted with RX, or C1-C4 alkylsulfinyl optionally substituted with RX; or D. halogen, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, phenyl, pyrazolyl, each of C3-C4 cycloalkyl, phenyl, pyrazolyl, independently of each other, is substituted with one to three RX substituents; OR6, piperidin-2-one-1-yl, pyridin-2-one-1-yl, azetidin-1-yl optionally substituted with RX, pyrrolidine-1-yl, C3-C6 cycloalkyl-C1-C4 alkyl optionally substituted with RX, C3-C6 cycloalkyl-C1-C3 alkoxy optionally substituted with RX, C1-C5 cyanoalkyl, C1-C5 cyanoalkoxy, C1-C4 alkylsulfonyl optionally substituted with RX, or C1-C4 alkylsulfinyl optionally substituted with RX; or E. halogen, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, phenyl or pyrazolyl, each of C3-C4 cycloalkyl, phenyl, pyrazolyl, independently of each other, is substituted with one to two RX, OR6, azetidine-1-yl substituents optionally substituted with RX, C3-C6 cycloalkyl-C1-C4 alkyl optionally substituted with RX, C3-C6 cycloalkyl-C1-C3 alkoxy optionally substituted with RX, C1-C4 alkylsulfonyl optionally substituted with RX, or C1-C4 alkylsulfinyl optionally substituted with RX; or F. halogen, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, C3-C4 cycloalkyl substituted with one to two RX substituents; OR6, C3-C6 cycloalkyl-C1-C4 alkyl, C3-C6 cycloalkyl-C1-C4 alkyl substituted with RX, C1-C4 alkylsulfonyl, C1-C4 alkylsulfonyl substituted with RX, C1-C4 alkylsulfinyl, or C1-C4 alkylsulfinyl substituted with RX; or G. halogen, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, C3-C4 cycloalkyl substituted with one to two halogens, C1-C3 alkyl, or C1-C3 haloalkyl; C3-C4 cycloalkylmethyl, C3-C4 cycloalkylmethyl substituted with one to two halogens, C1-C3 alkyl, or C1-C3 haloalkyl; or C1-C2 alkylsulfonyl substituted with one to three halogens; or H. halogen, C1-C3 alkyl, C1-C3 haloalkyl, cyclopropyl, cyclopropyl substituted with one to two halogens, methyl, or trifluoromethyl, cyclopropylmethyl substituted with one to two halogens, or trifluoromethyl; or C1-C2 alkylsulfonyl substituted with one to three halogens; or I. halogen, C1-C3 haloalkyl, cyclopropyl substituted with one to two fluorine, methyl, or trifluoromethyl, cyano, cyclopropylmethyl substituted with one to two fluorine, or trifluoromethylsulfonyl; or J. halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkylthio, C1-C3 alkoxy, C1-C3 haloalkoxy, CN, C3-C6 cycloalkyl, C3-C6 cycloalkyl substituted with one to three substituents independently selected from C1-C3 alkyl, C1-C3 haloalkyl, cyano, and halogen; C3-C6 cycloalkyl-C1-C4 alkyl, C3-C6 cycloalkyl-C1-C4 alkyl substituted with one to five substituents independently selected from C1-C3 alkyl, C1-C3 haloalkyl, cyano, and halogen; C1-C5 cyanoalkyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylsulfinyl, C1-C4 haloalkylsulfinyl, C3-C6 cycloalkylsulfonyl, C3-C6 cycloalkylsulfinyl, or C3-C6 cycloalkylsulfonyl; either K. halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkylthio, C1-C3 alkoxy, C1-C3 haloalkoxy, CN, C3-C6 cycloalkyl, C3-C6 cycloalkyl substituted with one or two substituents independently selected from C1-C3 haloalkyl, cyano, and halogen; C3-C6 cycloalkyl-C1-C4 alkyl, C3-C6 cycloalkyl-C1-C4 alkyl substituted with one to three substituents independently selected from C1-C3 haloalkyl, cyano, and halogen; C1-C5 cyanoalkyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylsulfinyl, C1-C4 haloalkylsulfinyl, C3-C6 cycloalkylsulfonyl, C3-C6 cycloalkylsulfinyl, or C3-C6 cycloalkylsulfonyl; or L.halogen, C1-C3 haloalkyl, C1-C3 haloalkylthio, C1-C3 haloalkoxy, C3-C6 cycloalkyl, C3-C6 cycloalkyl substituted with one or two substituents independently selected from C1-C3 haloalkyl, cyano and halogen; C3-C6 cycloalkyl C1-C4 alkyl, C3-C6 cycloalkyl C1-C4 alkyl substituted with one to three substituents independently selected from C1-C3 haloalkyl, cyano, and halogen, C1-C5 cyanoalkyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylsulfinyl, C1-C4 haloalkylsulfinyl, C3-C6 cycloalkylsulfanyl, C3-C6 cycloalkylsulfinyl, or C3-C6 cycloalkylsulfonyl; or. M. halogen or C1-C3 haloalkyl; or N. chloro, fluorine, bromine, difluoromethyl, or trifluoromethyl; either O. fluorine, chlorine, bromine, or trifluoromethyl; either P. trifluoromethyl; or Q. chlorine or trifluoromethyl; R. chlorine, bromine, iodine or trifluoromethyl. In an embodiment of each aspect of the invention, R2b is A. hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkylsulfanyl, C1-C3 alkoxy, C1-C3 haloalkoxy, halogen, NO2, SF5, CN, C(O)NH2, C(O)OH, C(S)NH2, C3-C6 cycloalkyl, C3-C6 cycloalkyl substituted with one to three substituents selected independently of Rx, C3-C6 cycloalkylcarbonyl, phenyl, phenyl substituted with one to three substituents selected independently of Rx, heteroaryl, heteroaryl substituted with one to three substituents selected independently of Rx, OR6, piperidin-2-one-1-yl, piperidin-2-one-1-yl substituted with one to two substituents selected independently of Rx, pyridin-2-one-1-yl, pyridin-2-one-1-yl substituted with one to two substituents selected independently of Rx, azetidin-1-yl, azetidin-1-yl substituted with one to two substituents selected independently of Rx, pyrrolidin-1-yl,pyrrolidine-1-yl substituted with one to two substituents selected independently of Rx, C3-C6 cycloalkyl-C1-C4 alkyl, C3-C6 cycloalkyl-C1-C4 alkyl substituted with one to two substituents selected independently of Rx, C3-C6 cycloalkyl-C1-C3 alkoxy, C3-C6 cycloalkyl-C1-C3 alkoxy substituted with one to two substituents selected independently of Rx, C1-C5 cyanoalkyl, C1-C5 cyanoalkoxy, C1-C4 alkylsulfanyl, C1-C4 alkylsulfanyl substituted with one to three substituents selected independently of Rx, C1-C4 alkylsulfonyl, C1-C4 alkylsulfonyl substituted with one to three substituents selected independently of Rx, C1-C4 alkylsulfinyl, and C1-C4 alkylsulfinyl substituted with one to three substituents selected independently of Rx; or, B. halogen, C1-C3 haloalkyl, C1-C3 haloalkylthio, C1-C3 alkoxy, C1-C3 haloalkoxy, or CN; either C. halogen, C1-C3 haloalkyl, or C1-C3 haloalkoxy; or D. halogen or C1-C3 haloalkyl; or E. chloro, fluorine, bromine, difluoromethyl, or trifluoromethyl; either F. fluorine, chlorine, bromine, or trifluoromethyl; either G. trifluoromethyl; or H. chloro or trifluoromethyl; or I. chlorine, bromine, iodine or trifluoromethyl. In an embodiment of each aspect of the invention, R3 is A. C1-C3 alkyl or C1-C3 haloalkyl; or B. methyl or trifluoromethyl; either C. methyl. In an embodiment of each aspect of the invention, Q is TO. either B. Qa where R4 is R4a or R4b; either C. Qa where R4 is R4a; or D. Qa where R4 is R4b; or E. Qb where R4 is R4a or R4b; either F. Qb where R4 is R4a; or G. Qb where R4 is R4b. In an embodiment of each aspect of the invention, Qa is A. selected from QA-1 to QA-16; or B. selected from QA-1, QA-6, QA-7, QA-10, and QA-15; or C. QA-1 or QA-15; or D. selected from QA-1 to QA-16, where R4 is R4a; or E. selected from QA-1 to QA-16, where R4 is R4b; or F. selected from QA-1, Qa-6, Qa-7, QA-10, and QA-15; where R4 is R4a; or G. selected from QA-1, Qa-6, Qa-7, QA-10, and QA-15; where R4 is R4b; or H. QA-1 or QA-15, where R4 is R4a; or I. QA-1 or QA-15, where R4 is R4b; J. QA-1 and R4 is R4a or R4b, In an embodiment of each aspect of the invention, Qb is A. selects QB-1 through QB-13; either B. QB-1; or C. is selected from QB-1 to QB-13, where R4 is R4a; or D. is selected from QB-1 to QB-13, where R4 is R4b; either E. QB-1, and R4 is R4a; or F. QB-1, and R4 is R4a. In an embodiment of each aspect of the invention, R4 is TO. , where the zigzag line represents the connection from R4 to Qa or Qb; and where A14, A24, and A34 are, independently of each other, N or CH; or B. where the zigzag line represents the connection from R4 to Qa or Qb; and where A14, A24, and A34 are, independently of each other, N or CH; or where the zigzag line represents the connection of R4 to Qa or Qb; and where A14 is N or CH. In an embodiment of each aspect of the invention, where R4 is R4a and A. A14, A24, and A34 are, independently of each other, N or CH, provided that at least one is N; or A14, A24, and A34 are, independently of each other, N or CH, provided that one is N and the other two are CH; or B. A14, A24, and A34 are, independently of each other, N or CH, provided that at least one is CH; or C. A14, A24, and A34 are, independently of each other, N or CH, on the condition that one is CH and the other two are N; D. A14 is N, A24 is N or CH, and A34 is N or CH; or E. A14 is N or CH, A24 is N, and A34 is N or CH; or F. A14 is N or CH, A24 is N or CH, and A34 is N; or G. A14 is CH, A24 is N or CH, and A34 is N or CH; or H. A14 is N or CH, A24 is CH, and A34 is N or CH; or I. A14 is N or CH, A24 is N or CH, and A34 is CH; or J. A14 is N, A24 is N, and A34 is N or CH; or K. A14 is N, A24 is CH, and A34 is N or CH; or L. A14 is CH, A24 is N, and A34 is N or CH; or M. A14 is CH, A24 is CH, and A34 is N or CH; or N. A14 is N, A24 is N or CH, and A34 is N; or O. A14 is N, A24 is N or CH, and A34 is CH; or P. A14 is CH, A24 is N or CH, and A34 is N; or Q. A14 is CH, A24 is N or CH, and A34 is CH; or R. A14 is N or CH, A24 is N, and A34 is N; or S. A14 is N or CH, A24 is N, and A34 is CH; or T. A14 is N or CH, A24 is CH, and A34 is N; or U. A14 is N or CH, A24 is CH, and A34 is CH; or V. A14 is N, A24 is N, and A34 is N; or W. A14 is N, A24 is N, and A34 is CH; or X. A14 is N, A24 is CH, and A34 is N; or And. A14 is CH, A24 is N, and A34 is N; or Z. A14 is N, A24 is CH, and A34 is CH; or AA. A14 is CH, A24 is N, and A34 is CH; or BB. A14 is CH, A24 is CH, and A34 is N; or CC. A14 is CH, A24 is CH, and A34 is CH; DD. A14 is CH, A24 is CH and A34 is CH. In an embodiment of each aspect of the invention, where R4 is R4b A. A14 is CH; or B. A14 is N. In one embodiment of each aspect of the invention, R4a is an oxo-triazinyl moiety, or an oxo-diazinyl moiety, or an oxo-pyridyl moiety. Preferably, R4a is an oxo-diazinyl moiety. In one embodiment of each aspect of the invention, R4a is an oxopyridyl, oxopyrimidyl, oxopyrazinyl, or oxopyridazinyl moiety. In one embodiment of each aspect of the invention, R4b is an oxo-dihydro-pyridyl or oxo-dihydro-pyridazinyl moiety. R4a and R4b are each connected via a carbon atom in the respective ring to the compound moiety ("the connecting carbon atom"). The connecting carbon atom and the carbonyl group C=O are in a position relative to each other in the oxopyridyl, oxopyrimidyl, oxopyrazinyl, or oxopyridazinyl moiety. R4a and R4b have a nitrogen atom substituted in an ortho position with respect to the carbonyl group C=O. This substituted nitrogen atom is substituted with R4c.In one embodiment of each aspect of the invention, R4a is an oxopyridyl moiety (A14, A24, and A34 are CH, i.e., R4a is of the DD embodiment). In one embodiment of each aspect of the invention, R4a has an unsubstituted nitrogen atom in the second ortho position with respect to the carbonyl group C=O. In this case, R4a is an oxopyrimidyl moiety (A14 and A24 are CH, and A34 is N, i.e., R4a is of the CC embodiment), where the carbonyl group C=O is between the two nitrogen atoms of the ring. In one embodiment of each aspect of the invention, R4a has an unsubstituted nitrogen atom in the meta position with respect to the carbonyl group C=O. In this case, R4a is an oxopyrazinyl residue (A14 and A34 are CH, A24 is N, i.e., R4a is of embodiment BB) or an oxopyridazinyl residue (A14 is N, A24 and A34 are CH, i.e., R4a is of embodiment AA).In one embodiment of each aspect of the invention, R4a is an oxopyridazinyl moiety (A14 is N, A24 and A34 are CH, i.e., R4a is of embodiment AA). In one embodiment of each aspect of the invention, R4b is an oxo-dihydropyridazinyl moiety (A14 is N, i.e., R4b is of embodiment A). In one embodiment of each aspect of the invention, R4b is an oxo-dihydropyridyl moiety (A14 is CH, i.e., R4b is of embodiment A). In an embodiment of every aspect of the invention, R4c is A. C1-C3 alkyl, C1-C3 haloalkyl, allyl, propargyl, or C3-C6 cycloalkyl-C1-C4 alkyl; or B. C1-C2 alkyl, C1-C2 haloalkyl, allyl, propargyl, or C3-C4 cycloalkyl-C1-C2 alkyl; or C. methyl, ethyl, difluoromethyl, 2,2-difluoroethyl, 2,2,2-trifluoromethyl, allyl, propargyl, or cyclopropylmethyl; or D. methyl, ethyl, difluoromethyl, 2,2-difluoroethyl, allyl, propargyl, or cyclopropylmethyl; either E. methyl, ethyl, allyl, propargyl, or cyclopropylmethyl; either F. methyl or ethyl; or G. methyl or allyl; or H. methyl or propargyl; or I. methyl or cyclopropylmethyl; either J. methyl. In an embodiment of each aspect of the invention, where Q is Qa, R5 is A. hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, C1-C3 alkoxy, C3-C4 alkoxy-C(O)-, (C1-C3 alkoxy)2CH-, halogen, CN, NH2C(O)-, amino (i.e., NH2), (C1-C3 alkyl)amino, di(C1-C3 alkyl)amino, hydroxyl, C3-C4 halocycloalkyl, C3-C4 cyanocycloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C1-C4 haloalkylsulfanyl, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylsulfanyl, alkylsulfinyl C1-C4, C1-C4 alkylsulfonyl, C1-C3 alkoxy-C1-C3 alkyl, C1-C3 alkoxy-C1-C3 alkoxy-C1-C3 alkyl, (C1-C3 alkyl)sulfonylamino, (C1-C3 alkyl)sulfonyl (C1-C3 alkyl)amino, (C1-C3 alkyl) NHC (O) , (C1-C3 alkyl) 2NC (O) , (C1-C3 cycloalkyl) NHC (O) , (C1-C3 cycloalkyl) (C1-C3 alkyl) NC (O) , (C1-C3 alkyl) C (O) (C1-C3 alkyl) N, (C1-C3 alkyl) C (O) NH, (C1-C3 alkyl) C (O) , (C1-C3 alkoxy) C (O) , HC (O) , diphenylmethanimine, C1-C3 haloalkoxy, phenyl, or a 5-membered heteroaromatic ring;or R5 is phenyl substituted with one to three substituents selected from C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C3-C4 cycloalkyl, halogen, CN and hydroxyl; or R5 is a 5-membered heteroaromatic ring substituted with one to three substituents selected from C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C3-C4 cycloalkyl, halogen, CN and hydroxyl; or; B. hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, C1-C3 alkoxy, halogen, C1-C3 alkoxy-C1-C3 alkyl, C1-C3 alkoxy-C1-C3 alkoxy-C1-C3 alkyl, (C1-C3 alkyl)C(O), (C1-C3 alkoxy)C(O), HC(O), C1-C3 haloalkoxy or a 5-membered heteroaromatic ring wherein the 5-membered heteroaromatic ring may be optionally substituted with one to three substituents selected from C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C3-C4 cycloalkyl, halogen, CN or hydroxyl; or C. hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, C1-C3 alkoxy, halogen, C1-C3 alkoxy-C1-C3 alkyl, C1-C3 alkoxy-C1-C3 alkoxy-C1-C3 alkyl, (C1-C3 alkyl) C (O) , (C1-C3 alkoxy) C (O) , HC (O) or C1-C3 haloalkoxy; or D. hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, C1-C3 alkoxy, halogen, Cl, Br, C1-C3 alkoxy-C1-C3 alkyl, C1-C3 alkoxy-C1-C3 alkoxy-C1-C3 alkyl, (C1-C3 alkyl) C (O) , (C1-C3 alkoxy) C (O) or C1-C2 haloalkoxy; or E. hydrogen, C1-C3 alkyl, C1-C3 alkoxy, C3-C4 cycloalkyl, C1-C3 haloalkoxy, halogen, C1-C3 alkoxy-C1-C3 alkyl, C1-C3 alkoxy-C1-C3 alkoxy-C1-C3 alkyl, (C1-C3 alkyl) C (O) , HC (O) or (C1-C3 alkoxy) C (O) ; or F. hydrogen, C1-C2 alkyl, C1-C2 alkoxy, C3-C4 cycloalkyl, C1-C2 haloalkoxy, halogen, C1-C2 alkoxy-C1-C2 alkyl, C1-C2 alkoxy-C1-C2 alkoxy-C1-C2 alkyl, (C1-C2 alkyl) C (O) , HC (O) , or (C1-C2 alkoxy) C (O) ; or G. hydrogen, methyl, trifluoromethoxy, methoxy, cyclopropyl, 2,2-difluroroethoxy, 2,2,2-trifluroroethoxy, difluoromethoxy, 2,2,2-trifluroroethyl, chloro, bromo, methoxyethoxy, methylcarbonyl or methoxycarbonyl; either H. hydrogen, methyl, trifluoromethoxy, methoxy, cyclopropyl, difluoromethoxy, chloro, bromine, methoxyethoxy, methylcarbonyl, or methoxycarbonyl; either I. hydrogen, methyl, methoxyl, cyclopropyl, chlorine, or methoxyethoxyl; or J. hydrogen, or methyl; or K. hydrogen. In an embodiment of each aspect of the invention, where Q is Qb, R5a is A. hydrogen, halogen, CN, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, C1-C3 alkoxy or C1-C3 haloalkoxy; or B. hydrogen, halogen, CN, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl or C1-C3 alkoxy; or C. hydrogen, halogen, CN, C1-C3 alkyl, C1-C3 haloalkyl or C1-C3 alkoxy; or D. hydrogen, halogen, CN, C1-C3 alkyl or C1-C3 alkoxy; or E. hydrogen or halogen; or F. hydrogen. In an embodiment of each aspect of the invention, where Q is Qb, R5b is A. hydrogen, halogen, CN, C1-C3 haloalkyl, C3-C4 cycloalkyl, C1-C3 alkoxy or C1-C3 haloalkoxy; or B. hydrogen, halogen or C1-C3 alkoxy; or C. hydrogen. In an embodiment of each aspect of the invention, R6 is A. phenyl, benzyl, heteroaryl or C3-C6 cycloalkyl, each of which, independently of each other, is optionally substituted with a substituent selected from RX; or B. phenyl, benzyl, cyclopropyl or cyclopropyl substituted with a substituent selected from RX. In an embodiment of each aspect of the invention, RX is selected independently of: A. halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy, NO2, SF5, CN, C(O)NH2, C(S)NH2, C1-C4 haloalkylsulfanyl, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylsulfanyl, C1-C4 alkylsulfinyl and C1-C4 alkylsulfonyl; or B. halogen, C1-C3 haloalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy or CN; either C. F, Cl, Br, OCF2H, OCH3 or CN. In an embodiment of each aspect of the invention, RY is selected independently from: A. hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, hydroxyl, C1-C3 alkoxy, C1-C3 haloalkoxy, halogen, CN and cyclopropyl; or B. hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy, halogen, CN and cyclopropyl; or C. hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy and cyclopropyl; or D. hydrogen, C1-C3 alkyl, chlorine, C1-C3 haloalkyl, and C1-C3 alkoxy; or E. hydrogen, chlorine, methyl, trifluoromethyl, and methoxyl; or F. hydrogen, chlorine, methyl; or G. chlorine, hydrogen. In an embodiment of each aspect of the invention, RZ is selected independently from: A. oxo, halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy and CN; or B. oxo, halogen, C1-C3 haloalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy or CN; either C. oxo, F, Cl, Br, OCF2H, OCH3 or CN. Accordingly, the present invention makes available a compound of formula (I) having the substituents A1, A2, A3, A4, A5, x0, Qa, Qb, R, R1, R2a, R2b, R3, R4c, R5, R5a, R5b, R6, RX, RY, and RZ as defined above in all combinations / each permutation. Accordingly, a compound of formula (I) is made available, for example, with A1, A2, and A3 of embodiment S (i.e., A1=A2-A3, taken together, are NR-C(=O)-N), A4 and A5 of embodiment E (i.e., A4 and A5 are both CH), R of embodiment B (i.e., R is hydrogen, methyl, ethyl, difluoroethyl, or trifluoroethyl), R1 of embodiment I (i.e., R1 is hydrogen, methyl, or cyclopropylmethyl), R2a of embodiment M (i.e., R2a is a halogen or C1-C3 haloalkyl), such as R2a of embodiment O (i.e., R2a is fluorine, chlorine, bromine, or trifluoromethyl), R2b of embodiment E (i.e., R2b is chlorine, fluorine, bromine, difluoromethyl, or trifluoromethyl), R3 of embodiment B (i.e., R3 is methyl or trifluoromethyl), Q of embodiment C (i.e., Q is Qa where R4 is R4a), where Qa is of embodiment H (i.e., Qa is QA-1 or QA-15), R4a is of embodiment I (i.e., A14 is N or CH, A24 is CH, and A34 is N or CH), R4c of embodiment G (i.e.,R4c is methyl or allyl) ., Furthermore, a compound of formula (I) is made available, for example, with A1, A2, and A3 of embodiment J (i.e., A1 and A3 are N, and A2 is CRY), with RY of embodiment F (i.e., RY is hydrogen, chlorine, methyl), A4 and A5 of embodiment E (i.e., A4 and A5 are both CH), R1 of embodiment F (i.e., R1 is hydrogen, C1-C3 alkyl, C1-C3 cyanoalkyl, C1-C3 alkoxy-C1-C3 alkyl, C1-C3 haloalkyl, C2-C4 alkenyl, C2-C4 haloalkenyl, C2-C4 alkynyl, C2-C4 haloalkynyl, C3-C4 cycloalkyl-C1-C2 alkyl, benzyloxycarbonyl, or benzyl), such as R2a of embodiment M (i.e., R2a is a halogen or C1-C3 haloalkyl), R2b of embodiment C (i.e., R2b is a halogen, C1-C3 haloalkyl, or C1-C3 haloalkoxy), R3 of embodiment C (i.e., R3 is methyl), Q of embodiment C (i.e., Q is Qa where R4 is R4a), where Qa is QA-1, R4a is of embodiment AA (i.e., A14 is N, A24 is CH, and A34 is CH), R4c of embodiment I (i.e.,R4c is methyl or cyclopropylmethyl., Furthermore, a compound of formula (I) is made available, for example, with A1, A2 and A3 of embodiment C (i.e., A1 and A3 are N, and A2 is CRY); or A1=A2- A3, taken together, are NR-C (=O) -N), with RY of embodiment G (i.e., RY is hydrogen or chlorine) and R of embodiment G (i.e., R is methyl or hydrogen), A4 and A5 of embodiment E (i.e., A4 and A5 are both CH), R1 of embodiment J (i.e., R1 is hydrogen or methyl); R2a of embodiment R (i.e., R2a is chlorine, bromine, iodine or trifluoromethyl), R2b of embodiment I (i.e., R2b is chlorine, bromine, iodine or trifluoromethyl), R3 of embodiment C (i.e., R3 is methyl), Q of embodiment B (i.e., Q is Qa, where R4 is R4a or R4b), where Qa is QA-1, R4a is of embodiment AA (i.e., A14 is N, A24 is CH and A34 is CH), R4b is of embodiment B (i.e., A14 is N) and R4c of embodiment F (i.e., R4c is methyl or ethyl). In one embodiment, the compound of formula (I) is formula (I*a), (I*b), (I*c), (I*d), (I*e) or (I*f) (with the asterisk indicating a stereogenic center), where A1, A2, A3, A4, A5, R, R1, R2a, R2b, R3, R4c, R5, R5a, R5b, and RY are as defined in the first aspect, each with corresponding embodiments as described above. In one embodiment, compounds having preferred stereochemistry represented by formula (I) would also be preferred to compounds of formulas (I*a), (I*b), (I*c), (I*d), (I*e), or (I*f). In a preferred embodiment, a compound of formula (Ia), (Ib), (Ic), (Id), (Ie), or (If) with the following stereochemistry is preferred: where A1, A2, A3, A4, A5, R, R1, R2a, R2b, R3, R4c, R5, R5a, R5b and RY are as defined in the first aspect, and stereoisomers, enantiomers, tautomers, and N-oxides, of compounds of formula (Ia), (Ib), (Ic), (Id), (Ie) or (If), and agrochemically acceptable salts thereof. Compounds of formula (I) can be prepared by those skilled in the art using known methods. More specifically, compounds of formula (I), and intermediate products thereof, can be prepared as described below in the schemes and examples. Certain stereogenic centers have been left unspecified for clarity and are not intended to limit the content of the schemes in any way. The procedure according to the invention for preparing compounds of formula I is carried out by methods known to those skilled in the art. Compounds of formula (I) where A1, A2, A3, A4, A5, R1, R3, Q, R2a and R2b have the same meaning as given above for compounds of formula (I), can be prepared by reaction of an amine of formula (III) or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride salt or a hydrobromide salt, or trifluoroacetic acid, or any other equivalent salt), wherein R1, R3 and Q have the same meaning given above for compounds of formula (I), with a compound of formula (II) where A1, A2, A3, A4, A5, R2a, and R2b have the same meaning given above for compounds of formula (I), and where X1 is a leaving group, such as a halogen, hydroxyl, or sulfonate. Throughout the description, for example in Schemes 1 to 11 below, or in Tables A-1 to A-78, Tables B-1 to B-78, Tables C-1 to C-21 and Tables D-1 to D-21, T represents where A1, A2, A3, A4, A5, R2a and R2b have the same meaning given above for compounds of formula (I) , and where the stepped line represents the connection to the rest of the compounds, such as the compounds of formula (I) , (Ia) , (Ib) , (Ic) , (Id) , (Ie) , (If) , (Ig) , (Ih) , (II) , (IV) , (IVa) , (X) , (XI) , (XVII) in Schemes 1 to 11. Scheme 1: Compounds of formula (I) can be prepared, for example, by reacting a compound of formula (II), where X1 is a leaving group, such as a halogen, hydroxyl, or sulfonate, e.g., chloride, and where T has the meaning given above, with a compound of formula (III), or a salt thereof, where R1, R3, and Q have the same meaning as given above for compounds of formula (I). In the case where X1 is a hydroxyl, it may be advantageous to carry out the reaction in the presence of a dehydrating reagent, e.g., a peptide coupling reagent, such as, for example, a carbodiimide or cyclic anhydride of propanophosphonic acid (T3P®).Such reactions can be carried out undiluted or in a solvent, preferably in a solvent such as an organic solvent, for example, acetonitrile, tetrahydrofuran, 2-methyltetrahydrofuran, ethyl acetate, N,N-dimethylacetamide or N,N-dimethylformamide in a temperature range of -100 to +300°C, preferably between room temperature and 200°C, with or without the presence of a catalyst, for example, a metal catalyst such as a palladium complex, and with or without the addition of a base, such as an inorganic base such as potassium carbonate, or an organic base such as, for example, triethylamine, diisopropylethylamine or pyridine. Compounds of formula (II) are either known or can be prepared by analogy to descriptions found, for example, in documents WO 2021 / 083936 and WO 2021 / 177160 or can be prepared by methods known to a person skilled in the art. Scheme 2: Compounds of formula (III) or a salt thereof, can be prepared, for example, as shown in scheme 2. The treatment of a compound of formula (V) , where R3 and Q have the same meaning as given above for compounds of formula (I) and where X2 is a leaving group, such as a halogen or sulfonate, for example bromide, with an amine of formula (XIX) , where R1 has the same meaning as given above for compounds of formula I, provides compounds of formula (III) , where Q, R1 and R3 have the same meaning as given above for compounds of formula I.The reaction can be carried out undiluted or in a solvent, preferably an organic solvent such as acetonitrile, over a temperature range of -100 to +300°C, preferably between room temperature and 200°C, with or without the addition of a base, such as an inorganic base such as potassium carbonate, or an organic base such as triethylamine. Alternatively, treating a compound of formula (VII), where R3 and Q have the same meaning as given above for compounds of formula (I), with an amine of formula (XIX), or a salt thereof, where R1 has the same meaning as given above for compounds of formula I, yields compounds of formula (III), where Q, R1, and R3 have the same meaning as given above for compounds of formula I.This reaction is carried out in the presence of a reducing agent, such as hydrogen or a hydride, such as sodium borohydride, with or without a catalyst, such as a hydrogenation catalyst, such as palladium on carbon, with or without an acid, such as acetic acid, or a Lewis acid, such as zinc bromide or titanium(IV) isopropoxide, in or without a solvent, such as methanol. The reaction can be carried out over a temperature range of -100 to +300°C, preferably between room temperature and 200°C. Such methods, and the range of conditions for carrying them out, are applicable to the alkylation of amines and to the reductive alkylation of amines (e.g., in the presence of NaBH(OAc)3 or NaBH3CN, in a suitable solvent, preferably acetic acid, at room temperature, analogously to WO2002 / 088073; or, alternatively, by using a combination of Ti(i-OiPr)4 and NaBH4 as described in Synthesis 2003 (14), 2206) are well known to a person skilled in the art. Amines of formula (XIX), or a salt thereof, where R1 has the same meaning as given above for compounds of formula (I), are either known or can be prepared by methods known to those skilled in the art. Scheme 3: Alternatively, compounds of formula (I) can be prepared, for example, by reacting the compound of formula (IV), where T has the same meaning as given above in Scheme 1, and R1 has the same meaning as given above for compounds of formula (I), with a compound of formula (V), where R3 and Q have the same meaning as given above for compounds of formula (I), and X2 is a leaving group, such as a halogen or sulfonate, for example, chloride or bromide. The reaction can be carried out undiluted or in a solvent, preferably in a solvent such as an organic solvent, for example, acetonitrile, in a temperature range of -100 to +300 °C, preferably between room temperature and 200 °C, with or without the addition of a base, such as an inorganic base, for example, potassium carbonate, or an organic base, such as, for example, triethylamine.These methods for the alkylation of amines, and the range of conditions for carrying them out, are well known to someone skilled in the art. Alternatively, a compound of formula (I) can be prepared by reacting a compound of formula (IVa), where T has the same meaning as given above in Scheme 1, with a compound of formula (VII), where R3 and Q have the same meaning as given above for compounds of formula (I). This reaction is carried out in the presence of a reducing agent, such as, for example, hydrogen or a hydride, such as sodium borohydride, with or without a catalyst, such as a hydrogenation catalyst, for example, palladium on carbon, with or without an acid, such as acetic acid or a Lewis acid, such as zinc bromide, in or without a solvent, such as, for example, methanol.The reaction can be carried out over a temperature range of -100 to +300°C, preferably between room temperature and 200°C. Such methods for the reductive alkylation of amines, and the range of conditions for carrying them out, are well known to a person skilled in the art. Scheme 4: Compounds of formula (V) can be prepared, for example, as shown in Scheme 4. Treatment of a compound of formula VIII with a halogenating agent, such as chlorine, bromine, or N-bromosuccinimide, for example, yields a compound of formula (V), where the leaving group X2 is a halogen, for example, chloride or bromide. This reaction is carried out with or without a solvent, preferably in a solvent, with or without an additive, such as a radical initiator, for example, benzoyl peroxide or azoisobutyronyryl. The reaction can be carried out abo with or without exposure to visible or ultraviolet light, and can be performed over a temperature range of -100 to +300 °C, preferably between room temperature and 200 °C. Alternatively, a compound of formula VII can be treated with a reducing agent, followed by reaction with a sulfonyl chloride, for example, methanesulfonyl chloride, to give a compound of formula V, where the leaving group X2 is a sulfonate, for example, a mesylate. This reaction can be carried out in a solvent, or without a solvent, in the presence of a base, such as an inorganic base, for example, potassium carbonate, or an organic base, such as an amine base, for example, trimethylamine, or without a base, and can be carried out over a temperature range of -100 to +300°C, preferably between room temperature and 200°C.A suitable reducing agent could be, for example, hydrogen, or a hydride such as sodium borohydride, with or without a catalyst, such as a hydrogenation catalyst, for example, palladium on carbon, with or without an acid, such as acetic acid, or a Lewis acid, such as zinc bromide, in or without a solvent, such as, for example, methanol. The reaction can be carried out over a temperature range of -100 to +300°C, preferably between room temperature and 200°C. Such methods for the halogenation, reduction of carbonyl compounds, and sulfonylation of alcohols, and the range of conditions for carrying them out, are well known to a person skilled in the art. Compounds of formula (VII) and compounds of formula (VIII) are either known or can be prepared by methods known to a person skilled in the art. Scheme 5: Alternatively, compounds of formula (Ib), where T has the same meaning as given above in Scheme 1 and R1, R3 and Q have the same meaning as given above for compounds of formula (I), except that R1 is other than hydrogen, can be made, for example, as shown in Scheme 5. A compound of formula (Ia), where T has the same meaning as given above in Scheme 1, and R3 and Q have the same meaning as given above for compounds of formula (I), can be reacted with a compound of formula (VI), where R1 has the same meaning as given above for compounds of formula (I) except that R1 is other than hydrogen, and where X3 is a leaving group, such as a halogen or sulfonate, for example, a chloride, bromide, iodide or mesylate, giving a compound of formula (Ib).This reaction can be carried out undiluted or in a solvent, preferably an organic solvent such as acetonitrile, N,N-dimethylformamide (DMF), or N,N-dimethylacetamide (DMA), at temperatures ranging from -100 to +300 °C, preferably between room temperature and 200 °C, with or without the addition of a base, such as an inorganic base such as sodium, potassium, or cesium carbonate, or an organic base such as triethylamine, diisopropylethylamine, or pyridine. Such methods for the alkylation of amines, and the range of conditions for carrying them out, are well known to a person skilled in the art. Compounds of formula (VI) , wherein R1 has the same meaning as that given above for compounds of formula (I) , except that R1 is different from hydrogen, and wherein X3 is a leaving group, such as a halogen or sulfonate, for example a chloride, bromide, iodide or mesylate, are known or can be prepared by methods known to a person skilled in the art. Scheme 6: Compounds of formula (Ic), where T has the same meaning as given above in Scheme 1 and R3 and R4 have the same meaning as given above for compounds of formula (I), can be prepared, for example, as shown in Scheme 6. The reaction of a compound of formula (II), where T has the same meaning as given above in Scheme 1 and where X1 is a leaving group, such as a halogen or sulfonate, for example, chloride, with a compound of formula (IX), where R3 has the same meaning as given above for compounds of formula (I), gives a compound of formula (X), where T has the same meaning as given above in Scheme 1, and where R3 has the same meaning as given above for compounds of formula (I).The reaction can be carried out undiluted or in a solvent, preferably in a solvent such as an organic solvent, for example, acetonitrile. tetrahydrofuran, 2-metoltetrahydrofuran, ethyl acetate, N,N-dimethylacetamide or N,N-dimethylformamide, in a temperature range of -100 to +300°C, preferably between room temperature and 200°C, with or without the presence of a catalyst, for example, a metal catalyst, such as a palladium complex, and with or without the addition of a base, such as an inorganic base, for example, sodium, potassium or cesium carbonate, or an organic base, such as, for example, triethylamine, diisopropylethylamine or pyridine. Further treatment of the compound of formula (X) , wherein T has the same meaning as provided above in Scheme 1, and wherein R3 has the same meaning as provided above for compounds of formula (I) , (N,N-dimethylformamide dimethyl acetal, DMF-DMA) with the known compound (XIII) , wherein T has the same meaning as provided above in Scheme 1, and wherein R3 has the same meaning as provided above for compounds of formula (I) yields a compound of formula (XI) .This reaction can be carried out undiluted or in a solvent, preferably in a solvent such as an organic solvent, for example, dichloromethane, 2-methyltetrahydrofuran or dioxane, in a temperature range of -100 to +300°C, preferably between room temperature and 100°C, or between room temperature and 50°C, without a base or in the presence of a base, such as an inorganic base, for example, sodium, potassium or cesium carbonate, or an organic base, such as, for example, triethylamine, diisopropylethylamine or pyridine. Furthermore, the reaction of the compound of formula (XI) , wherein T has the same meaning as given above in Scheme 1, and wherein R3 has the same meaning as given above for compounds of formula (I) with a hydrazine compound of formula (XII) or a tautomer thereof, or a salt thereof, wherein R4 has the same meaning as given above for compounds of formula (I) , preferably R4 is R4a as defined above for compounds of formula (I) , yields the compound of formula (Ic) , wherein T has the same meaning as given above in Scheme 1, and wherein R3 and R4 have the same meaning as given above for compounds of formula (I) , preferably R4 is R4a as defined above for compounds of formula (I) .This reaction can be carried out pure or in a solvent, preferably in a solvent such as an organic solvent, for example, 1,4-dioxane, or acetic acid, or a mixture of 1,4-dioxane and acetic acid, in a temperature range of -100 to +300°C, preferably between room temperature and 200°C, or between room temperature and 80°C. Within this sequence of transformations, the intermediate compounds of formula (X) and formula (XI) can be used as crude products for the subsequent step, or they can be purified, for example, by chromatography, and used in purified form for the next transformation. Compounds of formula (IX), or a salt thereof, wherein R3 has the same meaning as has been given above for compounds of formula (I), are known, or can be prepared by methods known to a person skilled in the art. Compound of the formula (li) wherein A1, A2, A3, A4, A5, R1, R3, R4, R5, R2a and R2b have the same meaning as given above for compounds of formula (I), can be prepared by the reaction of an amine of formula (I1), or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride salt or a hydrobromide salt, or a salt of trifluoroacetic acid, or any other equivalent salt), where R1, R3, R4 and R5 are as described in formula (I), with a compound of formula (II) where A1, A2, A3, A4, A5, R2a and R2b are as described in formula (I) and X1 is a leaving group, such as a halogen or a sulfonate, for example, chloride, under conditions already described in Scheme 1. Scheme 7: The compound of formula (Ie), where T has the same meaning as given above in Scheme 1, and R1, R3, R4c, and R5 have the same meaning as given above for compounds of formula (I), can be prepared (Scheme 7) from compounds of formula (Id), where T has the same meaning as given above in Scheme 1, and R1, R3, R4c, and R5 have the same meaning as given above for compounds of formula (I), by a hydrogenation reaction. This reaction can be carried out in the presence of hydrogen or by transfer hydrogenation, such as, for example, in the presence of formic acid or a formic acid salt. The reaction can be carried out in the presence of a catalyst, for example, a homogeneous or heterogeneous catalyst. For example, the reaction is carried out in the presence of a palladium catalyst, such as palladium on carbon.It may be advantageous to carry out the reaction in a solvent, or in pure form, preferably in a solvent such as methanol or ethanol. The reaction can be carried out over a temperature range of -100 to +300°C, preferably between room temperature and 200°C, or between room temperature and 80°C, optionally in a pressurized vessel. Scheme 7a Similarly, the compound of formula (Ih) , wherein T has the same meaning as provided above in Scheme 1, and R1, R3, R4c, R5a and R5b have the same meaning as provided above for compounds of formula (I) , can be prepared (Scheme 7a) from compounds of formula (Ig) , wherein T has the same meaning as provided above in Scheme 1, R1, R3, R4c, R5a and R5b have the same meaning as provided above for compounds of formula (I) , by a hydrogenation reaction under conditions analogous to those described in Scheme 7. Scheme 8: Compounds of formula (XII-1), the subset of compounds of formula (XII), wherein R4 is specifically R4a or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride salt or a hydrobromide salt or a salt of trifluoroacetic acid or any other equivalent salt), wherein A14, A24, A34 and R4c have the same meaning as defined above for compounds of formula (I), can be prepared (Scheme 8) by treating a compound of formula (XV), wherein A14, A24, A34 and R4c have the same meaning as defined above for compounds of formula (I) and X4 is a leaving group, such as, for example, a halogen, a sulfonate, C1-C4 sulfanil, C1-C4 sulfinil or C1-C4 sulfonyl, with hydrazine or with hydrate of hydrazine or salts thereof, with hydrated hydrazine.The reaction can be carried out in pure form or in a solvent, such as water, or alcohols such as methanol or ethanol, or methoxycyclopentane, at a temperature between -100°C and 200°C, most commonly between 0°C and 150°C, such as 100°C. Such reactions are known from the literature, for example, Bioorganic & Medicinal Chemistry Letters (2012), 22(2), 1226-1229. Many compounds of formula (XV) are known or even commercially available, or can be prepared by known methods.In particular, a compound of formula (XV), wherein A14, A24, A34 and R4c have the same meaning as defined above for compounds of formula (I), and X4 is a leaving group, such as, for example, a halogen, a sulfonate, C1-C4 sulfanyl, C1-C4 sulfinil or C1-C4 sulfonyl, with a reagent of formula R4c-X6, wherein R4c has the same meaning as defined above for compounds of formula (I), and X6 is a leaving group, such as a halogen or sulfonate, for example, a chloride, bromide, iodide or mesylate.This reaction can be carried out in pure form or in a solvent, preferably an organic solvent such as acetonitrile, N,N-dimethylformamide (DMF), or N,N-dimethylacetamide (DMA), or mixtures thereof, over a temperature range of -100 to +300°C, preferably between room temperature and 200°C, with or without the addition of a base, such as an inorganic base, such as sodium, potassium, or cesium carbonate, or an organic base, such as triethylamine, diisopropioethylamine, or pyridine. Alkylation methods of this type, and the range of conditions for carrying them out, are well known to those skilled in the art and are described, for example, in Bioorganic & Medicinal Chemistry Letters (2012), 22(2), 1226–1229. Reagents of the formula R4c-X6 and compounds of the formula (XVa) with a tautomer thereof are known or even commercially available or can be prepared by known methods. Compounds of formula (XIIa), a subset of compounds of formula (XII-1), wherein A14 is N, or a salt thereof, wherein A24, A34 and R4c have the same meaning as defined above for compounds of formula (I), may exist in different tautomeric forms, such as (XIIb) and / or (XIIc) or a salt thereof wherein A24, A34 and R4c have the same meaning as defined above for compounds of formula (I). This invention covers all tautomers of this type and mixtures thereof in all proportions. Scheme 9: Compounds of formula (XVI), wherein A14, A24, A34 and R4c have the same meaning as defined above for compounds of formula (I), and M1 is a metal-containing substituent, for example a boron substituent or a tin substituent, such as, for example, tributylstannyl (M1 is -SnBu3), borone (M1 is -B(OH)2) or a boronate such as 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl, can be prepared (Scheme 9) by treating compounds of formula (XV), wherein A14, A24, A34 and R4c have the same meaning as defined above for compounds of formula (I), and X4 is a leaving group, such as, for example, a halogen, a sulfonate, sulfanyl C1-C4, C1-C4 sulfinyl or C1-C4 sulfonyl, with tributyl (tributylstannyl)stannane, or with hypoboric acid, or with 4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane (also known as bis(pinacolate)diborone).The reaction can be carried out in the presence of a catalyst, such as a metal catalyst, for example, a palladium catalyst, for example, palladium acetate, and in the presence of a ligand, such as a phosphine ligand, for example, 2-dicyclohexylphosphine-2',4',6'-triisopropylbiphenyl (X-Phos). The reaction can be carried out in the presence of a base, such as an alkoxide or a carboxylate base, for example, potassium acetate. The reaction can be carried out pure or in a solvent, for example, dioxane or toluene, at a temperature between -100°C and 200°C, most commonly between 0°C and 150°C, such as 100°C. Some compounds of formula (XVI) or even are commercially available, or can be prepared by known methods. Scheme 10: Compounds of formula (If), where T has the same meaning as given above in Scheme 1, and where A14, A24, A34, R1, R4c, R5a, and R5b have the same meaning as given above for compounds of formula (I), can be prepared (Scheme 10) from compounds of formula (XVII), where T has the same meaning as given above in Scheme 1, and where R1, R3, R5a, and R5b have the same meaning as given above for compounds of formula (I), and where X5 is a leaving group such as, for example, chlorine, bromine, or iodine, with compounds of formula (XVI), where A14, A24, A34, and R4c have the same meaning as defined above for compounds of formula (I), and M1 is a metal-containing substituent having the same meaning given above in Scheme 9.The reaction can be carried out in the presence of a catalyst, such as a palladium catalyst, for example, 1,1'-bis(diphenylphosphino)ferrocene[palladium(II)]dichloride (PdCl2dppf), and in the presence of a base, such as a carbonate base, for example, CS2CO3, or a carboxylate base, for example, potassium acetate. The reaction can be carried out pure or in a solvent, for example, dioxane, at a temperature between -100°C and 200°C, most commonly between 0°C and 150°C, such as, for example, at 85°C. Reactions of this type, known as Suzuki-Miyaura or Stille cross-coupling reactions, are familiar to those skilled in the art. Compounds of formula (XVII), wherein T has the same meaning as provided above in Scheme 1, and wherein R1, R3, R5a and R5b have the same meaning as provided above for compounds of formula (I) and wherein X5 is a leaving group, such as, for example, chlorine, bromine or iodine, can be prepared by reacting compounds of formula (XVIIa) or a salt thereof, wherein R1, R3, R5a and R5b have the same meaning as provided above for compounds of formula (I) and wherein X5 is a leaving group such as, for example, chlorine, bromine or iodine, with compounds of formula (II), wherein T has the same meaning as provided above in Scheme 1, and wherein X1 is a leaving group, such as a halogen or sulfonate, for example chloride, under conditions analogous to those described above in Scheme 1.Compounds of formula (XVIIa) or a salt thereof, wherein T has the same meaning as provided above in Scheme 1, and wherein R1, R3, R5a and R5b have the same meaning as provided above for compounds of formula (I), and wherein X5 is a leaving group, such as, for example, chlorine, bromine or iodine, are known from the literature, for example, from documents WO2021 / 170881, WO2021 / 037614, WO2020 / 208036, WO2020 / 201398 or WO2020 / 070049, or can be prepared in analogy to descriptions found therein. Scheme 11: Compounds of formula (XXII), wherein R3a and R4a are as defined for compounds of formula (I), can be prepared (Scheme 11) from compounds of formula (XX), wherein R3a and R4a are as defined for compounds of formula (I) and X- is an anion, by treatment with a base, such as, for example, a hydroxide base or a carbonate base, e.g., sodium hydroxide or potassium carbonate, or an ion-exchange resin. Such procedures are well known to a person skilled in the art and are known from the literature and textbooks. The X- anion is the conjugate base of an acid, such as an inorganic acid, for example, hydrochloric acid, hydrobromic acid, hydrogen fluoride, hydrogen iodide, sulfuric acid, or the like, or of an organic acid, such as a carboxylic acid or a sulfonic acid, for example, trifluoroacetic acid, methanesulfonic acid, or paratoluenesulfonic acid. A large number of such acids are known to a person skilled in the art. Compounds of formula (XX), where R3a and R4a are as defined for compounds of formula (I) and X is an anion, can be prepared from compounds of formula (XXI), where R3a and R4a are as defined for compounds of formula (I), by treatment with an acid, such as the acids listed above. The reaction can be carried out pure or in a solvent, for example, an organic solvent such as methanol, CPME, tetrahydrofuran, 2-methyltetrahydrofuran, dichloromethane, or dioxane, or in an inorganic solvent such as water, or in a mixture of such solvents. The reaction can be carried out over a temperature range of -100°C to 200°C, most commonly between 0°C and 150°C, such as at room temperature. Compounds of formula (XXI), wherein R3a and R4a are as defined for compounds of formula (I), can be prepared, for example, from compounds of formula (XII-1) or a tautomer thereof or a salt thereof, wherein R4a is as defined for compounds of formula (I), by treatment with compounds of formula (XVIII), wherein R3a is as defined for compounds of formula (I). The reaction can be carried out pure or in a solvent, for example an organic solvent, or in a mixture of solvents, such as dioxane and acetic acid as the solvent. The reaction can be carried out in the presence or absence of a drying agent, such as, for example, molecular sieves, at a temperature between -100°C and 200°C, more commonly between 0°C and 150°C, such as, for example, at 80°C.Compounds of formula (XVIII), wherein R3a is as defined for compounds of formula (I), are known, for example, from WO2021083936 or WO2021165195, or can be prepared by analogy to descriptions found therein. Compounds of formula (XX-1), a subset of compounds of formula (XX), wherein R3 and R4c have the same meaning as defined above for compounds of formula (I) and X- is an anion having the same meaning as defined above in Scheme 11, can be prepared (Scheme 12) from compounds of formula (XXI-1), a subset of compounds of formula (XXI), wherein R3 and R4c have the same meaning as defined above for compounds of formula (I), by treatment with an acid under conditions already described above in Scheme 11 (transformation of XXI into XX). Compounds of formula (XX-1), a subset of compound of formula (XXI), wherein R3 and R4c have the same meaning as defined above for compounds of formula (I), can be prepared by treating a compound of formula (XXIII) or a tautomer thereof, wherein R3 has the same meaning as defined above for compounds of formula (I), with a reagent of formula R4c-X6, wherein R4c has the same meaning as defined above for compounds of formula (I) and X6 is a leaving group, such as a halogen or sulfonate, for example, a chloride, bromide, iodide, or mesylate under conditions already described above in Scheme 8 (transformation of XVa into XV). A compound of formula (XXIII) or a tautomer thereof, wherein R3 has the same meaning as defined above for compounds of formula (I), can be prepared by treating compounds of formula (XIV), wherein R3 has the same meaning as defined above for compounds of formula (I) and wherein X7 is a leaving group, such as a halogen, for example a chloride, bromide, or iodide, with, for example, benzaldoxime PhC=NOH, preferably (E)-benzaldehyde oxime, in the presence of a base, such as potassium or cesium carbonate, optionally in the presence of a palladium catalyst such as RockPhos-G3-palladacycle (methanesulfonate of [(2-di-tert-butylphosphino-3-methoxy-6-methyl-2,4,6-triisopropyl-1,1-biphenyl)-2- (2-aminobiphenyl) palladium (II) in an aprotic solvent such as acetonitrile or N,N-dimethylformamide in Angew.Chem. Int. Ed.56 (16) , 4478-4482, 2017. Compounds of formula (XXIV), wherein R3 has the same meaning as defined above for compounds of formula (I) and wherein X7 is a leaving group, such as a halogen, for example a chloride, bromide or iodide, can be prepared by treating compounds of formula (XXV), or a tautomer thereof, or a salt thereof wherein X7 is a leaving group such as a halogen, for example a chloride, bromide or iodide, with a compound of formula (XVIII), wherein R3 is as defined for compounds of formula (I), in conditions similar to those already described above in Scheme 11 (transformation of XII-1+XVIII into XXI). Compounds of the formula (XXV) , or a tautomer thereof or a salt thereof, wherein X7 is a leaving group, such as a halogen, for example a chloride, bromide or iodide, are known or even commercially available or can be prepared by known methods. Compounds of formula (XXIII) (all substituents are defined above in Scheme 12) may exist in a different tautomeric form wherein the zigzag line represents the connection to the rest of said compounds of formula (XXIII). This invention covers all tautomers of this type and mixtures thereof in all proportions. Scheme 13: Compounds of formula (XXVII), wherein R3 and R4c have the same meaning as defined above for compounds of formula (I) and X- is an anion having the same meaning as provided above in Scheme 11, can be prepared (Scheme 13) from compounds of formula (XXVI), wherein R3 and R4c have the same meaning as defined above for compounds of formula (I), by treatment with an acid under conditions already described above in Scheme 11 (transformation of XXI into XX). Compounds of formula (XXVI), wherein R3 and R4c have the same meaning as defined above for compounds of formula (I), can be prepared from compounds of formula (XXI-I) described above, wherein R3 and R4c have the same meaning as defined above for compounds of formula (I), by a hydrogenation reaction under conditions analogous to those already described above in Scheme 7. Scheme 14: Compounds of formula (XXVIII) or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride salt or a hydrobromide salt, or a salt of trifluoroacetic acid, or any other equivalent salt), wherein R3, R4c, R5a and R5b have the same meaning as defined above for compounds of formula (I), can be prepared (Scheme 14) from compounds of formula (VII-1), a subset of compounds of formula (VII), wherein R3, R4c, R5a and R5b have the same meaning as defined above for compounds of formula (I), by a reductive amination reaction under conditions analogous to those described above in Scheme 2 (transformation of VII into III). Compounds of formula (VII-1), a subset of compounds of formula (VII), wherein R3, R4c, R5a and R5b have the same meaning as defined above for compounds of formula (I), can be prepared by treating compounds of formula (XXIX) wherein R3, R5a and R5b have the same meaning as defined above for compounds of formula I, and wherein X6 is a leaving group, such as a halogen, for example a chloride, bromide or iodide, with a compound of formula (XVI-1), a subset of compounds of formula (XVI), wherein R4c has the same meaning as defined above for compounds of formula (I) and M1 is a metal-containing substituent, having the same meaning as provided above in Scheme 9 under similar conditions, already described above in Scheme 10 (transformation of XVII + XVI into If).Compounds of formula (XXIX) , wherein R3, R5a and R5b have the same meaning as defined above for compounds of formula (I) , wherein X6 is a leaving group, such as a halogen, for example a chloride, bromide or iodide, are known or even commercially available, or can be prepared by known methods. Alternatively, compounds of formula (VII-1), a subset of compounds of formula (VII), wherein R3, R4c, R5a and R5b have the same meaning as defined above for compounds of formula (I), can be prepared by oxidation of compounds of formula (XXXI) described below (Scheme 15) wherein R3, R4c, R5a and R5b have the same meaning as defined above for compounds of formula (I), for example using Dess-Martin per and odinane (or similar hypervalent iodine reagents), commonly carried out in chlorinated solvents such as dichloromethane or chloroform, at temperatures between 0 and 50°C, preferably around room temperature. Scheme 15: Alternatively, compounds of formula (XXVIII), or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride salt or a hydrobromide salt or a salt of trichloroacetic acid or any other equivalent salt), wherein R3, R4c, R5a and R5b have the same meaning as defined above for compounds of formula (I), can be prepared (Scheme 15) from compounds of formula (XXX), wherein R3, R4c, R5a and R5b have the same meaning as defined above for compounds of formula (I) and Z3 is -NPhth (N-phthalimide group) or -NBoc2 (N-bis (tert.-butyloxycarbonyl) ) , typically by treatment with hydrazine (preferably hydrazine hydrate or hydrazine monohydrate) in an alcoholic solvent, such as ethanol or isopropanol (Z3 is -NPhth) , or with an acid such as trifluoroacetic acid or hydrochloric acid in the presence of a suitable solvent, such as dichloromethane, tetrahydrofuran, 2-methyltetrahydrofuran or dioxane (Z3 is -NBoc2) n deprotection conditions known to a person skilled in the art, and are described in the literature such as, for example, in Protective Groups Inc Organic Synthesis, 3rd Edition Theodora W. Green (The Rowland Institute for Science) and Peter GM Wuts (Pharmacia and Upjohn Company), John Wiley & Sons, Inc., New York, NY.1999, ISBN 0-471-16019-9. Compounds of formula (XXX), wherein R3, R4c, R5a, and R5b have the same meaning as defined above for compounds of formula (I) and Z3 is -NPhth (N-phthalimide group) or NBoc2 (N-bis(tert-butyloxycarbonyl) group), can be prepared from compounds of formula (XXXI), wherein R3, R4c, R5a, and R5b have the same meaning as defined above for compounds of formula (I), by a Mitsunobu reaction. Such a reaction involves treating compounds of formula (XXXI) with an azodicarboxylate, such as diethyl azodicarboxylate or diisopropyl azodicarboxylate, in the presence of a phosphine, such as triphenylphosphine or trimethylphosphine, and an amine such as phthalimide (HNPhth) or a bis(tert-butoxycarbonyl)amino group. (HNBoc2) . The Mitsunobu reactions (and conditions for carrying them out) are known to those skilled in the art and are described, for example, in Chem. Rev.2009, 109, 2551-2651. Compounds of formula (XXXI), wherein R3, R4c, R5a, and R5b have the same meaning as defined above for compounds of formula (I), can be prepared from silyl ether compounds of formula (XXXII), wherein R3, R4c, R5a, and R5b have the same meaning as defined above for compounds of formula (I), and wherein each of the Ra groups is independently C1-C4 alkyl, by deprotection, for example by fluoride treatment, for example with tetrabutylammonium fluoride, in an inert solvent such as, for example, tetrahydrofuran or 2-methyltetrahydrofuran. The reaction can be carried out over a temperature range of -10°C to 80°C, for example, between 0°C and 30°C. Deprotection reactions of this type are known to a person skilled in the art and are described in the literature, for example in: Protective Groups in Organic Synthesis, 3rd Edition Theodora W.Green (The Rowland Institute for Science) and Peter G. M. Wuts (Pharmacia and Upjohn Company), John Wiley & Sons, Inc., New York, NY.1999, ISBN 0-471-16019-9. Alternatively, compounds of formula (XXXI), wherein R3, R4c, R5a and R5b have the same meaning as defined above for compounds of formula (I), can be prepared by reducing compounds of formula (VII-1) described above (Scheme 14), a subset of compounds of formula (VII), wherein R3, R4c, R5a and R5b have the same meaning as defined above for compounds of formula (I), for example with sodium borohydride NaBH4, under conditions known to a person skilled in the art (see, for example, WO2012 / 082997, p.141), preferably in MeOH as the solvent. Compounds of formula (XXXII), wherein R3, R4c, R5a, and R5b have the same meaning as defined above for compounds of formula (I), and wherein each of the Ra groups is independently C1-C4 alkyl, can be prepared from silyl ether compounds of formula (XXXIII), wherein R3, R4c, R5a, and R5b have the same meaning as defined above for compounds of formula (I), X9 is a leaving group such as a halogen, for example a bromide or iodide, and wherein each of the Ra groups is independently C1-C4 alkyl, by metalation, such as by treatment with a Turbo Grignard reagent (iPrMgCl·LiCl) or with butyllithium. Metalations of this type are known to a skilled worker and are described in the literature, for example in Carey, Francis A. (2007). "Organometallic compounds of Group I and II metals". Advanced Organic Chemistry: Reaction and Synthesis Pt. B (Kindle ed.). Springer.ISBN 978-0-387-44899-2. The lithium or magnesium species thus generated can be transmetalated, for example, with a zinc halide, for example, zinc chloride, and subsequently coupled with compounds of formula (XV-1), a subset of compounds of formula (XV), wherein R4c has the same meaning as defined above for compounds of formula (I), and X4 is a leaving group, such as a halogen, for example, a bromide or iodide, in the presence of a catalyst, for example, a palladium catalyst, for example, tris(dibenzylideneacetone)dipalladium(0), and a ligand, for example, a phosphine ligand, such as, for example, tri(2-furyl)phosphine, in an inert solvent, such as, for example, tetrahydrofuran or 2-methyltetrahydrofuran. The reaction can be carried out in a temperature range of -100ºC to 100ºC, for example between -78ºC and 80ºC.This transformation is known to an expert in the technique, for example, as the Negishi cross-coupling reaction, and described in the literature, for example in Jie Jack Li, Name Reactions, A Collection of Detailed. Mechanisms and Synthetic Applications, Springer, ISBN: 978-3-030-50865-4. Compounds of formula (XXXIII), wherein R3, R4c, R5a, and R5b have the same meaning as defined above for compounds of formula (I), X9 is a leaving group such as a halogen, for example, a bromide or iodide, and wherein each of the Ra groups is independently C1-C4 alkyl, can be prepared from compounds of formula (XXXIV), wherein R3, R5a, and R5b have the same meaning as defined above for compounds of formula (I), and X9 is a leaving group such as a halogen, for example, a bromide or iodide, by treatment with a silylating agent of formula Ra3Si-Xa, wherein Xa is a leaving group such as, for example, chloride, bromide, iodide, or triflate, and wherein each of the Ra groups is independently C1-C4 alkyl (Ra3Si is trialkylsilyl, for example dimethyl-tert.-butylsilyl, in Ra3Si-Xa compounds, Ra is a linear or branched C1-C4 alkyl such as methyl or tert.-butyl), in the presence of a base, such as an amine base, for example, imidazole, in an inert solvent such as, for example, tetrahydrofuran or 2-methyltetrahydrofuran. The reaction can be carried out over a temperature range of 0°C to 100°C, for example, between 10°C and 80°C. Silylation reactions of this type are known to those skilled in the art and are described in the literature, such as, for example, in: Protective Groups in Organic Synthesis, 3rd Edition, Theodora W. Green (The Rowland Institute for Science) and Peter GM Wuts (Pharmacy and Upjohn Company). John Wiley & Sons, Inc., New York, NY. 1999, ISBN 0-471-16019-9. Compounds of formula (XXXIV), wherein R3, R5a and R5b have the same meaning as defined above for compounds of formula (I) and X9 is a leaving group, such as a halogen, for example a bromide or iodide, can be prepared from compounds of formula (XXXV), wherein R5a and R5b have the same meaning as defined above for compounds of formula (I), and X9 is a leaving group such as a halogen, for example a bromide or iodide, by treatment with a base such as a lithium amide base, for example lithium 2,2,6,6-tetramethylpiperidide, followed by reaction of the lithiated species with aldehyde compounds of formula (XXXVI), wherein R3 has the same meaning as defined above for compounds of formula (I). This reaction can be carried out in pure form or in a solvent, for example, an organic solvent, such as tetrahydrofuran or 2-methyltetrahydrofuran as a solvent.The reaction can be carried out in a temperature range of -100°C to 100°C, for example, between -80°C and 0°C, for example, at 0°C or -78°C. Compounds of formula (XXXV), where R5a and R5b have the same meaning as defined above for compounds of formula (I) and X9 is a leaving group, such as a halogen, for example a bromide or iodide, and compounds of formula (XXXVI), where R3 has the same meaning as defined above for compounds of formula (I), are known or even commercially available, or can be prepared by known methods. Scheme 16 Compounds of formula (XXVIIIb) or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride salt or a hydrobromide salt, or a salt of trifluoroacetic acid or any other equivalent salt), wherein R1, R3, R4c, R5a and R5b have the same meaning as defined above for compounds of formula (I), may be prepared (Scheme 16) by treating compounds of formula (XXVIIIa) or a salt thereof, wherein R3, R4c, R5a and R5b have the same meaning as defined above for compounds of formula (I), with compounds of formula (XXXVII), wherein R1 is as defined in formula I, by a reductive amination reaction under conditions analogous to those described above in Scheme 2 (transformation of VII into III). Compounds of formula (XXVIIIa) or a salt thereof, wherein R3, R4c, R5a, and R5b have the same meaning as defined above for compounds of formula (I), can be obtained by biocatalyzed deracemization of compounds of formula (XXVIII) or a salt thereof, wherein R3, R4c, R5a, and R5b have the same meaning as defined above for compounds of formula (I). This can be done, for example, using a lipase, e.g., lipase B from Candida Antarctica or lipase from Pseudomonas fluorescens, possibly in immobilized form (e.g., Novozinc® 435), in the presence of an acyl donor, e.g., ethyl methoxyacetate, vinyl acetate, in a suitable solvent such as acetonitrile or methyl tert-butyl ether, at temperatures between 20°C and 100°C. Procedures of this type are described, for example, in J. Org. Chem. 2007, 72, 6918-6923 or Adv. Synth. Catal. 2007, 349, 1481-1488.The expected stereochemical results of enzymatic deracemization of this type are known to experts in the technique and are documented in the literature, for example, in J. Org. Chem.1991, 56, 2656-2665 or J. Am. Chem. Soc.2015, 137, 3996-4009. Scheme 17: In an alternative procedure (Scheme 17), compounds of formula (XXVIII) or a salt thereof, wherein R3, R4c, R5a and R5b have the same meaning as defined above for compounds of formula (I), can be obtained from compounds of formula (XXX-1), wherein R3, R4c, R5a and R5b have the same meaning as defined above for compounds of formula (I) and Z3 is -NPhth (N-phthalimide group) or -NBoc2 (N-bis(tert-butyloxycarbonyl) group), under deprotection conditions already described above in Scheme 15 (transformation of XXX into XXVIII). Compounds of formula (XXX-1), where R3, R4c, R5a, and R5b have the same meaning as defined above for compounds of formula (I) and Z3 is -NPhth (N-phthalimide group) or -NBoc2 (N-bis(tert-butyloxycarbonyl) group), can be obtained from compounds of formula (XXX-1), where R3, R4c, R5a, and R5b have the same meaning as defined above for compounds of formula (I), by a Mitsunobu reaction with phthalimide (HNPhth) or bis(tert-butoxycarbonyl)amide (HNBoc2), under the conditions already described in Scheme 15 (transformation of XXXI to XXX). Procedures of this type are known to those skilled in the art for further stereocenter inversion. Compounds of formula (XXXI-1), wherein R3, R4c, R5a, and R5b have the same meaning as defined above for compounds of formula (I), can be obtained by enantioselective reduction of ketones of formula (VII-1), wherein R3, R4c, R5a, and R5b have the same meaning as defined above for compounds of formula (I). Reductions of this type can be carried out using a catalyst, for example, a ruthenium catalyst or a rhodium catalyst with a chiral ligand such as RuCl[(R,R)-TsDPEN]. (mesitylene) or RuBF4[(R,R)-TsDPEN](p-cymene) , in the presence of a hydrogen donor system such as, for example, HCOOH / Et3N or HCO2NH4. Procedures of this type are described in the literature, for example, in J. Org. Chem.2017, 82, 5607. Alternatively, compounds of formula (XXVIIIa) or a salt thereof, wherein R3, R4c, R5a and R5b have the same meaning as defined above for compounds of formula (I), can be obtained by reduction of azide compounds of formula (XXXVIII), wherein R3, R4c, R5a and R5b have the same meaning as defined above for compounds of formula (I), by treatment with, for example, triphenylphosphine (or tributylphosphine) and water (2-step Staudinger reduction), or by hydrogenation, using, for example, a palladium catalyst in the presence of hydrogen.Procedures and conditions for azide reductions of this type are well known to a person skilled in the art and are known from the literature and textbooks. Compounds of formula (XXXVIII), wherein R3, R4c, R5a and R5b have the same meaning as defined above for compounds of formula (I), can be obtained by treating alcoholic compounds of formula (XXXI-1), wherein R3, R4c, R5a and R5b have the same meaning as defined above for compounds of formula (I), with an azidation reagent such as diphenyl phosphoryl azide (among others such as sodium azide, trimethylsilyl azide or tetrabutylammonium azide), in a solvent such as toluene, tetrahydrofuran or 2-methyltetrahydrofuran, in the presence of a base such as, for example, 1,8-diazabicyclo(5.4.0)undec-7-ene DBU, and at temperatures preferably around room temperature.Procedures of this type are known to experts in the technique for proceeding with stereocenter inversion and are described in the literature, for example, in Adv. Synth. Catal.2018, 360, 2157-2165. Any of the compounds of formula (XX), (XXII) (substituents as defined in Scheme 11), formula (XX-1) (substituents as defined in Scheme 12), formula (XXVII) (substituents as defined in Scheme 13), formula (XXVIII) (substituents as defined in Schemes 14 / 15), formula XXVIII (substituents as defined in Schemes 16 / 17) and formula (XXVIIIb) (substituents as defined in Scheme 16) or (where applicable) a salt thereof or (where applicable) a free base thereof, represents a particular subset of compounds of formula (III) defined above in Scheme 1, and may therefore be used in accordance with the descriptions set forth in said Scheme 1 for the preparation of compounds of formula (I) . Compounds of formula (XXVIII), (XXVIIIa) or (XXVIIIb) (definitions of substituents in Schemes 14, 15, 16 and 17) where the fragment wherein R4c is as defined above under formula (I) and wherein the zigzag line represents the connection to the rest of said compounds of formula (XXVIII), (XXVIIIa) or (XXVIIIb), is replaced by the fragment It is possible to access by analogy the chemical descriptions found in Schemes 14, 15, 16 and 17, but replacing the starting materials of formulas XVI-1 and XV-1, respectively, with compounds of formulas XVI-2 and XV-2, where R4c, X4 and M1 retain their definitions: Compounds of this type of formula XVI-2 and XV-2 are known or even commercially available, or can be prepared by known methods. Depending on the procedure or reaction conditions, the reactants can be reacted in the presence of a base. Some examples of suitable bases are alkali metal or alkaline earth metal hydroxides, alkali metal or alkaline earth metal hydrides, alkali metal or alkaline earth metal amides, alkali metal or alkaline earth metal alkoxides, alkali metal or alkaline earth metal acetates, alkali metal or alkaline earth metal carbonates, alkali metal or alkaline earth metal dialkylamides or alkylsilylamides, alkylamines, alkali metal or alkaline earth metal alkylenediamines, saturated or unsaturated N-alkylated or free cycloalkylamines, basic heterocycles, ammonium hydroxides, and carbocyclic amines.Some examples that can be mentioned are sodium hydroxide, sodium hydride, sodium amide, sodium methoxide, sodium acetate, sodium carbonate, potassium tert-butoxide, potassium hydroxide, potassium carbonate, potassium hydride, lithium diisopropylamide, potassium bis(trimethylsilyl)amide, calcium hydride, triethylamine, diisopropylethylamine, triethylenediamine, cyclohexylamine, N-cyclohexyl-N,N-dimethylamine, N,N-diethylaniline, pyridine, 4-(N,N-dimethylamino)pyridine, quinuclidine, N-methylmorpholine, benzyltrimethylammonium hydroxide and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU). The reactants can be reacted with each other as such, that is, without adding any solvent or diluent. However, in most cases, it is convenient to add an inert solvent or diluent, or a mixture of these. If the reaction is carried out in the presence of a base, bases used in excess, such as triethylamine, pyridine, N-methylmorpholine, or N,N-diethylaniline, can also act as solvents or diluents. The reactions are advantageously carried out at a temperature in the range of approximately -80 °C to approximately +140 °C, preferably from approximately -30 °C to approximately +100 °C, in many cases in the range between ambient temperature and approximately +80 °C. Depending on the choice of reaction conditions and starting materials that are suitable in each case, it is possible, for example, in a reaction step, to replace only one substituent with another substituent according to the invention, or a plurality of substituents can be replaced with other substituents according to the invention in the same reaction step. Salts of compounds of formula (I) can be prepared in a manner that is well known. Therefore, for example, acid addition salts of compounds of formula (I) are obtained by treatment with a suitable acid or a suitable ion-exchange reagent, and base salts are obtained by treatment with a suitable base or a suitable ion-exchange reagent. Salts of compounds of formula (I) can be converted in the usual way into free compounds (I), acid addition salts, for example by treatment with a suitable basic compound or with a suitable ion exchange reagent, and salts with bases, for example by treatment with a suitable acid or with a suitable ion exchange reagent. Salts of compounds of formula (I) can be converted in a manner known in itself into other salts of compounds of formula (I), acid addition salts, for example, by treating an inorganic acid salt, such as hydrochloride, with a suitable metal salt, such as a sodium, barium, or silver salt, of an acid, for example, with silver acetate, in a suitable solvent in which an inorganic salt forming, for example, silver chloride, is insoluble and thus precipitates in the reaction mixture. Depending on the procedure or reaction conditions, compounds of formula (I), which have salt-forming properties, can be obtained in free form or in the form of salts. The compounds of formula (I) and, where appropriate, the tautomers thereof, in each case in free or salt form, may be present in the form of one of the possible isomers or as a mixture thereof, for example, in the form of pure isomers such as enantiomers and / or diastereomers, or as mixtures of isomers such as mixtures of enantiomers, for example, racemates, mixtures of diastereomers or mixtures of racemates, depending on the number, absolute and relative configuration of the asymmetric carbon atoms present in the molecule and / or depending on the configuration of the non-aromatic double bonds present in the molecule; the invention relates to pure isomers and also to all possible mixtures of isomers, and shall be interpreted in each case in this sense in the foregoing and hereafter, even when stereochemical details are not specifically mentioned in each case. Mixtures of diastereomers or racemates of compounds of formula (I), in free form or as salts, which can be obtained depending on the starting materials and procedures selected, can be separated in a known way to obtain the pure diastereomers or racemates based on the physicochemical differences of the components, for example, by crystallization, distillation, and / or fractional chromatography. Mixtures of enantiomers, such as racemates, which can be obtained similarly, can be resolved into the optical enantiomers by known methods, for example, by recrystallization in an optically active solvent, by chromatography on chiral adsorbents, for example, high-performance liquid chromatography (HPLC) on acetylcellulose, with the aid of suitable microorganisms, by cleavage with specific immobilized enzymes, or through the formation of inclusion compounds, for example,using chiral crown ethers, where only one enantiomer is in complex form, or by conversion into diastereomeric salts, for example, by reacting a basic racemate of the final product with an optically active acid, such as a carboxylic acid, for example, camphor, tartaric or malic acid, or a sulfonic acid, for example, camphorsulfonic acid, and separating the mixture of diastereomers that can be obtained in this way, for example, by fractional crystallization based on their different solubilities, to obtain the diastereomers, from which the desired enantiomer can be released by the action of suitable agents, for example, basic agents. Pure diastereomers or enantiomers according to the invention can be obtained not only by separating suitable isomer mixtures, but also by generally known methods of diastereoselective or enantioselective synthesis, for example, by carrying out the process according to the invention with starting materials having suitable stereochemistry. N-oxides can be prepared by reacting a compound of formula (I) with a suitable oxidizing agent, for example, the H2O2 / urea adduct in the presence of an acid anhydride, e.g., trifluoroacetic anhydride. Such oxidations are known in the literature, for example, in J. Med. Chem., 32 (12), 2561-73, 1989 or in WO 2000 / 15615. It is advantageous to isolate or synthesize in each case the most biologically effective isomer, for example, the enantiomer or the diastereomer or the mixture of isomers, for example, a mixture of enantiomers or a mixture of diastereomers, if the individual components have different biological activity. Compounds of formula (I) and, where appropriate, tautomers thereof, in each case in free or saline form, may also be obtained, if appropriate, in the form of hydrates and / or may include other solvents, for example, those that may have been used for the crystallization of compounds that are present in solid form. Compounds of formula (I) according to the following Tables A-1 to A-78, B-1 to B-78, C-1 to C-21, and D-1 to D-21 may be prepared according to the methods described above. The examples below are intended to illustrate the invention and show preferred compounds of formula I, in the form of a compound of formula (IA), (IB), (IC), and (ID). Tables A-1 to A-78 (Formula IA) Table A-1 provides 32 compounds from A-1.001 to A-1.032 of formula IA where A14 is N, A24 is N, A34 is N, R1 is H, R3 is CH3, R4c is CH3, and T are as defined in Table Z. For example, A-1.002 is Table A-2 provides 32 compounds from A-2.001 to A-2.032 of formula IA where A14 is N, A24 is N, A34 is N, R1 is H, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table A-3 provides 32 compounds from A-3.001 to A-3.032 of formula IA where A14 is N, A24 is N, A34 is N, R1 is H, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table A-4 provides 32 compounds from A-4.001 to A-4.032 of formula IA where A14 is N, A24 is N, A34 is N, R1 is CH3, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table A-5 provides 32 compounds from A-5.001 to A-5.032 of formula IA where A14 is N, A24 is N, A34 is N, R1 is CH3, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table A-6 provides 32 compounds from A-6.001 to A-6.032 of formula IA where A14 is N, A24 is N, A34 is N, R1 is CH3, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table A-7 provides 32 compounds from A-7.001 to A-7.032 of formula IA where A14 is N, A24 is N, A34 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table A-8 provides 32 compounds from A-8.001 to A-8.032 of formula IA where A14 is N, A24 is N, A34 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table A-9 provides 32 compounds from A-9.001 to A-9.032 of formula IA where A14 is N, A24 is N, A34 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table A-10 provides 32 compounds from A-10.001 to A-10.032 of formula IA where A14 is N, A24 is N, A34 is CH, R1 is H, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table A-11 provides 32 compounds from A-11.001 to A-11.032 of formula IA where A14 is N, A24 is N, A34 is CH, R1 is H, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table A-12 provides 32 compounds from A-12.001 to A-12.032 of formula IA where A14 is N, A24 is N, A34 is CH, R1 is H, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table A-13 provides 32 compounds from A-13.001 to A-13.032 of formula IA where A14 is N, A24 is N, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table A-14 provides 32 compounds from A-14.001 to A-14.032 of formula IA where A14 is N, A24 is N, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table A-15 provides 32 compounds from A-15.001 to A-15.032 of formula IA where A14 is N, A24 is N, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table A-16 provides 32 compounds from A-16.001 to A-16.032 of formula IA where A14 is N, A24 is N, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table A-17 provides 32 compounds from A-17.001 to A-17.032 of formula IA where A14 is N, A24 is N, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table A-18 provides 32 compounds from A-18.001 to A-18.032 of formula IA where A14 is N, A24 is N, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table A-19 provides 32 compounds from A-19.001 to A-19.032 of formula IA where A14 is N, A24 is CH, A34 is N, R1 is H, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table A-20 provides 32 compounds from A-20.001 to A-20.032 of formula IA where A14 is N, A24 is CH, A34 is N, R1 is H, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table A-21 provides 32 compounds from A-21.001 to A-21.032 of formula IA where A14 is N, A24 is CH, A34 is N, R1 is H, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table A-22 provides 32 compounds from A-22.001 to A-22.032 of formula IA where A14 is N, A24 is CH, A34 is N, R1 is CH3, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table A-23 provides 32 compounds from A-23.001 to A-23.032 of formula IA where A14 is N, A24 is CH, A34 is N, R1 is CH3, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table A-24 provides 32 compounds from A-24.001 to A-24.032 of formula IA where A14 is N, A24 is CH, A34 is N, R1 is CH3, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table A-25 provides 32 compounds from A-25.001 to A-25.032 of formula IA where A14 is N, A24 is CH, A34 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table A-26 provides 32 compounds from A-26.001 to A-26.032 of formula IA where A14 is N, A24 is CH, A34 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table A-27 provides 32 compounds from A-27.001 to A-27.032 of formula IA where A14 is N, A24 is CH, A34 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table A-28 provides 32 compounds from A-28.001 to A-28.032 of formula IA where A14 is N, A24 is CH, A34 is CH, R1 is H, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table A-29 provides 32 compounds from A-29.001 to A-29.032 of formula IA where A14 is N, A24 is CH, A34 is CH, R1 is H, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table A-30 provides 32 compounds from A-30.001 to A-30.032 of formula IA where A14 is N, A24 is CH, A34 is CH, R1 is H, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table A-31 provides 32 compounds from A-31.001 to A-31.032 of formula IA where A14 is N, A24 is CH, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table A-32 provides 32 compounds from A-32.001 to A-32.032 of formula IA where A14 is N, A24 is CH, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table A-33 provides 32 compounds from A-33.001 to A-33.032 of formula IA where A14 is N, A24 is CH, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table A-34 provides 32 compounds from A-34.001 to A-34.032 of formula IA where A14 is N, A24 is CH, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table A-35 provides 32 compounds from A-35.001 to A-35.032 of formula IA where A14 is N, A24 is CH, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table A-36 provides 32 compounds from A-36.001 to A-36.032 of formula IA where A14 is N, A24 is CH, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table A-37 provides 32 compounds from A-37.001 to A-37.032 of formula IA where A14 is CH, A24 is N, A34 is N, R1 is H, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table A-38 provides 32 compounds from A-38.001 to A-38.032 of formula IA where A14 is CH, A24 is N, A34 is N, R1 is H, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table A-39 provides 32 compounds from A-39.001 to A-39.032 of formula IA where A14 is CH, A24 is N, A34 is N, R1 is H, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table A-40 provides 32 compounds from A-40.001 to A-40.032 of formula IA where A14 is CH, A24 is N, A34 is N, R1 is CH3, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table A-41 provides 32 compounds from A-41.001 to A-41.032 of formula IA where A14 is CH, A24 is N, A34 is N, R1 is CH3, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table A-42 provides 32 compounds from A-42.001 to A-42.032 of formula IA where A14 is CH, A24 is N, A34 is N, R1 is CH3, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table A-43 provides 32 compounds from A-43.001 to A-43.032 of formula IA where A14 is CH, A24 is N, A34 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table A-44 provides 32 compounds from A-44.001 to A-44.032 of formula IA where A14 is CH, A24 is N, A34 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table A-45 provides 32 compounds from A-45.001 to A-45.032 of formula IA where A14 is CH, A24 is N, A34 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table A-46 provides 32 compounds from A-46.001 to A-46.032 of formula IA where A14 is CH, A24 is N, A34 is CH, R1 is H, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table A-47 provides 32 compounds from A-47.001 to A-47.032 of formula IA where A14 is CH, A24 is N, A34 is CH, R1 is H, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table A-48 provides 32 compounds from A-48.001 to A-48.032 of formula IA where A14 is CH, A24 is N, A34 is CH, R1 is H, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table A-49 provides 32 compounds from A-49.001 to A-49.032 of formula IA where A14 is CH, A24 is N, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table A-50 provides 32 compounds from A-50.001 to A-50.032 of formula IA where A14 is CH, A24 is N, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table A-51 provides 32 compounds from A-51.001 to A-51.032 of formula IA where A14 is CH, A24 is N, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table A-52 provides 32 compounds from A-52.001 to A-52.032 of formula IA where A14 is CH, A24 is N, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table A-53 provides 32 compounds from A-53.001 to A-53.032 of formula IA where A14 is CH, A24 is N, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table A-54 provides 32 compounds from A-54.001 to A-54.032 of formula IA where A14 is CH, A24 is N, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table A-55 provides 32 compounds from A-55.001 to A-55.032 of formula IA where A14 is CH, A24 is CH, A34 is N, R1 is H, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table A-56 provides 32 compounds from A-56.001 to A-56.032 of formula IA where A14 is CH, A24 is CH, A34 is N, R1 is H, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table A-57 provides 32 compounds from A-57.001 to A-57.032 of formula IA where A14 is CH, A24 is CH, A34 is N, R1 is H, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table A-58 provides 32 compounds from A-58.001 to A-58.032 of formula IA where A14 is CH, A24 is CH, A34 is N, R1 is CH3, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table A-59 provides 32 compounds from A-59.001 to A-59.032 of formula IA where A14 is CH, A24 is CH, A34 is N, R1 is CH3, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table A-60 provides 32 compounds from A-60.001 to A-60.032 of formula IA where A14 is CH, A24 is CH, A34 is N, R1 is CH3, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table A-61 provides 32 compounds from A-61.001 to A-61.032 of formula IA where A14 is CH, A24 is CH, A34 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table A-62 provides 32 compounds from A-62.001 to A-62.032 of formula IA where A14 is CH, A24 is CH, A34 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table A-63 provides 32 compounds from A-63.001 to A-63.032 of formula IA where A14 is CH, A24 is CH, A34 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table A-64 provides 32 compounds from A-64.001 to A-64.032 of formula IA where A14 is CH, A24 is CH, A34 is CH, R1 is H, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table A-65 provides 32 compounds from A-65.001 to A-65.032 of formula IA where A14 is CH, A24 is CH, A34 is CH, R1 is H, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table A-66 provides 32 compounds from A-66.001 to A-66.032 of formula IA where A14 is CH, A24 is CH, A34 is CH, R1 is H, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table A-67 provides 32 compounds from A-67.001 to A-67.032 of formula IA where A14 is CH, A24 is CH, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table A-68 provides 32 compounds from A-68.001 to A-68.032 of formula IA where A14 is CH, A24 is CH, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table A-69 provides 32 compounds from A-69.001 to A-69.032 of formula IA where A14 is CH, A24 is CH, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table A-70 provides 32 compounds from A-70.001 to A-70.032 of formula IA where A14 is CH, A24 is CH, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table A-71 provides 32 compounds from A-71.001 to A-71.032 of formula IA where A14 is CH, A24 is CH, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table A-72 provides 32 compounds from A-72.001 to A-72.032 of formula IA where A14 is CH, A24 is CH, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table A-73 provides 32 compounds from A-73.001 to A-73.032 of formula IA where A14 is N, A24 is CH, A34 is CH, R1 is H, R3 is CH3, R4c is CH2CH3 and T are as defined in Table Z. Table A-74 provides 32 compounds from A-74.001 to A-74.032 of formula IA where A14 is N, A24 is CH, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH2CH3 and T are as defined in Table Z. Table A-75 provides 32 compounds from A-75.001 to A-75.032 of formula IA where A14 is N, A24 is CH, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2CH3 and T are as defined in Table Z. Table A-76 provides 32 compounds from A-76.001 to A-76.032 of formula IA where A14 is CH, A24 is N, A34 is CH, R1 is H, R3 is CH3, R4c is CH2CH3 and T are as defined in Table Z. Table A-77 provides 32 compounds from A-77.001 to A-77.032 of formula IA where A14 is CH, A24 is N, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH2CH3 and T are as defined in Table Z. Table A-78 provides 32 compounds from A-78.001 to A-78.032 of formula IA where A14 is CH, A24 is N, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2CH3 and T are as defined in Table Z. Tables B-1 to B-78 (formula IB) Table B-1 provides 32 compounds from B-1.001 to B-1.032 of formula IB where A14 is N, A24 is N, A34 is N, R1 is H, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table B-2 provides 32 compounds from B-2.001 to B-2.032 of formula IB where A14 is N, A24 is N, A34 is N, R1 is H, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table B-3 provides 32 compounds from B-3.001 to B-3.032 of formula IB where A14 is N, A24 is N, A34 is N, R1 is H, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table B-4 provides 32 compounds from B-4.001 to B-4.032 of formula IB where A14 is N, A24 is N, A34 is N, R1 is CH3, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table B-5 provides 32 compounds from B-5.001 to B-5.032 of formula IB where A14 is N, A24 is N, A34 is N, R1 is CH3, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table B-6 provides 32 compounds from B-6.001 to B-6.032 of formula IB where A14 is N, A24 is N, A34 is N, R1 is CH3, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table B-7 provides 32 compounds from B-7.001 to B-7.032 of formula IB where A14 is N, A24 is N, A34 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table B-8 provides 32 compounds from B-8.001 to B-8.032 of formula IB where A14 is N, A24 is N, A34 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table B-9 provides 32 compounds from B-9.001 to B-9.032 of formula IB where A14 is N, A24 is N, A34 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table B-10 provides 32 compounds from B-10.001 to B-10.032 of formula IB where A14 is N, A24 is N, A34 is CH, R1 is H, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table B-11 provides 32 compounds from B-11.001 to B-11.032 of formula IB where A14 is N, A24 is N, A34 is CH, R1 is H, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table B-12 provides 32 compounds from B-12.001 to B-12.032 of formula IB where A14 is N, A24 is N, A34 is CH, R1 is H, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table B-13 provides 32 compounds from B-13.001 to B-13.032 of formula IB where A14 is N, A24 is N, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table B-14 provides 32 compounds from B-14.001 to B-14.032 of formula IB where A14 is N, A24 is N, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table B-15 provides 32 compounds from B-15.001 to B-15.032 of formula IB where A14 is N, A24 is N, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table B-16 provides 32 compounds from B-16.001 to B-16.032 of formula IB where A14 is N, A24 is N, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table B-17 provides 32 compounds from B-17.001 to B-17.032 of formula IB where A14 is N, A24 is N, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table B-18 provides 32 compounds from B-18.001 to B-18.032 of formula IB where A14 is N, A24 is N, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table B-19 provides 32 compounds from B-19.001 to B-19.032 of formula IB where A14 is N, A24 is CH, A34 is N, R1 is H, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table B-20 provides 32 compounds from B-20.001 to B-20.032 of formula IB where A14 is N, A24 is CH, A34 is N, R1 is H, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table B-21 provides 32 compounds from B-21.001 to B-21.032 of formula IB where A14 is N, A24 is CH, A34 is N, R1 is H, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table B-22 provides 32 compounds from B-22.001 to B-22.032 of formula IB where A14 is N, A24 is CH, A34 is N, R1 is CH3, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table B-23 provides 32 compounds from B-23.001 to B-23.032 of formula IB where A14 is N, A24 is CH, A34 is N, R1 is CH3, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table B-24 provides 32 compounds from B-24.001 to B-24.032 of formula IB where A14 is N, A24 is CH, A34 is N, R1 is CH3, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table B-25 provides 32 compounds from B-25.001 to B-25.032 of formula IB where A14 is N, A24 is CH, A34 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table B-26 provides 32 compounds from B-26.001 to B-26.032 of formula IB where A14 is N, A24 is CH, A34 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table B-27 provides 32 compounds from B-27.001 to B-27.032 of formula IB where A14 is N, A24 is CH, A34 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table B-28 provides 32 compounds from B-28.001 to B-28.032 of formula IB where A14 is N, A24 is CH, A34 is CH, R1 is H, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table B-29 provides 32 compounds from B-29.001 to B-29.032 of formula IB where A14 is N, A24 is CH, A34 is CH, R1 is H, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table B-30 provides 32 compounds from B-30.001 to B-30.032 of formula IB where A14 is N, A24 is CH, A34 is CH, R1 is H, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table B-31 provides 32 compounds from B-31.001 to B-31.032 of formula IB where A14 is N, A24 is CH, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table B-32 provides 32 compounds from B-32.001 to B-32.032 of formula IB where A14 is N, A24 is CH, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table B-33 provides 32 compounds from B-33.001 to B-33.032 of formula IB where A14 is N, A24 is CH, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table B-34 provides 32 compounds from B-34.001 to B-34.032 of formula IB where A14 is N, A24 is CH, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table B-35 provides 32 compounds from B-35.001 to B-35.032 of formula IB where A14 is N, A24 is CH, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table B-36 provides 32 compounds from B-12.001 to B-36.032 of formula IB where A14 is N, A24 is CH, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table B-37 provides 32 compounds from B-37.001 to B-37.032 of formula IB where A14 is CH, A24 is N, A34 is N, R1 is H, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table B-38 provides 32 compounds from B-38.001 to B-38.032 of formula IB where A14 is CH, A24 is N, A34 is N, R1 is H, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table B-39 provides 32 compounds from B-39.001 to B-39.032 of formula IB where A14 is CH, A24 is N, A34 is N, R1 is H, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table B-40 provides 32 compounds from B-40.001 to B-40.032 of formula IB where A14 is CH, A24 is N, A34 is N, R1 is CH3, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table B-41 provides 32 compounds from B-41.001 to B-41.032 of formula IB where A14 is CH, A24 is N, A34 is N, R1 is CH3, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table B-42 provides 32 compounds from B-42.001 to B-42.032 of formula IB where A14 is CH, A24 is N, A34 is N, R1 is CH3, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table B-43 provides 32 compounds from B-43.001 to B-43.032 of formula IB where A14 is CH, A24 is N, A34 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table B-44 provides 32 compounds from B-44.001 to B-44.032 of formula IB where A14 is CH, A24 is N, A34 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table B-45 provides 32 compounds from B-45.001 to B-45.032 of formula IB where A14 is CH, A24 is N, A34 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table B-46 provides 32 compounds from B-46.001 to B-46.032 of formula IB where A14 is CH, A24 is N, A34 is CH, R1 is H, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table B-47 provides 32 compounds from B-47.001 to B-47.032 of formula IB where A14 is CH, A24 is N, A34 is CH, R1 is H, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table B-48 provides 32 compounds from B-48.001 to B-48.032 of formula IB where A14 is CH, A24 is N, A34 is CH, R1 is H, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table B-49 provides 32 compounds from B-49.001 to B-49.032 of formula IB where A14 is CH, A24 is N, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH3, and T are as defined in Table Z. Table B-50 provides 32 compounds from B-50.001 to B-50.032 of formula IB where A14 is CH, A24 is N, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table B-51 provides 32 compounds from B-51.001 to B-51.032 of formula IB where A14 is CH, A24 is N, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table B-52 provides 32 compounds from B-52.001 to B-52.032 of formula IB where A14 is CH, A24 is N, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table B-53 provides 32 compounds from B-53.001 to B-53.032 of formula IB where A14 is CH, A24 is N, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table B-54 provides 32 compounds from B-54.001 to B-54.032 of formula IB where A14 is CH, A24 is N, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table B-55 provides 32 compounds from B-55.001 to B-55.032 of formula IB where A14 is CH, A24 is CH, A34 is N, R1 is H, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table B-56 ​​provides 32 compounds from B-56.001 to B-56.032 of formula IB where A14 is CH, A24 is CH, A34 is N, R1 is H, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table B-57 provides 32 compounds from B-57.001 to B-57.032 of formula IB where A14 is CH, A24 is CH, A34 is N, R1 is H, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table B-58 provides 32 compounds from B-58.001 to B-58.032 of formula IB where A14 is CH, A24 is CH, A34 is N, R1 is CH3, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table B-59 provides 32 compounds from B-59.001 to B-59.032 of formula IB where A14 is CH, A24 is CH, A34 is N, R1 is CH3, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table B-60 provides 32 compounds from B-60.001 to B-60.032 of formula IB where A14 is CH, A24 is CH, A34 is N, R1 is CH3, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table B-61 provides 32 compounds from B-61.001 to B-61.032 of formula IB where A14 is CH, A24 is CH, A34 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table B-62 provides 32 compounds from B-62.001 to B-62.032 of formula IB where A14 is CH, A24 is CH, A34 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table B-63 provides 32 compounds from B-63.001 to B-63.032 of formula IB where A14 is CH, A24 is CH, A34 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table B-64 provides 32 compounds from B-64.001 to B-64.032 of formula IB where A14 is CH, A24 is CH, A34 is CH, R1 is H, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table B-65 provides 32 compounds from B-65.001 to B-65.032 of formula IB where A14 is CH, A24 is CH, A34 is CH, R1 is H, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table B-66 provides 32 compounds from B-66.001 to B-66.032 of formula IB where A14 is CH, A24 is CH, A34 is CH, R1 is H, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table B-67 provides 32 compounds from B-67.001 to B-67.032 of formula IB where A14 is CH, A24 is CH, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table B-68 provides 32 compounds from B-68.001 to B-68.032 of formula IB where A14 is CH, A24 is CH, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table B-69 provides 32 compounds from B-69.001 to B-69.032 of formula IB where A14 is CH, A24 is CH, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table B-70 provides 32 compounds from B-70.001 to B-70.032 of formula IB where A14 is CH, A24 is CH, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table B-71 provides 32 compounds from B-71.001 to B-71.032 of formula IB where A14 is CH, A24 is CH, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table B-72 provides 32 compounds from B-72.001 to B-72.032 of formula IB where A14 is CH, A24 is CH, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table B-73 provides 32 compounds from B-73.001 to B-73.032 of formula IB where A14 is N, A24 is CH, A34 is CH, R1 is H, R3 is CH3, R4c is CH2CH3 and T are as defined in Table Z. Table B-74 provides 32 compounds from B-74.001 to B-74.032 of formula IB where A14 is N, A24 is CH, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH2CH3 and T are as defined in Table Z. Table B-75 provides 32 compounds from B-75.001 to B-75.032 of formula IB where A14 is N, A24 is CH, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2CH3 and T are as defined in Table Z. Table B-76 provides 32 compounds from B-76.001 to B-76.032 of formula IB where A14 is CH, A24 is N, A34 is CH, R1 is H, R3 is CH3, R4c is CH2CH3 and T are as defined in Table Z. Table B-77 provides 32 compounds from B-77.001 to B-77.032 of formula IB where A14 is CH, A24 is N, A34 is CH, R1 is CH3, R3 is CH3, R4c is CH2CH3 and T are as defined in Table Z. Table B-78 provides 32 compounds from B-78.001 to B-78.032 of formula IB where A14 is CH, A24 is N, A34 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2CH3 and T are as defined in Table Z. Tables C-1 to C-21 (Formula IC) Table C-1 provides 32 compounds from C-1.001 to C-1.032 of formula IC where A14 is N, R is H, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table C-2 provides 32 compounds from C-2.001 to C-2.032 of formula IC where A14 is N, R1 is H, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table C-3 provides 32 compounds from C-3.001 to C-3.032 of formula IC where A14 is N, R1 is H, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table C-4 provides 32 compounds from C-4.001 to C-4.032 of formula IC where A14 is N, R1 is CH3, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table C-5 provides 32 compounds from C-5.001 to C-5.032 of formula IC where A14 is N, R1 is CH3, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table C-6 provides 32 compounds from C-6.001 to C-6.032 of formula IC where A14 is N, R1 is CH3, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table C-7 provides 32 compounds from C-7.001 to C-7.032 of formula IC where A14 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table C-8 provides 32 compounds from C-8.001 to C-8.032 of formula IC where A14 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table C-9 provides 32 compounds from C-9.001 to C-9.032 of formula IC where A14 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table C-10 provides 32 compounds from C-10.001 to C-10.032 of formula IC where A14 is CH, R1 is H, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table C-11 provides 32 compounds from C-11.001 to C-11.032 of formula IC where A14 is CH, R1 is H, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table C-12 provides 32 compounds from C-12.001 to C-12.032 of formula IC where A14 is CH, R1 is H, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table C-13 provides 32 compounds from C-13.001 to C-13.032 of formula IC where A14 is CH, R1 is CH3, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table C-14 provides 32 compounds from C-14.001 to C-14.032 of formula IC where A14 is CH, R1 is CH3, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table C-15 provides 32 compounds from C-15.001 to C-15.032 of formula IC where A14 is CH, R1 is CH3, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table C-16 provides 32 compounds from C-16.001 to C-16.032 of formula IC where A14 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table C-17 provides 32 compounds from C-17.001 to C-17.032 of formula IC where A14 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table C-18 provides 32 compounds from C-18.001 to C-18.032 of formula IC where A14 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table C-19 provides 32 compounds from C-19.001 to C-19.032 of formula IC where A14 is N, R1 is H, R3 is CH3, R4c is CH2CH3 and T are as defined in Table Z. Table C-20 provides 32 compounds from C-20.001 to C-20.032 of formula IC where A14 is N, R1 is H, R3 is CH3, R4c is CH2CH3 and T are as defined in Table Z. Table C-21 provides 32 compounds from C-21.001 to C-21.032 of formula IC where A14 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2CH3 and T are as defined in Table Z. Tables D-1 to D-21 (Formula ID) Table D-1 provides 32 compounds from D-1.001 to D-1.032 of formula ID where A14 is N, R1 is H, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table D-2 provides 32 compounds from D-2.001 to D-2.032 of formula ID where A14 is N, R1 is H, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table D-3 provides 32 compounds from D-3.001 to D-3.032 of formula ID where A14 is N, R1 is H, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table D-4 provides 32 compounds from D-4.001 to D-4.032 of formula ID where A14 is N, R1 is CH3, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table D-5 provides 32 compounds from D-5.001 to D-5.032 of formula ID where A14 is N, R1 is CH3, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table D-6 provides 32 compounds from D-6.001 to D-6.032 of formula ID where A14 is N, R1 is CH3, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table D-7 provides 32 compounds from D-7.001 to D-7.032 of formula ID where A14 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table D-8 provides 32 compounds from D-8.001 to D-8.032 of formula ID where A14 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table D-9 provides 32 compounds from D-9.001 to D-9.032 of formula ID where A14 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table D-10 provides 32 compounds from D-10.001 to D-10.032 of formula ID where A14 is CH, R1 is H, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table D-11 provides 32 compounds from D-11.001 to D-11.032 of formula ID where A14 is CH, R1 is H, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table D-12 provides 32 compounds from D-12.001 to D-12.032 of formula ID where A14 is CH, R1 is H, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table D-13 provides 32 compounds from D-13.001 to D-13.032 of formula ID where A14 is CH, R1 is CH3, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table D-14 provides 32 compounds from D-14.001 to D-14.032 of formula ID where A14 is CH, R1 is CH3, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table D-15 provides 32 compounds from D-15.001 to D-15.032 of formula ID where A14 is CH, R1 is CH3, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table D-16 provides 32 compounds from D-16.001 to D-16.032 of formula ID where A14 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH3 and T are as defined in Table Z. Table D-17 provides 32 compounds from D-17.001 to D-17.032 of formula ID where A14 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-CF2H and T are as defined in Table Z. Table D-18 provides 32 compounds from D-18.001 to D-18.032 of formula ID where A14 is CH, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2-cyclopropyl and T are as defined in Table Z. Table D-19 provides 32 compounds from D-19.001 to D-19.032 of formula ID where A14 is N, R1 is H, R3 is CH3, R4c is CH2CH3 and T are as defined in Table Z. Table D-20 provides 32 compounds from D-20.001 to D-20.032 of formula ID where A14 is N, R1 is CH3, R3 is CH3, R4c is CH2CH3 and T are as defined in Table Z. Table D-21 provides 32 compounds from D-21.001 to D-21.032 of formula ID where A14 is N, R1 is CH2-cyclopropyl, R3 is CH3, R4c is CH2CH3 and T are as defined in Table Z. Certain intermediate compounds with formulas II(i), III(i), IV(i), IVa(i), V(i), VI(i), VII(i), VIII(i), IX(i), X(i), XI(i), XII(i), XIV(i), XV(i), XVI(i), XX(i), XXI(i), and XXII(i) are also available, some of which are novel. For example: a compound of formula XII(i), or a tautomer thereof, or a salt thereof: XII (i) where A14, A24, A34 and R4c are as defined in any one of Tables A-1 to A-78, and Tables B-1 to B-78 provided that such compound is not iridazinone, nor a tautomer thereof; nor 6-hydrazinyl-2-ethyl-3 (2H)-pyridazinone, nor a tautomer thereof, both of which can be identified from Herberich et al, 2011, Bioorganic & Medicinal Chemistry Letters, vol.22, no. 2, pages 1226-1229, "Identification of triazolopyridazinones as potent p38[alpha] inhibitors". -compounds of formula XVI (i): where one of A14 and A24 is N, the other is CH, R4c are as defined in any one of Tables A-1 to A-78 and Tables B-1 to B-78, and M1 is a metal-containing substituent, for example, a boron substituent or a tin substituent, such as, for example, tributylstannyl, borone, or 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl, provided that such compounds of formula XVI(i) are not: - 2-methyl-6-trimethylstannyl-pyridazin-3-one (CAS 2254337-53-4), - [5-oxo-4-(2,2,2-trifluoroethyl)pyrazin-2-yl]boronic acid (CAS 2509138-33-2), - 5- (4, 4, 5, 5-tetramethyl-1, 3, 2-dioxaborolan-2-yl) -1- (2, 2, 2-trifluoroethyl) pyrazin-2-one (CAS 2509138-04-7), - (2-methyl-6- (4, 4, 5, 5-tetramethyl-1, 3, 2-dioxaborolan-2-yl)pyridazin-3-one (CAS 1610374-18-9), - 2-isopropyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridazin-3-one (CAS 2768712-84-9), - (1-methyl-6-oxo-pyridazin-3-yl)boronic acid (CAS 1872185-45-9) , nor - (1-isopropyl-6-oxo-pyridazin-3-yl) boronic acid (CAS 2334476-21-8). - compounds of the formulas XX (i) , XXI (i) and XXII (i) , where R4a, including A14, A24, A34 and R4c, is as defined in any one of Tables A-1 to A-78, and Tables B-1 to B-78, and where X- is an anion, i.e., the conjugate base of an acid, such as an inorganic acid, e.g., hydrochloric acid, hydrobromic acid, hydrogen fluoride, hydrogen iodide, sulfuric acid or the like, or of an organic acid, such as a carboxylic acid or a sulfonic acid, e.g., trifluoroacetic acid, or methanesulfonic acid, or para-toluenesulfonic acid. - compounds of formulas XXVI(i), XXVII(i) and XXVII-a(i), where R4b, including A14 and R4c, is as defined in any one of Tables C-1 to C-21 and Tables D-1 to D-21, and where X- is an anion, i.e., the conjugate base of an acid, such as an inorganic acid, for example, hydrochloric acid, hydrobromic acid, hydrogen fluoride, hydrogen iodide, sulfuric acid, or the like, or of an organic acid, such as a carboxylic acid or a sulfonic acid, for example, trifluoroacetic acid, methanesulfonic acid, or para-toluenesulfonic acid. Preferably, A14 is N, and R4c is selected from methyl or ethyl. Accordingly, in a further aspect, the present invention makes available compounds of formulas II(i), III(i), IV(i), IVa(i), V(i), VI(i), VII(i), VIII(i), IX(i), X(i), XI(i), XII(i), XIV(i), XV(i), XVI(i), XX(i), XXI(i), and XXII(i), wherein in each case, when applicable, A1, A2, A3, A4, A5, X0, R1, R2a, R2b, R3, Qa (including R5, R4c and R4 as R4a or R4b), Qb (including R5a, R5b, R4c and R4 as R4a or R4b), R4, R4a (including A14, A24, A34) and R4c), R4b (including A14 and R4c), RX, RY, and RZ are as defined for formula (I) in the first aspect, and - T is where the zigzag line represents the connection to the rest of the compounds of formulas (II) , (IV) , (IVa) , (X) , (XI) , (XVII) - with respect to compounds of formula II (i) , X1 is a leaving group, such as a halogen, hydroxyl or sulfonate, for example, chloride; - with respect to compounds of formula V(i), X2 is a leaving group, such as a halogen, for example chloride or bromide, or a sulfonate, for example mesylate; - with respect to compounds of formula VI (i) , X2 is a leaving group, such as a halogen, for example a chloride, bromide, iodide, or a sulfonate, for example a mesylate; - with respect to compounds of formula XV(i), X4 is a leaving group, such as, for example, a halogen, for example, chlorine, a sulfonate, C1-C4 sulfanil, C1-C4 sulfinil or C1-C4 sulfonyl; - with respect to compounds of formula XVI(i), M1 is a metal-containing substituent, for example a boron substituent or a tin substituent, such as, for example, tributylstanyl, borone or 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl; - with respect to compounds of formula XX(i), X- is an anion, i.e., the conjugate base of an acid, such as an inorganic acid, for example, hydrochloric acid, hydrobromic acid, hydrogen fluoride, hydrogen iodide, sulfuric acid or the like, or of an organic acid, such as a carboxylic acid or a sulfonic acid, for example, trifluoroacetic acid, or methanesulfonic acid, or para-toluenesulfonic acid. Furthermore, the corresponding realizations illustrated for formula (I) also apply to compounds of formulas II (i) , III (i) , IV (i) , IVa (i) , V (i) , VI (i) , VII ( i) , VIII (i) , IX (i) , X (i) , XI (i) , XII (i) , XIV (i) , XV (i) , XVI (i) , XX (i) , XXI ( i) , and XXII (i) , as applicable. The compounds of formula (I) according to the invention are valuable active ingredients for prevention and / or treatment in pest control, even at low application rates. They have a highly favorable biocidal spectrum and are well-tolerated by warm-blooded animals, fish, and plants. The active ingredients according to the invention act against all developmental stages or individual stages of normally susceptible, but also resistant, animal pests, such as insects or members of the order Acarina. The insecticidal or acaricidal activity of the active ingredients according to the invention can manifest itself directly, i.e., in the destruction of the pests, which occurs immediately or only after a certain time has elapsed, for example, during ecdysis, or indirectly, for example, in a reduced oviposition and / or incubation rate. Some examples of the previously mentioned animal plagues are: del orden de los ácaros, por ejemplo, Acalitus spp, Aculus spp, Acaricalus spp, Aceria spp, Acarus siro, Amblyomma spp., Argas spp., Boophilus spp., Brevipalpus spp., Br y obia spp, Calipitrimerus spp., Chorioptes spp., Dermanyssus gallinae, Dermatophagoides spp, Eotetranychus spp, Eriophyes spp., Hemitarsonemus spp, Hyalomma spp., Ixodes spp., Olygonychus spp, Ornithodoros spp., Polyphagotarsone latus, Panonychus spp., Phyllocoptruta oleivora, Phytonemus spp, Polyphagotarsonemus spp, Psoroptes spp., Rhipicephalus spp., Rhizoglyphus spp., Sarcoptes spp., Steneotarsonemus spp, Tarsonemus spp. and Tetranychus spp.; del orden de los anópluros, por ejemplo, Haematopinus spp., Linognathus spp., Pediculus spp., Pemphigus spp. and Phylloxera spp.; del orden de los coleópteros, por ejemplo, Agriotes spp., Amphimallon majale, Anomala orientalis, Anthonomus spp., Aphodius spp., Astylus atromaculatus, Ataenius spp., Atomaria linearis, Chaetocnema tibialis, Cerotoma spp., Conoderus spp., Cosmopolites spp., Cotinis nitida, Curculio spp., Cyclocephala spp., Dermestes spp., Diabrotica spp., Diloboderus abderus, Epilachna spp., Eremnus spp., Heteronychus arator, Hypothenemus hampei, Lagria vilosa, Leptinotarsa ​​decemlineata, Lissorhoptrus spp., Liogenys spp., Maecolaspis spp., Maladera castanea, Megascelis spp., Melighetes aeneus, Melolontha spp., Myochrous armatus, Or y caephilus spp., Otiorhynchus spp., Phyllophaga spp., Phlyctinus spp., Popillia spp., Psylliodes spp., Rhyssomatus aubtilis, Rhizopertha spp., Scarabeidae, Sitophilus spp., Sitotroga spp., Somaticus spp., Sphenophorus spp., Sternechus subsignatus, Tenebrio spp., Tribolium spp. and Trogoderma spp.; del orden de los dípteros, por ejemplo, Aedes spp., Anopheles spp., Antherigona soccata, Bactrocea oleae, Bibio hortulanus, Bradysia spp., Calliphora er y throcephala, Ceratitis spp., Chrysomyia spp., Culex spp., Cuterebra spp., Dacus spp., Delia spp., Drosophila melanogaster, Fannia spp., Gastrophilus spp., Geomyza tripunctata, Glossina spp., Hypoderma spp., Hyppobosca spp., Liriomyza spp., Lucilia spp., Melanagromyza spp., Musca spp., Oestrus spp., Orseolia spp., Oscinella frit, Pegomyia hyoscyami, Phorbia spp., Rhagoletis spp., Rivelia quadrifasciata, Scatella spp., Sciara spp., Stomoxys spp., Tabanus spp., Tannia spp. and Tipula spp.; of the order Hemiptera, for example, Acanthocoris scabrator, Acrosternum spp, Adelphocoris lineolatus, Aleurodes spp., Amblypelta nitida, Bathycoelia thalassina, Blissus spp, Cimex spp., Clavigralla tomentosicollis, Creontiades spp, Distantiella theobroma, Dichelops furcatus, Dysdercus spp., Edessa spp, Euchistus spp., Eurydema pulchrum, Eurygaster spp., Halyomorpha halys, Horcias nobilellus, Leptocorisa spp., Lygus spp, Margarodes spp, Murgantia histrionic, Neomegalotomus spp, Nesidiocoris tenuis, Nezara spp., Nysius simulans, Oebalus insularis, Piesma spp., Piezodorus spp, Rhodnius spp., Sahlbergella singularis, Scaptocoris castanea, Scotinophara spp., Thyanta spp, Triatoma spp., Vatiga illudens; of the order Homoptera, for example, Acyrthosium pisum, Adalges spp, Agalliana ensigera, Agonoscena targionii, Aleurodicus spp, Aleurocanthus spp, Aleurolobus barodensis, Aleurothrixus floccosus, Aleyrodes brassicae, Amarasca biguttula, Amritodus atkinsoni, Aonidiella spp., Aphididae, Aphis spp., Aspidiotus spp., Aulacorthum solani, Bactericera cockerelli, Bemisia spp, Brachycaudus spp, Brevicor y ne brassicae, Cacopsylla spp, Cavariella aegopodii Scop., Ceroplaster spp., Chry somphalus aonidium, Chry somphalus dictyospermi, Cicadella spp, Cofana spectra, Cr y ptomyzus spp, Cicadulina spp, Coccus hesperidum, Dalbulus maidis, Dialeurodes spp, Diaphorina citri, Diuraphis noxia, Dysaphis spp, Empoasca spp., Eriosoma larigerum, Er y throneura spp., Gascardia spp., Glycaspis brimblecombei, Hyadaphis pseudobrassicae, Hyalopterus spp, Hyperomyzus pallidus, Idioscopus clypealis, Jacobiasca lybica, Laodelphax spp., Lecanium corni, Lepidosaphes spp., Lopaphis er y simi, Lyogenys maidis, Macrosiphum spp., Mahanarva spp, Metcalfa pruinosa, Metopolophium dirhodum, Myndus crudus, Myzus spp., Neotoxoptera sp, Nephotettix spp., Nilaparvata spp., Nippolachnus piri Mats, Odonaspis ruthae, Oregma lanigera Zehnter, Parabemisia myricae, Paratrioza cockerelli, Parlatoria spp., Pemphigus spp., Peregrinus maidis, Perkinsiella spp, Phorodon humuli, Phylloxera spp, Planococcus spp., Pseudaulacaspis spp., Pseudococcus spp., Pseudatomoscelis seriatus, Psylla spp., Pulvinaria aethiopica, Quadraspidiotus spp., Quesada gigas, Recilia dorsalis, Rhopalosiphum spp., Saissetia spp., Scaphoideus spp., Schizaphis spp., Sitobion spp., Sogatella furcifera, Spissistilus festinus, Tarophagus Proserpina, Toxoptera spp, Trialeurodes spp, Tridiscus sporoboli, Trionymus spp, Trioza er y treae, Unaspis citri, Zygina flammigera, Zyginidia scutellaris, ;. del orden hymenópteros, por ejemplo, Acromyrmex, Arge spp., Atta spp., Cephus spp., Diprion spp., Diprionidae, Gilpinia polytoma, Hoplocampa spp., Lasius spp., Monomorium pharaonis, Neodiprion spp., Pogonomyrmex spp., Slenopsis invicta, Solenopsis spp. y Vespa spp.; del orden de los isópteros, por ejemplo, Coptotermes spp, Cornitermes cumulans, Incisitermes spp, Macrotermes spp, Mastotermes spp, Microtermes spp, Reticulitermes spp.; Solenopsis geminate; of the order Lepidoptera, for example, Acleris spp., Adoxophyes spp., Aegeria spp., Agrotis spp., Alabama argillaceae, Amylois spp., Anticarsia gemmatalis, Archips spp., Argyresthia spp., Argyrotaenia spp., Autographa spp., Bucculatrix thurberiella Busseola fusca, Cadra cautella, Carposina nipponensis, Chilo spp., Choristoneura spp., Chr y soteuchia topiaria, Clysia ambiguella, Cnaphalocrocis spp., Cnephasia spp., Cochylis spp., Coleophora spp., Colias lesbia, Cosmophila flava, Crambus spp., Crocidolomia binotalis, Cr y ptophlebia leucotreta, Cydalima perspectalis, Cydia spp., Diaphania perspectalis, Diatraea spp., Diparopsis castanea, Earias spp., Eldana saccharina, Ephestia spp., Epinotia spp., Estigmene acrea, Etiella zinckinella, Eucosma spp., Eupoecilia ambiguella, Euproctis spp., Euxoa spp., Feltia jaculiferia, Grapholita spp., Hedya nubiferana, Heliothis spp., Hellula undalis, Herpetogramma spp., Hyphantria cunea, Keiferia lycopersicella, Lasmopalpus lignosellus, Leucoptera scitella, Lithocollethis spp., Lobesia botrana, Loxostege bifidalis, Lymantria spp., Lyonetia spp., Malacosoma spp., Mamestra brassicae, Manduca sexta, Mythimna spp., Noctua spp., Operophtera spp., Orniodes indica, Ostrinia nubilalis, Pammene spp., Pandemis spp., Panolis flammea, Papaipema nebris, Pectinophora gossypiela, Perileucoptera coffeella, Pseudaletia unipuncta, Phthorimaea operculella, Pieris rapae, Pieris spp., Plutella xylostella, Prays spp., Pseudoplusia spp., Rachiplusia nu, Richia albicosta, Scirpophaga spp., Sesamia spp., Sparganothis spp., Spodoptera spp., Sylepta derogate, Synanthedon spp., Thaumetopoea spp., Tortrix spp., Trichoplusia ni, Tuta absoluta and Yponomeuta spp.;. of the order Mallophaga, por ejemplo, Damalinea spp. y Trichodectes spp.; del orden de los ortópteros, por ejemplo, Blatta spp., Blattella spp., Gr y llotalpa spp., Leucophaea woode, Locusta spp., Neocurtilla hexadactyla, Periplaneta spp., Scapteriscus spp, and Schistocerca spp.; of the order Psocoptera, for example, Liposcelis spp.; of the order Siphonaptera, for example, Ceratophyllus spp., Ctenocephalides spp. and Xenopsylla cheopis; of the order Thysanoptera, for example, Calliothrips phaseoli, Frankliniella spp., Heliothrips spp, Hercinothrips spp., Parthenothrips spp, Scirtothrips aurantii, Sericothrips variabilis, Taeniothrips spp., Thrips spp; of the order Thysanura, for example, Lepisma saccharina. In an additional aspect, the invention may also relate to a method for controlling damage to plants and parts thereof caused by plant-parasitic nematodes (endoparasitic, semi-endoparasitic and ectoparasitic nematodes), especially plant-parasitic nematodes such as root-knot nematodes, Meloidogyne hapla, Meloidogyne incognita, Meloidogyne javanica, Meloidogyne arenaria and other species of Meloidogyne; cyst-forming nematodes, Globodera rostochiensis and other species of Globodera; Heterodera avenae, Heterodera glycines, Heterodera schachtii, Heterodera trifolii and other species of Heterodera; seed-gall nematodes, species of Anguina; stem and leaf nematodes, species of Aphelenchoides; stinging nematodes, Belonolaimus longicaudatus and other species of Belonolaimus; pine nematodes, Bursaphelenchus xylophilus and other species of Bursaphelenchus;ring nematodes, species of Criconema, Criconemella, Criconemoides, Mesocriconema; stem and bulb nematodes, Ditylenchus destructor, Ditylenchus dipsaci and other species of Ditylenchus; puncture nematodes, species of Dolichodorus; coil nematodes, Heliocotylenchus multicinctus and other species of Helicotylenchus; sheath and envelope nematodes, species of Hemicycliophora and Hemicriconemoides; species of Hirshmanniella; spear nematodes, species of Hoploaimus; false root-knot nematodes, species of Nacobbus; needle nematodes, Longidorus elongatus and other species of Longidorus; pin-nematodes, species of Pratylenchus; Lesion nematodes, Pratylenchus neglectus, Pratylenchus penetrans, Pratylenchus curvitatus, Pratylenchus goodeyi and other Pratylenchus species; burrowing nematodes, Radopholus similis and other Radopholus species;Reniform nematodes, Rotylenchus robustus, Rotylenchus reniformis and other Rotylenchus species; Scutellonema species; short-rooted, thick-rooted nematodes, Trichodorus primitivus and other Trichodorus species, Paratrichodorus species; stunting nematodes, Tylenchorhynchus claytoni, Tylenchorhynchus dubius and other Tylenchorhynchus species; citrus nematodes, Tylenchulus species; dagger nematodes, Xiphinema species; and other species of plant-parasitic nematodes, such as Subanguina spp., Hypsoperine spp., Macroposthonia spp., Melinius spp., Punctodera spp. and Quinisulcius spp.; The compounds of the invention may also have activity against molluscs. Some examples include, for example, Ampullariidae; Arion (A. ater, A. circumscriptus, A. hortensis, A. rufus); Bradybaenidae (Bradybaena fruticum); Cepaea (C. hortensis, C. Nemoralis); ochlodina; Deroceras (D. agrestis, D. empiricorum, D. laeve, D. reticulatum); Discus (D. rotundatus); Euomphalia; Galba (G. trunculata); Helicelia (H. itala, H. obvia); Helicidae (Helicigona arbustorum); Helicodiscus; Helix (H. aperta); Limax (L. cinereoniger, L. flavus, L. marginatus, L. maximus, L. tenellus); Lymnaea; Milax (M. gagates, M. marginatus, M. sowerbyi); OPEAS; Pomacea (P. canaticulata); Wallonia and Zanitoides. The active principles according to the invention can be used to control, i.e., contain or destroy, pests of the type mentioned above that manifest themselves particularly in plants, especially in useful and ornamental plants in agriculture, horticulture and forestry, or in organs such as fruits, flowers, foliage, stems, tubers or roots of said plants and, in some cases, even the organs of the plants that are subsequently formed are kept protected against these pests. Suitable target crops include, in particular, cereals such as wheat, barley, rye, oats, rice, maize, or sorghum; beets such as sugar or fodder beets; fruit, for example, pome fruit, stone fruit, or berries, such as apples, pears, plums, peaches, almonds, cherries, or berries, for example, strawberries, raspberries, or blackberries; legume crops such as beans, lentils, peas, or soybeans; oil crops such as rapeseed, mustard, poppies, olives, sunflowers, coconut, castor beans, cocoa, or peanuts; cucurbits such as pumpkins, cucumbers, or melons; fiber plants such as cotton, flax, hemp, or jute; citrus fruits such as oranges, lemons, grapefruits, or tangerines; and vegetables such as spinach, lettuce, asparagus, cabbage, carrots, onions, tomatoes, potatoes, or peppers. laurels such as avocado, cinnamon or camphor;and also tobacco, nuts, coffee, eggplants, sugar cane, tea, pepper, grapevines, hops, the plantaginaceae family and latex-producing plants.; The compositions and / or methods of the present invention can also be used in any ornamental and / or vegetable crop, including flowers, shrubs, broadleaf and evergreen trees. Por ejemplo, la invención puede usarse en cualquiera de las siguientes species ornamentales: Ageratum spp., Alonsoa spp., Anemone spp., Anisodontea capsenisis, Anthemis spp., Antirrhinum spp., Aster spp., Begonia spp. (for example, B. elatior, B. semperflorens, B. tubéreux) , Bougainvillea spp., Brachycome spp., Brassica spp. (ornamental), Calceolaria spp., Capsicum annum, Catharanthus roseus, Canna spp., Centaurea spp., Chrysanthemum spp., Cineraria spp. (C. maritime) , Coreopsis spp., Crassula coccinea, Cuphea ignea, Dahlia spp., Delphinium spp., Dicentra spectabilis, Dorotheantus spp., Eustoma grandiflorum, Forsythia spp., Fuchsia spp., Geranium gnaphalium, Gerbera spp., Gomphrena globosa, Heliotropium spp., Helianthus spp., Hibiscus spp., Hortensia spp., Hydrangea spp., Hypoestes phyllostachya, Impatiens spp. (I. Walleriana) , Iresines spp., Kalanchoe spp., Lantana camara, Lavatera trimestris, Leonotis leonurus, Lilium spp., Mesembr y anthemum spp., Mimulus spp., Monarda spp., Nemesia spp., Tagetes spp., Dianthus spp. (carnation) , Canna spp., Oxalis spp., Bellis spp., Pelargonium spp. (P. peltatum, P. zonale) , Viola spp. (pansy) , Petunia spp., Phlox spp., Plecthranthus spp., Poinsettia spp., Parthenocissus spp. (P. quinquefolia, P. tricuspidata) , Primula spp., Ranunculus spp., Rhododendron spp., Rosa spp. (rose) , Rudbeckia spp., Saintpaulia spp., Salvia spp., Scaevola aemola, Schizanthus wisetonensis, Sedum spp., Solanum spp., Surfinia spp., Tagetes spp., Nicotinia spp., Verbena spp., Zinnia spp. and other garden plants. For example, the invention can be used in any of the following plant species: Allium spp. (A. sativum, A. cepa, A. oschaninii, A. Porrum, A. ascalonicum, A. fistulosum) , Anthriscus cerefolium, Apium graveolus, Asparagus officinalis, Beta vulgarus, Brassica spp. (B. Oleracea, B. Pekinensis, B. rapa) , Capsicum annuum, Cicer arietinum, Cichorium endivia, Cichorum spp. (C. intybus, C. endivia) , Citrillus lanatus, Cucumis spp. (C. sativus, C. melo) , Cucurbita spp. (C. pepo, C. maxima) , Cyanara spp. (C. scolymus, C. cardunculus) , Daucus carota, Foeniculum vulgare, Hypericum spp., Lactuca sativa, Lycopersicon spp. (L. esculentum, L. lycopersicum), Mentha spp., Ocimum basilicum, Petroselinum crispum, Phaseolus spp. (P. vulgaris, P. coccineus), Pisum sativum, Raphanus sativus, Rheum rhaponticum, Rosemarinus spp., Salvia spp., Scorzonera hispanica, Solanum melongena, Spinacea oleracea, Valerianella spp. (V. locusta, V. eriocarpa) and Vicia faba. Preferred ornamental species include African violet, Begonia, Dahlia, Gerbera, Hydrangea, Verbena, Rose, Kalanchoe, Poinsettia, Aster, Centaurea, Coreopsis, Delphinium, Monarda, Phlox, Rudbeckia, Sedum, Petunia, Viola, Impatiens, Geranium, Chr and santhemum, Ranunculus, Fuchsia, Salvia, Hydrangea, rosemary, sage, St. John's wort, mint, sweet pepper, tomato, and cucumber. The active ingredients according to the invention are particularly suitable for controlling Aphis craccivora, Diabrotica balteata, Heliothis virescens, Myzus persicae, Plutella xylostella, and Spodoptera littoralis in cotton, vegetable, corn, rice, and soybean crops. The active ingredients according to the invention are also particularly suitable for controlling Mamestra (preferably in vegetables), Cydia pomonella (preferably in apples), Empoasca (preferably in vegetables and vineyards), Leptinotarsa ​​(preferably in potatoes), and Chilo suppressalis (preferably in rice). Compounds of formula I are particularly suitable for the control of a pest of the order Hemiptera, for example, one or more of the species Bemisia tabaci, Aphis craccivora, Myzus persicae, Rhopalosiphum padi, Nilaparvata lugens and Euschistus heros (preferably on vegetables, soybeans and sugarcane); a pest of the order Lepidoptera, for example, one or more of the species Spodoptera littoralis, Spodoptera frugiperda, Plutella xylostella, Cnaphalocrocis medinalis, Cydia pomonella, Chr and sodeixis includes, Chilo suppressalis, Elasmopalpus lignosellus, Pseudoplusia includens and Tuta absoluta (preferably on vegetables and corn); a pest of the order Thysanoptera, such as the family Thripidae, for example, one or more of Thrips tabaci and Frankliniella occidentalis (preferably on vegetables); and soil pests (such as those of the order Coleoptera), for example, the species Diabrotica balteata, Agriotes spp. and Leptinotarsa ​​decemlineata (preferably in vegetables and corn). It should be understood that the term "crops" also includes cultivated plants that have been transformed by the use of recombinant DNA techniques in such a way that they are able to synthesize one or more selectively acting toxins, such as, for example, those known to come from toxin-producing bacteria, especially those of the genus Bacillus. The toxins that can be expressed in such transgenic plants include, for example, insecticidal proteins from Bacillus cereus or Bacillus popilliae; or insecticidal proteins from Bacillus thuringiensis such as β-endotoxins, for example, Cr and 1Ab, Cr and 1Ac, Cr and 1F, Cr and 1Fa2, Cr and 2Ab, Cr and 3A, Cr and 3Bb1 or Cr and 9C, or vegetative insecticidal proteins (Vip), for example, Vip1, Vip2, Vip3 or Vip3A; or insecticidal proteins from bacteria that colonize nematodes, for example, Photorhabdus spp. or Xenorhabdus spp., such as Photorhabdus luminescens, Xenorhabdus nematophilus; toxins produced by animals such as scorpion toxins, arachnid toxins, wasp toxins and other insect-specific neurotoxins; toxins produced by fungi such as streptomycete toxins, plant lectins such as pea lectins, barley lectins or snowdrop lectins; agglutinins;Proteinase inhibitors such as trypsin inhibitors, serine protease inhibitors, patatin inhibitors, cystatin, papain; ribosome-disrupting proteins (RIPs) such as ricin, maize RIP, abrin, lufin, saporin, or bryodin; enzymes involved in steroid metabolism such as 3-hydroxysteroid oxidase, ecdysteroid-UDP-glucosyltransferase, cholesterol oxidases, ecdysone inhibitors, HMG-CoA reductase, ion channel blockers such as sodium or calcium channel blockers, juvenile hormone esterase, diuretic hormone receptors, stilbene synthase, bibenzyl synthase, chitinases, and glucanases. In the context of the present invention, the term "endotoxins" shall be understood to mean, for example, Cr and 1Ab, Cr and 1Ac, Cr and 1F, Cr and 1Fa2, Cr and 2Ab, Cr and 3A, Cr and 3Bb1, or Cr and 9C, or vegetative insecticidal proteins (Vip), for example, Vip1, Vip2, Vip3, or Vip3A, and specifically also hybrid toxins, truncated toxins, and modified toxins. Hybrid toxins are produced recombinantly by a novel combination of different domains of these proteins (see, for example, WO 02 / 15701). Truncated toxins are known, for example, a truncated Cr and 1Ab toxin. In the case of modified toxins, one or more of the toxin's natural amino acids are replaced. In such amino acid replacements, protease recognition sequences that are either naturally present or not are preferably inserted into the toxin, for example, in the case of Cr and 3A055, a cathepsin G recognition sequence is inserted into a Cr and 3A toxin (see document WO 03 / 018810). Examples of such toxins or transgenic plants capable of synthesizing such toxins are disclosed in, for example, documents EP-A-0374753, WO 93 / 07278, WO 95 / 34656, EP-A-0427529, EP-A-451878, and WO 03 / 052073. Processes for the preparation of such transgenic plants are generally known to those skilled in the art and are described, for example, in the publications mentioned above. Cr and I type deoxyribonucleic acids and their preparation are described, for example, in documents WO 95 / 34656, EP-A-0367474, EP-A-0 401979, and WO 90 / 13651. The toxin contained in transgenic plants confers tolerance to harmful insects. These insects can belong to any taxonomic group, but are most commonly found among beetles (Coleoptera), biwing insects (Diptera), and moths (Lepidoptera). Transgenic plants containing one or more genes encoding insecticide resistance and expressing one or more toxins are known, and some are commercially available. Examples of such plants include: YieldGard (a corn variety expressing Cr and 1Ab toxins); YieldGard Rootworm® (a corn variety expressing Cr and 3Bb1 toxins); YieldGard Plus® (a corn variety expressing Cr and 1Ab and Cr and 3Bb1 toxins); Starlink® (a corn variety expressing Cr and 9C toxins); and Herculex I® (a corn variety expressing Cr and 1Fa2 toxins and the enzyme phosphinothricin N-acetyltransferase (PAT) for tolerance to the herbicide glufosinate ammonium).NuCOTN 33B® (cotton variety expressing a Cr and 1Ac toxin), Bollgard I® (cotton variety expressing a Cr and 1Ac toxin), Bollgard II® (cotton variety expressing a Cr and 1Ac toxin and a Cr and 2Ab toxin), VipCot® (cotton variety expressing a Vip3A toxin and a Cr and 1Ab toxin), NewLeaf® (potato variety expressing a Cr and 3A toxin), NatureGard®, Agrisure® GT Advantage (glyphosate tolerant trait GA21), Agrisure® CB Advantage (corn borer (CB) trait Bt11) and Protecta®.; Other examples of such genetically modified crops are: 1. Bt11 maize from Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31790 St. Sauveur, France, registration number C / FR / 96 / 05 / 10. Genetically modified Zea mays that has been made resistant to attack by the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) through the transgenic expression of a truncated Cr and 1Ab toxin. Bt11 maize also transgenically expresses the PAT enzyme to achieve tolerance to the herbicide glufosinate ammonium. 2. Bt176 maize from Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31790 St. Sauveur, France, registration number C / FR / 96 / 05 / 10. Genetically modified Zea mays that has been made resistant to attack by the European maize borer (Ostrinia nubilalis and Sesamia nonagrioides) through the transgenic expression of a Cr and 1Ab toxin. Bt176 maize also transgenically expresses the PAT enzyme to achieve tolerance to the herbicide glufosinate ammonium. 3. MIR604 maize from Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31790 St. Sauveur, France, registration number C / FR / 96 / 05 / 10. Maize that has been made insect-resistant by the transgenic expression of a modified Cr and 3A toxin. This toxin is Cr and 3A055 modified by the insertion of a recognition sequence for the protease cathepsin G. The preparation of such transgenic maize plants is described in WO 03 / 018810. 4. Monsanto Europe SA270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C / DE / 02 / 9. MON 863 expresses a Cr and 3Bb1 toxin and has resistance to certain insects of the order Coleoptera. 5. IPC 531 Cotton from Monsanto Europe SA 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C / ES / 96 / 02. 6. Maize 1507 from Pioneer Overseas Corporation, Avenue Tedesco, 7 B-1160 Brussels, Belgium, registration number C / NL / 00 / 10. Maize genetically modified to express the Cr and 1F proteins, in order to achieve resistance to certain insects of the order Lepidoptera, and to express the PAT protein, in order to achieve tolerance to the herbicide glufosinate ammonium. 7. NK603 × MON 810 maize from Monsanto Europe SA270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C / GB / 02 / M3 / 03. Hybrid maize varieties conventionally bred by crossing the genetically modified varieties NK603 and MON 810. NK603 × MON 810 maize transgenically expresses the CP4 EPSPS protein, obtained from Agrobacterium sp. strain CP4, which imparts tolerance to the herbicide Roundup® (containing glyphosate), and also a Cr and 1Ab toxin obtained from Bacillus thuringiensis subsp. kurstaki, which produces tolerance to certain lepidopteran pests, including the European corn borer. Transgenic crops of insect-resistant plants are also described in BATS (Zentrum für Biosicherheit und Nachhaltigkeit, Zentrum BATS, Clarastrasse 13, 4058 Basel, Switzerland) Report 2003, (http: / / bats.ch). It should be understood that the term "crops" also includes cultivated plants that have been transformed using recombinant DNA techniques so that they are capable of synthesizing antipathogenic substances that have a selective action, such as, for example, so-called "pathogen-related proteins" (PRPs; see, for example, EP-A-0392225). Examples of such antipathogenic substances and of transgenic plants capable of synthesizing such antipathogenic substances are known, for example, from EP-A-0392225, WO 95 / 33818, and EP-A-0353191. Those skilled in the art are generally familiar with the methods for producing such transgenic plants, and these are described, for example, in the publications mentioned above. Crops can also be modified to enhance resistance to fungal pathogens (e.g., Fusarium, Anthracnose or Phytophthora), bacterial pathogens (e.g., Pseudomonas) or viral pathogens (e.g., potato leaf curl virus, tomato spotted wilt virus, cucumber mosaic virus). The crops also include those that have enhanced resistance to nematodes, such as the soybean cyst nematode. Crops that are tolerant to abiotic stress include those that have increased tolerance to drought, high salinity, high temperature, cold, frost, or light radiation, for example, through the expression of NF-YB or other proteins known in the technique. The antipathogenic substances that can be expressed by such transgenic plants include, for example, ion channel blockers, such as sodium and calcium channel blockers, for example, the viral toxins KP1, KP4 or KP6; stilbene synthases; bibenzyl synthases; chitinases; glucanases; so-called "pathogenesis-related proteins" (PRPs; see, for example, document EP-A-0392225), antipathogenic substances produced by microorganisms, for example, peptide antibiotics or heterocyclic antibiotics (see, for example, document WO 95 / 33818) or protein or polypeptide factors involved in the defense of the plant against pathogens (referred to as "plant disease resistance genes", as described in document WO 03 / 000906). Other areas of use for the compositions according to the invention are the protection of stored goods and warehouses, and the protection of raw materials, such as wood, textiles, floor coverings or buildings, and also in the hygiene sector, in particular, the protection of humans, domestic animals and productive livestock against pests of the type mentioned. The present invention provides a compound of the first aspect for use in therapy. The present invention provides a compound of the first aspect for use in the control of parasites in or on an animal. The present invention further provides a compound of the first aspect for use in the control of ectoparasites on an animal. The present invention further provides a compound of the first aspect for use in the prevention and / or treatment of diseases transmitted by ectoparasites. The present invention provides for the use of a compound of the first aspect for the manufacture of a medicament for controlling parasites in or on an animal. The present invention further provides for the use of a compound of the first aspect for the manufacture of a medicament for controlling ectoparasites in an animal. The present invention further provides for the use of a compound of the first aspect for the manufacture of a medicament for preventing and / or treating diseases transmitted by ectoparasites. The present invention provides for the use of a compound of the first aspect in the control of parasites in or on an animal. The present invention further provides for the use of a compound of the first aspect in the control of ectoparasites in an animal. The term "control," when used in the context of parasites in or on an animal, refers to reducing the number of pests or parasites, eliminating pests or parasites, and / or preventing further infestation by pests or parasites. The term "treat", when used in the context of parasites in or on an animal, refers to restricting, slowing, stopping, or reversing the progression or severity of an existing disease or symptom. The term "prevent", when used in the context of parasites in or on an animal, refers to avoiding the development of a symptom or disease in the animal. The term "animal," when used in the context of parasites in or on an animal, can refer to a mammal or a non-mammal, such as a bird or fish. In the case of a mammal, it can be a human or non-human mammal. Non-human mammals include, but are not limited to, farm animals and pets. Farm animals include, but are not limited to, cattle, camelids, pigs, sheep, goats, and horses. Pets include, but are not limited to, dogs, cats, and rabbits. A "parasite" is a pest that lives in or on a host animal and benefits by obtaining nutrients at the host's expense. An "endoparasite" is a parasite that lives in the host animal. An "ectoparasite" is a parasite that lives on the host animal. Ectoparasites include, but are not limited to, mites, insects, and crustaceans (e.g., sea lice). The subclass Acari (or Acarina) comprises ticks and mites. Ticks include, but are not limited to, members of the following genera: Rhipicaphalus, e.g., Rhipicaphalus (Boophilus) microplus and Rhipicephalus sanguineus; Amblyomrna; Dermacentor; Haemaphysalis; Hyalomma; Ixodes; Rhipicentor; Margaropus; Argas; Otobius; and Ornithodoros.Mites include, but are not limited to, members of the following genera: Chorioptes, for example, Chorioptes bovis; Psoroptes, for example, Psoroptes ovis; Cheyletiella; Dermanyssus, for example, Dermanyssus gallinae; Orthnithonyssus; Demodex, for example, Demodex canis; Sarcoptes, for example, Sarcoptes scabiei; and Psorergates. Insects include, but are not limited to, members of the orders: Siphonaptera, Diptera, Phthiraptera, Lepidoptera, Coleoptera, and Homoptera. Members of the order Siphonaptera include, but are not limited to, Ctenocephalides felis and Ctenocephalides canis. Members of the order Diptera include, but are not limited to, Musca spp.; strid flies, for example, Gasterophilus intestinalis and Oestrus ovis; and biting flies. Horse flies, for example, Haematopata spp. and Tabunus spp.; Haematobia, for example, Haematobia irritans; Stomoxis; Lucilia; midges; and mosquitoes.Members of the class Phthiraptera include, but are not limited to, blood-sucking lice and chewing lice, e.g., Bovicola Ovis and Bovicola Bovis. The term "effective quantity," when used in the context of parasites in or on an animal, refers to the quantity or dose of the compound of the invention, or a salt thereof, which, upon administration of a single or multiple dose to the animal, produces the desired effect in or on the animal. The effective quantity can be readily determined by the diagnostic technician, such as someone skilled in the art, by using known techniques and observing the results obtained under similar circumstances.In determining the effective amount, the diagnostic technician considers several factors, including but not limited to: the mammal species; its size, age, and overall health; the parasite to be controlled and the degree of infestation; the specific disease or disorder involved; the degree of involvement or severity of the disease or disorder; the individual's response; the particular compound administered; the route of administration; the bioavailability characteristics of the administered preparation; the selected dosage regimen; the use of concurrent medication; and other relevant circumstances. The compounds of the invention can be administered to the animal by any route that produces the desired effect, including, but not limited to, topical, oral, parenteral, and subcutaneous routes. Topical administration is preferred. Suitable formulations for topical administration include, for example, solutions, emulsions, and suspensions, and may be in the form of a pour-on, spot-apply, spray, spray tunnel, or dip formulation. Alternatively, the compounds of the invention can be administered by means of a collar or ear tag. The salt forms of the compounds of the invention include both pharmaceutically acceptable salts and veterinarily acceptable salts, which may differ from agrochemically acceptable salts. Pharmaceutically and veterinarily acceptable salts and the usual methods for preparing them are well known in the art. See, for example, Gould, PL, "Salt selection for basic drugs", International Journal of Pharmaceutics, 33: 201-217 (1986); Bastin, RJ, et al. "Salt Selection and Optimization Procedures for Pharmaceutical New Chemical Entities", Organic Process Research and Development, 4: 427-435 (2000); and Berge, SM, et al., "Pharmaceutical Salts", Journal of Pharmaceutical Sciences, 66: 1-19, (1977). A person skilled in the art of synthesis will appreciate that the compounds of the invention are readily converted into, and can be isolated as, a salt, such as a hydrochloride-type salt, using techniques and conditions well known to a person skilled in the art.Furthermore, a person skilled in the synthesis technique will appreciate that the compounds of the invention are easily converted into, and can be isolated as, the corresponding free base from the corresponding salt. The present invention also provides a method for controlling pests (such as mosquitoes and other disease vectors; see also http: / / www.who.int / malaria / vector_control / irs / en / ). In one embodiment, the pest control method comprises applying the compositions of the invention to the target pests, their habitat, or a surface or substrate by brushing, rolling, spraying, diffusing, or immersion. By way of example, the method of the invention contemplates an IRS (Indoor Residual Spray) application to a surface such as a wall, ceiling, or floor. In another embodiment, the application of said compositions to a substrate such as a textile or nonwoven material in the form of (or that can be used to make) nets, clothing, bedding, curtains, and tents is contemplated. In one embodiment, the method for controlling these pests comprises applying an effective pesticide quantity of the compositions of the invention to the target pests, their location, or a surface or substrate to provide effective residual pesticidal activity on the surface or substrate. This application can be carried out by applying the pesticide composition of the invention with a brush, roller, by spraying, diffusion, or immersion. By way of example, an IRS application to a surface such as a wall, ceiling, or floor is contemplated by the method of the invention to provide effective residual pesticidal activity on the surface. In another embodiment, the application of these compositions for residual pest control is contemplated on a substrate such as a textile material in the form of (or that can be used to manufacture) netting, clothing, bedding, curtains, and tents. The substrates, including nonwoven materials, textiles, or nets to be treated, may be made of natural fibers such as cotton, raffia, jute, linen, sisal, burlap, or wool, or synthetic fibers such as polyamide, polyester, polypropylene, polyacrylonitrile, or similar materials. Polyesters are particularly suitable. Textile treatment methods are described, for example, in documents WO 2008 / 151984, WO 2003 / 034823, US 5631072, WO 2005 / 64072, WO2006 / 128870, EP 1724392, WO 2005113886, or WO 2007 / 090739. Other areas of application for the compositions according to the invention include the injection / treatment of tree trunks for all ornamental trees, as well as all types of fruit and nut trees. In the field of tree trunk injection / treatment, the compounds according to the present invention are particularly suitable against wood-boring insects of the order Lepidoptera, as mentioned above, and of the order Coleoptera, especially against the wood-borers listed in Tables A and B below: Table A. Examples of exotic wood borers of economic importance. Table B. Examples of economically important natural wood borers. The present invention can also be used to control any insect pest that may be present in the lawn, including, for example, beetles, caterpillars, fire ants, ground pearls, millipedes, woodlice, mites, mole crickets, mealybugs, weevils, ticks, snubs, southern stink bugs, and white grubs. The present invention can be used to control insect pests at various stages of their life cycle, including eggs, larvae, nymphs, and adults. In particular, the present invention can be used to control insect pests that feed on turfgrass roots, including white grubs (such as Cyclocephala spp. (e.g., masked beetle, C. lurida), Rhizotrogus spp. (e.g., European beetle, R. majalis), Cotinus spp. (e.g., green June beetle, C. nitida), Popillia spp. (e.g., Japanese beetle, P. japonica), Phyllophaga spp. (e.g., May / June beetle), Ataenius spp. (e.g., black turf ataenius, A. spretulus), Maladera spp. (e.g., Asian garden beetle, M. castanea, and Tomarus spp.), ground pearls (Margarodes spp.), mole crickets (tawny, southern, and short-flight, Scapteriscus spp., Gr and llotalpa africana) and crane fly larvae (European crane fly, Tipula spp.).The present invention can also be used to control grass insect pests that live in thatch, including armyworms (such as the fall armyworm Spodoptera frugiperda, and the common fall armyworm Pseudaletia unipuncta), cutworms, weevils (Sphenophorus spp., such as S. venatus verstitus and S. parvulus) and lawn moths (such as Crambus spp. and the tropical lawn moth, Herpetogramma phaeopteralis). The present invention can also be used to control above-ground, above-ground, grass-leaving insect pests, including stink bugs (such as southern stink bugs, Blissus insularis), common beet mite (Eriophyes cynodoniensis), Rhodes grass weevil (Antonina graminis), two-lined snipe (Propsapia bicincta), leafhoppers, cutworms (family Noctuidae), and green aphids. The present invention can also be used to control other lawn pests such as imported red fire ants (Solenopsis invicta) that create nests in lawns. In the hygiene sector, the compositions according to the invention are active against ectoparasites such as hard ticks, soft ticks, scabies mites, crop mites, flies (chewing and sucking), parasitic fly larvae, lice, hair lice, bird lice, and fleas. Examples of such parasites include: From the order Anoplurida: Haematopinus spp., Linognathus spp., Pediculus spp. and Phtirus spp., Solenopotes spp.; From the order Mallophagida: Trimenopon spp., Menopon spp., Trinoton spp., Bovicola spp., Werneckiella spp., Lepikentron spp., Damalina spp., Trichodectes spp. and Felicola spp.; Del orden Diptera y los subórdenes Nematocerina y Brachycerina, por ejemplo Aedes spp., Anopheles spp., Culex spp., Simulium spp., Eusimulium spp., Phlebotomus spp., Lutzomyia spp., Culicoides spp., Chr y sops spp., Hybomitra spp., Atylotus spp., Tabanus spp., Haematopota spp., Philipomyia spp., Braula spp., Musca spp., Hydrotaea spp., Stomoxys spp., Haematobia spp., Morellia spp., Fannia spp., Glossina spp., Calliphora spp., Lucilia spp., Chr y somyia spp., Wohlfahrtia spp., Sarcophaga spp., Oestrus spp., Hypoderma spp., Gasterophilus spp., Hippobosca spp., Lipoptena spp. y Melophagus spp. ; From the order of Siphonapterida, for example, Pulex spp., Ctenocephalides spp., Xenopsylla spp., Ceratophyllus spp.; From the order Heteropterida, for example, Cimex spp., Triatoma spp., Rhodnius spp., Panstrongylus spp.; From the order Blattarida, for example, Blatta orientalis, Periplaneta americana, Blattelagermanica and Supella spp.; From the subclass Acaria (acarids) and from the orders Meta- and Mesostigmata, for example, Argas spp., Ornithodorus spp., Otobius spp., Ixodes spp., Amblyomma spp., Boophilus spp., Dermacentor spp., Haemophysalis spp., Hyalomma spp., Rhipicephalus spp., Dermanyssus spp., Raillietia spp., Pneumonyssus spp., Sternostoma spp. and Varroa spp.; From the orders Actinedida (Prostigmata) and Acaridida (Astigmata), for example Acarapis spp., Cheyletiella spp., Ornithocheyletia spp., Myobia spp., Psorergatesspp., Demodexspp., Trombicula spp., Listrophorus spp., Acarus spp., Tyrophagus spp., Caloglyphus spp., Hypodectes spp., Pterolichus spp., Psoroptes spp., Chorioptes spp., Otodectes spp., Sarcoptes spp., Notoedres spp., Knemidocoptes spp., Cytodites spp. and Laminosioptes spp.. The compositions according to the invention are also suitable for protection against insect infestation in the case of materials such as wood, textiles, plastics, adhesives, glues, paints, paper and cardboard, leather, floor coverings and buildings. The compositions according to the invention can be used, for example, against the following pests: beetles such as Hylotrupes bajulus, Chloroforus pilosis, Anobium punctatum, Xestobium rufovillosum, Ptilinuspecticornis, Dendrobium pertinex, Ernobius mollis, Priobium carpini, Lyctus brunneus, Lyctus africanus, Lyctus planicollis, Lyctus linearis, Lyctus pubescens, Trogoxilon aequale, Minthesrugicollis, Xyleborus spec., Tr y ptodendron spec., Apate monachus, Bostr y chus capucins, Heterobostr y chus brunneus, Sinoxilon spec. y Dinoderus minutus, and also hymenópteros such as Sirex juvencus, Urocerus gigas, Urocerus gigas taignus y Urocerus augur, and termites such as Kalotermes flavicollis, Cr y ptotermes brevis, Heterotermes indicola, Reticulitermes flavipes, Reticulitermes santonensis, Reticulitermes lucifugus, Mastotermes darwiniensis, Zootermopsis nevadensis y Coptotermes formosanus, y pececillos such as Lepisma saccharina. The compounds of formulas (I) and (I'), or salts thereof, are especially suitable for controlling one or more selected pests of the families: Noctuidae, Plutellidae, Chr and Somelidae, Thripidae, Pentatomidae, Tortricidae, Delphacidae, Aphididae, Noctuidae, Crambidae, Meloidogynidae, and Heteroderidae. In a preferred embodiment in each aspect, a compound TX (where the abbreviation "TX" means "a compound selected from the compounds defined in Tables A-1 to A-78, B-1 to B-78, C-1 to C-21, and D-1 to D-21") controls one or more selected pests of the families: Noctuidae, Plutellidae, Chr and Somelidae, Thripidae, Pentatomidae, Tortricidae, Delphacidae, Aphididae, Noctuidae, Crambidae, Meloidogynidae, and Heteroderidae. The compounds of formulas (I) , and (I') , or salts thereof, are especially suitable for controlling one or more of the selected pests of the genus: Spodoptera spp, Plutella spp, Frankliniella spp, Thrips spp, Euschistus spp, Cydia spp, Nilaparvata spp, Myzus spp, Aphis spp, Diabrotica spp, Rhopalosiphum spp, Pseudoplusia spp and Chilo spp. In a preferred embodiment of each aspect, a TX compound (where the abbreviation "TX" means "a compound selected from the compounds defined in Tables A-1 to A-78, B-1 to B-78, C-1 to C-21 and D-1 to D-21") controls one or more selected pests of the genus: Spodoptera spp, Plutella spp, Frankliniella spp, Thrips spp, Euschistus spp, Cydia spp, Nilaparvata spp, Myzus spp, Aphis spp, Diabrotica spp, Rhopalosiphum spp, Pseudoplusia spp and Chilo spp. The compounds of formulas (I) , and (I') , or salts thereof, are especially suitable for controlling one or more of Spodoptera littoralis, Plutella xylostella, Frankliniella occidentalis, Thrips tabaci, Euschistus heros, Cydia pomonella, Nilaparvata lugens, Myzus persicae, Chr and sodeixis incIudens, Aphis craccivora, Diabrotica balteata, Rhopalosiphum padi and Chilo suppressalis. In a preferred implementation of each aspect, a TX composition (whence the abbreviation "TX" means "a composition selected from the compositions defined in Tables A-1 to A-78, B-1 to B-78, C-1 to C-21, and D-1 to D-21") controls no more than Spodoptera littoralis, Plutella xylostella, Frankliniella Occidentalis, Thrips tabaci, Euschistus heros, Cydia pomonella, Nilaparvata lugens, Myzus persicae, Chr y sodeixis incIudens, Aphis craccivora, Diabrotica balteata, Rhopalosiphum Padia, y Chilo Suppressalis, tal como Spodoptera littoralis + TX, Plutella xylostella + TX; Frankliniella Occidentalis + TX, Thrips tabaci + TX, Euschistus heros + TX, Cydia pomonella + TX, Nilaparvata lugens + TX, Myzus persicae + TX, Chr y sodeixis incIudens + TX, Aphis craccivora + TX, Diabrotica balteata + TX, Rhopalosiphum Padi + TX, y Chilo suppressalis + TX. In one embodiment, of each aspect, a compound of Tables A-1 to A-72, B-1 to B-72, C-1 to C-18 and D-1 to D-18 is suitable for controlling Spodoptera littoralis, Plutella xylostella, Frankliniella occidentalis, Thrips tabaci, Euschistus heros, Cydia pomonella, Nilaparvata lugens, Myzus persicae, Chr and sodeixis incIudens, Aphis craccivora, Diabrotica balteata, Rhopalosiphum padi, and Chilo suppressalis in cotton, vegetables, corn, cereal rice and soybean crops. In one embodiment, a compound from Tables A-1 to A-72, B-1 to B-72, C-1 to C-18 and D-1 to D-18 is suitable for controlling Mamestra (preferably in vegetables), Cydia pomonella (preferably in apples), Empoasca (preferably in vegetables, vines), Leptinotarsa ​​(preferably in patabals) and Chilo suppressalis (preferably in rice). The compounds according to the invention can offer numerous benefits, including, among others, favorable levels of biological activity for protecting plants against insects or properties suitable for use as agrochemical active ingredients (e.g., higher biological activity, a favorable spectrum of activity, a broader safety profile (against non-target organisms above and below ground, such as fish, birds, and bees), improved physicochemical properties, or greater biodegradability). In particular, it has been surprising to discover that certain compounds of formula (I) can exhibit an advantageous safety profile with respect to non-target arthropods, particularly pollinators such as honeybees, solitary bees, and bumblebees, most notably Apis mellifera. The compounds according to the invention can be used as pesticide agents in unmodified form, but are generally formulated in compositions of various forms using formulation aids such as carriers, solvents, and surfactants.The formulations may be in various physical forms, for example, as dustable powders, gels, wettable powders, water-dispersible granules, water-dispersible tablets, effervescent tablets, emulsifiable concentrates, microemulsifiable concentrates, oil-in-water emulsions, oil-fluids, aqueous dispersions, oily dispersions, suspoemulsions, capsule suspensions, emulsifiable granules, soluble liquids, water-soluble concentrates (with water or a water-miscible organic bis solvent as the vehicle), impregnated polymer films, or in other known forms, for example, the FAO Manual on Development and Use and the WHO Pesticide Fact Sheets, United Nations, First Edition, Second Revision (2010). Such formulations may be used directly or diluted before use.Dilutions can be carried out, for example, with water, liquid fertilizers, micronutrients, biological organisms, oil, or solvents. Formulations can be prepared, for example, by mixing the active ingredient with formulation adjuvants to obtain compositions in the form of finely divided solids, granules, solutions, dispersions, or emulsions. Active ingredients can also be formulated with other adjuvants, such as finely divided solids, mineral oils, vegetable or animal oils, modified vegetable or animal oils, organic solvents, water, surfactants, or combinations thereof. The active ingredients can also be contained in very fine microcapsules. The microcapsules contain the active ingredients in a porous carrier. This allows the active ingredients to be released into the environment in controlled amounts (e.g., slow release). The microcapsules typically have a diameter of 0.1 to 500 micrometers. They contain active ingredients in an amount of approximately 25 to 95% by weight of the capsule. The active ingredients can be in the form of a monolithic solid, as fine particles in a solid or liquid dispersion, or as a suitable solution. The encapsulating membranes may comprise, for example, natural or synthetic rubbers, cellulose, styrene / butadiene copolymers, polyacrylonitrile, polyacrylate, polyesters, polyamides, polyureas, polyurethane, or chemically modified polymers and starch xanthates or other polymers known to the skilled trade.Alternatively, very fine microcapsules can be formed in which the active ingredient is contained in the form of finely divided particles in a solid matrix of base substance, but the microcapsules themselves are not encapsulated. The formulation adjuvants that are suitable for the preparation of the compositions according to the invention are known per se. The following liquid carriers can be used: water, toluene, xylene, petroleum ether, vegetable oils, acetone, ethyl methyl ketone, cyclohexanone, acid anhydrides, acetonitrile, acetophenone, amyl acetate, 2-butanone, butylene carbonate, chlorobenzene, cyclohexane, cyclohexanol, alkyl esters of acetic acid, diacetone alcohol, 1,2-dichloropropane, diethanolamine, p-diethylbenzene, diethylene glycol, diethylene glycol abietate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, N,N-dimethylformamide, dimethyl sulfoxide, 1,4-dioxane, dipropylene glycol, dipropylene glycol methyl ether, dipropylene glycol dibenzoate diproxitol, alkylpyrrolidone, ethyl acetate, 2-ethylhexanol, ethylene carbonate, 1, 1, 1-trichloroethane, 2-heptanone, alpha-pinene, d-limonene, ethyl lactate, ethylene glycol,ethylene glycol butyl ether, ethylene glycol methyl ether, gamma-butyrolactone, glycerol, glyceryl acetate, glyceryl diacetate, glyceryl triacetate, hexadecane, hexylene glycol, isoamyl acetate, isobornyl acetate, isooctane, isophorone, isopropylbenzene, isopropyl myristate, lactic acid, laurylamine, mesityl oxide, methoxypropanol, isoamyl methyl ketone, isobutyl methyl ketone, methyl laurate, methyl octanoate, methyl oleate, m-xylene, n-hexane, n-octylamine, octadecanoic acid, octylamine acetate, oleic acid, oleylamine, o-xylene, phenol, polyethylene glycol, propionic acid, propyl lactate propylene carbonate, propylene glycol, propylene glycol methyl ether, p-xylene, toluene, triethyl phosphate, triethylene glycol, xylenesulfonic acid, paraffin, mineral oil, trichloroethylene, perchloroethylene, ethyl acetate, amyl acetate, butyl acetate, propylene glycol methyl ether, diethylene glycol methyl ether,methanol, ethanol, isopropanol, and higher molecular weight alcohols such as amyl alcohol, tetrahydrofurfuryl alcohol, hexanol, octanol, ethylene glycol, propylene glycol, glycerol, N-methyl-2-pyrrolidone, and the like. Suitable solid carriers include, for example, talc, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, kieselguhr, limestone, calcium carbonate, bentonite, calcium montmorillonite, cottonseed pods, wheat flour, soybean flour, pumice, wood flour, ground nut shells, lignin, and similar substances. A wide variety of surfactants can be conveniently used in both solid and liquid formulations, especially those that can be diluted with a carrier before use. Surfactants can be anionic, cationic, nonionic, or polymeric, and can be used as emulsifiers, wetting agents, suspending agents, or for other purposes. Some typical surfactants include, for example, alkyl sulfate salts, such as diethanolammonium lauryl sulfate; alkylyl sulfonate salts, such as calcium dodecylbenzenesulfonate; alkylphenol / alkylene oxide addition products, such as ethoxylated nonylphenol; alcohol / alkylene oxide addition products, such as ethoxylated tridecyl alcohol; soaps, such as sodium stearate; and alkylnaphthalene sulfonate salts, such as sodium dibutylnaphthalene sulfonate.Dialkyl esters of sulfosuccinate salts, such as sodium di(2-ethylhexyl) sulfosuccinate; sorbitol esters, such as sorbitol oleate; quaternary amines, such as lauryltrimethylammonium chloride; polyethylene glycol esters of fatty acids, such as polyethylene glycol stearate; block copolymers of ethylene oxide and propylene oxide; and salts of mono- and dialkyl phosphate esters; and also other substances described, for example, in McCutcheon's Detergents and Emulsifiers Annual, MC Publishing Corp., Ridgewood, New Jersey (1981). Other adjuvants that can be used in pesticide formulations include crystallization inhibitors, viscosity modifiers, suspending agents, colorants, antioxidants, foaming agents, light absorbers, blending adjuvants, antifoams, complexing agents, buffers and pH-neutralizing or modifying substances, corrosion inhibitors, fragrances, wetting agents, uptake enhancers, micronutrients, plasticizers, glidants, lubricants, dispersants, thickeners, antifreeze, microbicides, and liquid and solid fertilizers. The compositions according to the invention may include an additive comprising a vegetable or animal oil, a mineral oil, alkyl esters of such oils, or mixtures of such oils and oil derivatives. The amount of oily additive in the composition according to the invention is generally from 0.01 to 10%, based on the mixture to be applied. For example, the oily additive can be added to a spray tank at the desired concentration after a spray mixture has been prepared. Some preferred oily additives comprise mineral oils or a vegetable oil, for example, rapeseed oil, olive oil, or sunflower oil, emulsified vegetable oil, alkyl esters of vegetable oils, for example, methyl derivatives, or an animal oil, such as fish oil or beef tallow.Some preferred oily additives comprise alkyl esters of C8-C22 fatty acids, especially methyl derivatives of C12-C18 fatty acids, for example, the methyl esters of lauric acid, palmitic acid, and oleic acid (methyl laurate, methyl palmitate, and methyl oleate, respectively). Many oily derivatives are described in the Compendium of Herbicide Adjuvants, 10th edition, Southern Illinois University, 2010. The compositions of the invention generally comprise from 0.1 to 99% by weight, especially from 0.1 to 95% by weight, of compounds of the present invention, and from 1 to 99.9% by weight of a formulation adjuvant that preferably includes from 0 to 25% by weight of a surfactant. Although commercial products may preferably be formulated as concentrates, the end user will normally employ diluted formulations. Application rates vary widely and depend on soil type, application method, crop, target pest, prevailing weather conditions, and other factors determined by the application method, timing, and target crop. As a general guideline, compounds can be applied at a rate of 1 to 2000 L / ha, particularly 10 to 1000 L / ha. Formulation types include an emulsion concentrate (EC), a suspension concentrate (SC), a suspoemulsion (SE), a capsule suspension (CS), a water-dispersible granule (WG), an emulsifiable granule (EG), an emulsion, water in oil (EO), an emulsion, oil in water (EW), a microemulsion (ME), an oil dispersion (OD), a fluid miscible oil (OF), an oil-miscible liquid (OL), a soluble concentrate (SL), an ultra-low volume suspension (SU), an ultra-low volume liquid (UL), a technical concentrate (TK), a dispersible concentrate (DC), a wettable powder (WP), a soluble granule (SG), or any technically feasible formulation in combination with agriculturally acceptable adjuvants. The preferred formulations may have the following compositions (% by weight): Emulsifiable concentrates: active ingredient: from 1 to 95%, preferably from 60 to 90% surfactant: 1 to 30%, preferably 5 to 20% Liquid carrier: 1 to 80%, preferably 1 to 35% Fine powders: active ingredient: from 0.1 to 10%, preferably from 0.1 to 5% solid carrier: 99.9 to 90%, preferably 99.9 to 99% Concentrates in suspension: active ingredient: 5 to 75%, preferably 10 to 50% Water: 94 to 24%, preferably 88 to 30% surfactant: 1 to 40%, preferably 2 to 30% Moisturizing powders: active ingredient: from 0.5 to 90%, preferably from 1 to 80% surfactant: 0.5 to 20%, preferably 1 to 15% Solid carrier: 5 to 95%, preferably 15 to 90% Granules: active ingredient: from 0.1 to 30%, preferably from 0.1 to 15% Solid carrier: 99.5 to 70%, preferably 97 to 85% The following mixtures of the compounds of formula I with active ingredients are preferred (where the abbreviation "TX" means "a compound selected from the compounds defined in Tables A-1 to A-78, B-1 to B-78, C-1 to C-21 and D-1 to D-21, and Table P"): an adjuvant selected from the group of substances consisting of petroleum oils (alternative name) (628) + TX; abamectin + TX, acequinocil + TX, acetamiprid + TX, acetoprol + TX, acrinathrin + TX, acinonapir + TX, afidopyropene + TX, afoxolaner + TX, alanicarb + TX, allethrin + TX, alpha-cypermethrin + TX, alfamethrin + TX, amidoflumet + TX, aminocarb + TX, azocyclotine + TX, bensultap + TX, benzoximate + TX, benzpyrimoxan + TX, betacyfluthrin + TX, beta-cypermethrin + TX, bifenazate + TX, bifenthrin + TX, binapacryl + TX, bioalethrin + TX, S-bioalethrin + TX, bioresmethrin + TX, bistrifluron + TX, broflanilide + TX, broflutrinate + TX, bromophosetyl + TX, buprofezin + TX, butocarboxym + TX, Cadusafos + TX, carbaryl + TX, carbosulfan + TX, cartap + TX, CAS Number: 1632218-00-8 + TX, CAS Number: 1808115-49-2 + TX, CAS Number: 2032403-97-5 + TX, CAS Number: 2044701-44-0 + TX, CAS Number: 2128706-05-6 + TX, CAS Number: 2095470-94-1 + TX, CAS Number: 2377084-09-6 + TX, CAS Number: 1445683-71-5 + TX, CAS Number: 2408220-94-8 + TX, CAS Number: 2408220-91-5 + TX, CAS Number: 1365070-72-9 + TX,CAS Number: 2171099-09-3 + TX, CAS Number: 2396747-83-2 + TX, CAS Number: 2133042-31-4 + TX, CAS Number: 2133042-44-9 + TX, CAS Number: 1445684-82-1 + TX, CAS Number: 1445684-82-1 + TX, CAS Number: 1922957-45-6 + TX, CAS Number: 1922957-46-7 + TX, CAS Number: 1922957-47-8 + TX, CAS Number: 1922957-48-9 + TX, CAS Number: 2415706-16-8 + TX, CAS Number: 1594624-87-9 + TX, CAS Number: 1594637-65-6 + TX, CAS Number: 1594626-19-3 + TX, CAS Number: 1990457-52-7 + TX, CAS Number: 1990457-55-0 + TX, CAS Number: 1990457-57-2 + TX, CAS Number: 1990457-77-6 + TX, CAS Number: 1990457-66-3 + TX, CAS Number: 1990457-85-6 + TX, CAS Number: 2220132-55-6 + TX, CAS Number: 1255091-74-7 + TX, CAS Number: 1305319-70-3 + TX, CAS Number: 1442448-92-1 + TX, chlorantraniliprole + TX, chlordane + TX, recombinant double-stranded interfering RNA (GS2 specific for Leptinotarsa ​​decemlineata CAS Number 2719848-60-7 + TX, CAS Number: 1956329-03-5, chlorfenapyr + TX, chloropralethrin + TX, chromafenozide + TX,clenpyrin + TX, cloetocarb + TX, clothianidin + TX, 2-chlorophenyl N-methylcarbamate (CPMC) + TX, cyanofenphos + TX, cyantraniliprole + TX, cyclaniliprol + TX, cyclobutrifluram + TX, cycloprothrin + TX, cycloxaprid + TX, cyenopyrafen + TX, cietpyrafen (or etpyrafen) + TX, cyflumetofen + TX, cyfluthrin + TX, cyhalodiamide + TX, cyhalothrin + TX, cypermethrin + TX, cyphenothrin + TX, ciproflanilid + TX, cyromazine + TX, deltamethrin + TX, diafenthiuron + TX, dialifos + TX, dibromo + TX, dichloromesothiaz + TX, diflovidazin + TX, diflubenzuron + TX, dimpropyridaz + TX, dynactin + TX, dinocap + TX, dinotefuran + TX, dioxabenzophos + TX, emamectin (or benzoate of emamectin) + TX, empenthrin + TX, epsilon - momfluorothrin + TX, epsilon-metofluthrin + TX, esfenvalerate + TX, ethion + TX, ethiprol + TX, etofenprox + TX, etoxazole + TX, famfur + TX, fenazaquin + TX, fenfluthrin + TX, phenmezodithiaz + TX, fenitrothion + TX, fenobucarb + TX, fenothiocarb + TX, fenoxycarb + TX, fenpropathrin + TX,fenpiroximate + TX, fensulfotione + TX, fenthion + TX, fentineacetate + TX, fenvalerate + TX, ipronil + TX, flometoquine + TX, flonicamid + TX, fluacripirim + TX, fluazaindolizine + TX, fluazurón + TX, flubendiamide + TX, flubencimine + TX, fluchlordiniliprole + TX, flucitrinato + TX, flucicloxurón + TX, flucitrinato + TX, fluensulfon + TX, flufenerim + TX, flufenprox + TX, flufiprol + TX, fluhexafon + TX, flumethrin + TX, fluopiram + TX, flupentiofenox + TX, flupyradifuron + TX, flupirimin + TX, fluralaner + TX, fluvalinate + TX, fluxamethamide + TX, fostiazate + TX, gamma-cyhalothrin + TX, guadipir + TX, halofenozide + TX, halfenprox + TX, heptafluthrin + TX, hexythiazox + TX, hydramethylnon + TX, imiciaphos + TX, imidacloprid + TX, imiprothrin + TX, indazapyroxame + TX, indoxacarb + TX, iodomethan + TX, iprodione + TX, isocicloseram + TX, isothioate + TX, ivermectin + TX, kappa-bifenthrin + TX, kappa-tefluthrin + TX, lambda-cyhalothrin + TX, lepimectin + TX, lotilaner + TX,lufenurón + TX, metaflumizone + TX, metaldehyde + TX, metam + TX, methomyl + TX, methoxyfenozide + TX, metofluthrin + TX, metolcarb + TX, mexacarbate + TX, milbemectin + TX, momfluorothrin + TX, niclosamide + TX, nicofluprol + TX; nitenpyram + TX, nithiazine + TX, omethoate + TX, oxamyl + TX, oxazosulfyl + TX, parathion-ethyl + TX, permethrin + TX, phenothrin + TX, phosphocarb + TX, piperonyl butoxide + TX, pirimicarb + TX, pirimifos-ethyl + TX, pirimiphos-methyl + TX, polyhedrosis virus + TX, pralethrin + TX, profenofos + TX, profluthrin + TX, propargite + TX, propetamphos + TX, propoxur + TX, protiofos + TX, protrifenbuto + TX, piflubumide + TX, pymetrozine + TX, piraclofos + TX, pyrafluprol + TX, pyridaben + TX, pyridalyl + TX, pyrifluquinazone + TX, pyrimifen + TX, pyriminoestrobin + TX, pyriprol + TX, pyriproxyfen + TX, resmethrin + TX, sarolaner + TX, selamectin + TX, silafluofen + TX, spinotoram + TX, spinosad + TX, spirobudifen + TX; spirodiclofen + TX,spiromesifen + TX, spiropidione + TX, spirotetramat + TX, espidoxamat + TX, sulfoxaflor + TX, tebufenozide + TX, tebufenpyrad + TX, tebupirimifos + TX, tefluthrin + TX, temephos + TX, tetrachlorantraniliprole + TX, tetradifon + TX, tetramethrin + TX, tetramethylfluthrin + TX, tetranactin + TX, tetraniliprol + TX, theta-cypermethrin + TX, thiacloprid + TX, thiamethoxam + TX, thiocyclam + TX, thiodicarb + TX, tiofanox + TX, thiometon + TX, tiosultap + TX, tigolaner + TX, thiorantraniliprole + TX: thioxazaphene + TX, tolfenpyrad + TX, toxaphene + TX, tralomethrin + TX, transfluthrin + TX, triazamate + TX, triazophos + TX, trichlorfon + TX, trichloronate + TX, trichlorfon + TX, trifluenfuronate + TX, triflumezopyrim + TX, ticlopyrazoflor + TX, zetacypermethrin + TX, seaweed extract and molasses-derived fermentation product + TX, seaweed extract and molasses-derived fermentation product comprising urea + TX, amino acids + TX,potassium and molybdenum and manganese fermented with EDTA + TX, marine seaweed extract and fermented vegetable products + TX, marine seaweed extract and fermented vegetable products that include phytohormones + TX, vitamins + TX, raw materials with EDTA + TX, zinc + TX, and hierro + TX, azadirachtin + TX, Bacillus aizawai + TX, Bacillus chitinosporus AQ746 (NRRL registry no. B-21618) + TX, Bacillus firmus + TX, Bacillus kurstaki + TX, Bacillus mycoides AQ726 (NRRL registry no. B-21664) + TX, Bacillus pumilus (NRRL registry no. B-30087) + TX, Bacillus pumilus AQ717 (NRRL registry no. B-21662) + TX, Bacillus sp. AQ178 (ATCC registry no. 53522) + TX, Bacillus sp. AQ175 (ATCC registry no. 55608) + TX, Bacillus sp. AQ177 (ATCC registry no. 55609) + TX, Bacillus subtilis without specification + TX, Bacillus subtilis AQ153 (ATCC registry no. 55614) + TX, Bacillus subtilis AQ30002 (NRRL registry no. B-50421) + TX,Bacillus subtilis AQ30004 (NRRL registry number B- 50455) + TX, Bacillus subtilis AQ713 (NRRL registry number B-21661) + TX, Bacillus subtilis AQ743 (NRRL registry number B-21665) + TX, Bacillus thuringiensis AQ52 (NRRL registry number B-21619) + TX, Bacillus thuringiensis BD#32 (NRRL registry number B-21530) + TX, Bacillus thuringiensis subspec. kurstaki BMP 123 + TX, Beauveria bassiana + TX, D-limoneno + TX, granulovirus + TX, Harpin + TX, nucleopolihedrovirus de Helicoverpa armigera + TX, nucleopolihedrovirus de Helicoverpa zea + TX, nucleopolihedrovirus de Heliothis virescens + TX, nucleopolihedrovirus de Heliothis punctigera + TX, Metarhizium spp. + TX, Muscodor albus 620 (n.º de registro de NRRL 30547) + TX, Muscodor roseus A3-5 (n.º de registro de NRRL 30548) + TX, productos basados ​​en el árbol de nim + TX, Paecilomyces fumosoroseus + TX, Paecilomyces lilacinus + TX, Pasteuria nishizawae + TX, Pasteuria penetrans + TX, Pasteuria ramosa + TX, Pasteuria thornei + TX,Pasteuria usgae + TX, pcimene + TX, Plutella xylostella granulosis virus + TX, Plutella xylostella nucleopolyhedrovirus + TX, polyhedrosis virus + TX, pyrethrum + TX, QRD 420 (a mixture of terpenoids) + TX, QRD 452 (a mixture of terpenoids) + TX, QRD 460 (a mixture of terpenoids) + TX, Quillaja saponaria + TX, Rhodococcus globerulus AQ719 (NRRL Reg. No. B-21663) + TX, Spodoptera frugiperda nucleopolyhedrovirus + TX, Streptomyces galbus (NRRL Reg. No. 30232) + TX, Streptomyces sp. (NRRL registration no. B-30145) + TX, terpenoid mixture + TX, and Verticillium spp. + TX; an algaecide selected from the group of substances consisting of betoxazine [CCN] + TX, copper dioctanoate (IUPAC name) (170) + TX, copper sulfate (172) + TX, cybutrine [CCN] + TX, diclone (1052) + TX, dichlorophene (232) + TX, endothal (295) + TX, fentine (347) + TX, quicklime [CCN] + TX, nabam (566) + TX, quinoclamine (714) + TX, quinonamide (1379) + TX, simazine (730) + TX, triphenyltin acetate (IUPAC name) (347) and triphenyltin hydroxide (IUPAC name) (347) + TX; an anthelmintic selected from the group of substances consisting of abamectin (1) + TX, crufomate (1011) + TX, cyclobutyrifluram + TX, doramectin (alternative name) [CCN] + TX, emamectin (291) + TX, emamectin benzoate (291) + TX, eprinomectin (alternative name) [CCN] + TX, ivermectin (alternative name) [CCN] + TX, milbemycin oxime (alternative name) [CCN] + TX, moxidectin (alternative name) [CCN] + TX, piperazine [CCN] + TX, selamectin (alternative name) [CCN] + TX, spinosad (737) and thiophanate (1435) + TX; an avicide selected from the group of substances consisting of chloralose (127) + TX, endrine (1122) + TX, fenthion (346) + TX, pyridine-4-amine (IUPAC name) (23) and strychnine (745) + TX; a bactericide selected from the group of substances consisting of 1-hydroxy-1H-pyridin-2-thione (IUPAC name) (1222) + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (IUPAC name) (748) + TX, 8-hydroxyquinoline sulfate (446) + TX, bronopol (97) + TX, copper dioctanoate (IUPAC name) (170) + TX, copper hydroxide (IUPAC name) (169) + TX, cresol [CCN] + TX, dichlorophene (232) + TX, dipyrithione (1105) + TX, dodicine (1112) + TX, phenaminosulf (1144) + TX, formaldehyde (404) + TX, hydrargaphen (alternative name) [CCN] + TX, kasugamycin (483) + TX, hydrated kasugamycin hydrochloride (483) + TX, nickel bis(dimethyldithiocarbamate) (IUPAC name) (1308) + TX, nitrapyrine (580) + TX, octylinone (590) + TX, oxolinic acid (606) + TX, oxytetracycline (611) + TX, potassium hydroxyquinoline sulfate (446) + TX, probenazole (658) + TX, streptomycin (744) + TX, streptomycin sesquisulfate (744) + TX, teclophthalam (766) + TX, and thimerosal (alternative name) [CCN] + TX; a biological agent selected from the group of substances consisting of Adoxophyes orana GV (alternative name) (12) + TX, Agrobacterium radiobacter (alternative name) (13) + TX, Amblyseius spp. (alternative name) (19) + TX, Anagrapha falcifera NPV (alternative name) (28) + TX, Anagrus atomus (alternative name) (29) + TX, Aphelinus abdominalis (alternative name) (33) + TX, Aphidius colemani (alternative name) (34) + TX, Afidoletes afidimyza (alternative name) (35) + TX, Autographa californica NPV (alternative name) (38) + TX, Bacillus firmus (alternative name) (48) + TX, Bacillus sphaericus Neide (scientific name) (49) + TX, Bacillus thuringiensis Berliner (scientific name) (51) + TX, Bacillus thuringiensis subsp. aizawai (scientific name) (51) + TX, Bacillus thuringiensis subsp. israelensis (scientific name) (51) + TX, Bacillus thuringiensis subsp. japonensis (nombre scientific) (51) + TX, Bacillus thuringiensis subsp.kurstaki (scientific name) (51) + TX, Bacillus thuringiensis subsp. tenebrionis (scientific name) (51) + TX, Beauveria bassiana (alternate name) (53) + TX, Beauveria brongniartii (alternate name) (54) + TX, Chr and soperla carnea (alternate name) (151) + TX, Cr and ptolaemus ptolaemus (alternate name) (178) + TX Cydia pomonella GV (alternative name) (191) + TX, Dacnusa sibirica (alternative name) (212) + TX, Diglyphus isaea (alternative name) (254) + TX, Encarsia formosa (scientific name) (293) + TX, Eretmocerus eremicus (alternative name, 300) + TX Helicoverpa zea NPV (alternative name) (431) + TX, Heterorhabditis bacteriophora and H.megidis (alternative name) (433) + TX, Hippodamia convergens (alternative name) (442) + TX, Leptomastix dactylopii (alternative name) (488) + TX, Macrolophus caliginosus (alternative name) (491) + TX, Mamestra brassicae NPV (alternative name) (494) + TX, Metaphycus helvolus (alternative name) (522) + TX, Metarhizium anisopliae var. acridum (scientific name) (523) + TX, Metarhizium anisopliae var. anisopliae (scientific name) (523) + TX, Neodiprion sertifer NPV y N. lecontei NPV (alternative name) (575) + TX, Orius spp.(alternative name) (596) + TX, Paecilomyces fumosoroseus (alternative name) (613) + TX, Phytoseiulus persimilis (alternative name) (644) + TX, Spodoptera exigua multicapsidic nuclear polyhedrosis virus (scientific name) (741) + TX, Steinernema bibionis (alternative name) (742) + TX, Steinernema carpocapsae (alternative name) (742) + TX, Steinernema feltiae (alternative name) (742) + TX, Steinernema glaseri (alternative name) (742) + TX, Steinernema riobrave (alternative name) (742) + TX, Steinernema riobravis (alternative name) (742) + TX, Steinernema scapterisci (alternative name) (742) + TX, Steinernema spp. (alternative name) (742) + TX, Trichogramma spp. (alternative name) (826) + TX, Typhlodromus occidentalis (alternative name) (844) and Verticillium lecanii (alternative name) (848) + TX;. a soil sterilant selected from the group of substances consisting of iodomethane (IUPAC name) (542) and methyl bromide (537) + TX; a chemosterilizer selected from the group of substances consisting of afolate [CCN] + TX, bisazir (alternative name) [CCN] + TX, busulfan (alternative name) [CCN] + TX, diflubenzuron (250) + TX, dimatif (alternative name) [CCN] + TX, hemel [CCN] + TX, hempa [CCN] + TX, metepa [CCN] + TX, methiotepa [CCN] + TX, methyl afolate [CCN] + TX, morzid [CCN] + TX, penfluron (alternative name) [CCN] + TX, tepa [CCN] + TX, thiohempa (alternative name) [CCN] + TX, thiotepa (alternative name) [CCN] + TX, tretamine (alternative name) [CCN] and uredepa (alternative name) [CCN] + TX; an insect pheromone selected from the group of substances consisting of (E)-dec-5-en-1-yl acetate with (E)-dec-5-en-1-ol (IUPAC name) (222) + TX, (E)-tridec-4-en-1-yl acetate (IUPAC name) (829) + TX, (E)-6-methylhept-2-en-4-ol (IUPAC name) (541) + TX, (E,Z)-tetradeca-4,10-dien-1-yl acetate (IUPAC name) (779) + TX, (Z)-dodec-7-en-1-yl acetate (IUPAC name) (285) + TX, (Z)-hexadec-11-enal (IUPAC name) (436) + TX, (Z)-hexadec-11-en-1-yl acetate (IUPAC name) (437) + TX, (Z)-hexadec-13-en-11-yn-1-yl acetate (IUPAC name) (438) + TX, (Z)-icos-13-en-10-one (IUPAC name) (448) + TX, (Z)-tetradec-7-en-1-al (IUPAC name) (782) + TX, (Z)-tetradec-9-en-1-ol (IUPAC name) (783) + TX, (Z)-tetradec-9-en-1-yl acetate (IUPAC name) (784) + TX, (7E,9Z)-dodeca-7,9-dien-1-yl acetate (IUPAC name) (283) + TX, (9Z,11E) -tetradeca-9, 11-dien-1-yl (IUPAC name) (780) + TX, (9Z, 12E) -tetradeca-9, 12-dien-1-yl acetate (IUPAC name) (781) + TX, 14-methyloctadec-1-ene (IUPAC name) (545) + TX, 4-methylnonan-5-ol with 4-methylnonan-5-one (IUPAC name) (544) + TX, alpha-multistriatin (alternative name) [CCN] + TX, brevicomin (alternative name) [CCN] + TX, codlelure (alternative name) [CCN] + TX, codlemone (alternative name) (167) + TX, cuelure (alternative name) (179) + TX, disparlure (277) + TX, dodec-8-en-1-yl acetate (IUPAC name) (286) + TX, dodec-9-en-1-yl acetate (IUPAC name) (287) + TX, dodeca-8 + TX, 10-dien-1-yl acetate (IUPAC name) (284) + TX, dominicalure (alternative name) [CCN] + TX, ethyl 4-methyloctanoate (IUPAC name) (317) + TX, eugenol (alternative name) [CCN] + TX, frontalin (alternative name) [CCN] + TX, Gossyplure® (alternative name: 1:1 mixture of the (Z, E) and (Z, Z) isomers of hexadeca-7 acetate,11-dien-1-yl) (420) + TX, grandlure (421) + TX, grandlure I (alternative name) (421) + TX, grandlure II (alternative name) (421) + TX, grandlure III (alternative name) (421) + TX, grandlure IV (alternative name) (421) + TX, hexalure [CCN] + TX, ipsdienol (alternative name) [CCN] + TX, ipsenol (alternative name) [CCN] + TX, japonilure (alternative name) (481) + TX, lineatin (alternative name) [CCN] + TX, litlure (alternative name) [CCN] + TX, looplure (alternative name) [CCN] + TX, medlure [CCN] + TX, megatomoic acid (alternative name) [CCN] + TX, methyl eugenol (alternative name) (540) + TX, muscalure (563) + TX, acetate of octadeca-2, 13-dien-1-yl (IUPAC number) (588) + TX, octadeca-3, 13-dien-1-yl acetate (IUPAC number) (589) + TX, orfralure (alternative number) [CCN] + TX, orictalure (alternative number) (317) + TX, ostramon (alternative number) [CCN] + TX, siglure [CCN] + TX, sordidin (alternative number) (736) + TX,sulcatol (alternative name) [CCN] + TX, tetradec-11-en-1-yl acetate (IUPAC name) (785) + TX, trimedlure (839) + TX, trimedlure A (alternative name) (839) + TX, trimedlure B1 (alternative name) (839) + TX, trimedlure B2 (alternative name) (839) + TX, trimedlure C (alternative name) (839) and trunc-call (alternative name) [CCN] + TX;, an insect repellent selected from the group of substances consisting of 2-(octylthio)ethanol (IUPAC name) (591) + TX, butopyronoxyl (933) + TX, butoxy (polypropylene glycol) (936) + TX, dibutyl adipate (IUPAC name) (1046) + TX, dibutyl phthalate (1047) + TX, dibutyl succinate (IUPAC name) (1048) + TX, diethyltoluamide [CCN] + TX, dimethyl carbate [CCN] + TX, dimethyl phthalate [CCN] + TX, ethylhexanediol (1137) + TX, hexamide [CCN] + TX, methoquin-butyl (1276) + TX, methylneodecanamide [CCN] + TX, oxamate [CCN] and picaridin [CCN] + TX; a molluscicide selected from the group of substances consisting of bis(tributyltin) oxide (IUPAC name) (913) + TX, bromoacetamide [CCN] + TX, calcium arsenate [CCN] + TX, chlorocarb (999) + TX, copper acetoarsenite [CCN] + TX, copper sulfate (172) + TX, fentin (347) + TX, ferric phosphate (IUPAC name) (352) + TX, metaldehyde (518) + TX, methiocarb (530) + TX, niclosamide (576) + TX, niclosamide olamine (576) + TX, pentachlorophenol (623) + TX, sodium pentachlorophenoxide (623) + TX, tazimcarb (1412) + TX, thiodicarb (799) + TX, tributyltin oxide (913) + TX, trifenmorph (1454) + TX, trimetacarb (840) + TX, triphenyltin acetate (IUPAC name) (347) and triphenyltin hydroxide (IUPAC name) (347) + TX, pyriprol [394730-71-3] + TX; a nematicide selected from the group of substances consisting of AKD-3088 (compound code) + TX, 1,2-dibromo-3-chloropropane (IUPAC / Chemical Abstracts name) (1045) + TX, 1,2-dichloropropane (IUPAC / Chemical Abstracts name) (1062) + TX, 1,2-dichloropropane with 1,3-dichloropropene (IUPAC name) (1063) + TX, 1,3-dichloropropene (233) + TX, 1,1-3,4-dichlorotetrahydrothiophene dioxide (IUPAC / Chemical Abstracts name) (1065) + TX, 3-(4-chlorophenyl)-5-methylrhodanine (IUPAC name) (980) + TX, 5-methyl-6-thioxo-1,3, 5-thiadiazinan-3-ylacetic (IUPAC name) (1286) + TX, 6-isopentenylaminopurine (alternative name) (210) + TX, abamectin (1) + TX, acetoprol [CCN] + TX, alanicarb (15) + TX, aldicarb (16) + TX, aldoxycarb (863) + TX, AZ 60541 (compound code) + TX, benzlothiaz [CCN] + TX, benomyl (62) + TX, butylpyridaben (alternative name) + TX, cadusaphos (109) + TX, carbofuran (118) + TX, carbon disulfide (945) + TX, carbosulfan (119) + TX,chloropicrin (141) + TX, chlorpyrifos (145) + TX, chlorotocarb (999) + TX, cyclobutyluram + TX, cytokinins (alternative name) (210) + TX, dazomet (216) + TX, DBCP (1045) + TX, DCIP (218) + TX, diamidaphos (1044) + TX, diclofenthion (1051) + TX, dicliphos (alternative name) + TX, dimethoate (262) + TX, doramectin (alternative name) [CCN] + TX, emamectin (291) + TX, emamectin benzoate (291) + TX, eprinomectin (alternative name) [CCN] + TX, ethoprophos (312) + TX, ethylene dibromide (316) + TX, fenamiphos (326) + TX, fenpyrad (alternative name) + TX, fensulfothione (1158) + TX, fosthiazate (408) + TX, fostiethan (1196) + TX, furfural (alternative name) [CCN] + TX, GY-81 (development code) (423) + TX, heterophos [CCN] + TX, iodomethane (IUPAC name) (542) + TX, isamidophos (1230) + TX, isazophos (1231) + TX, ivermectin (alternative name) [CCN] + TX, kinetin (alternative name) (210) + TX, mecarfon (1258) + TX, metam (519) + TX,metam-potassium (alternative name) (519) + TX, metam-sodium (519) + TX, methyl bromide (537) + TX, methyl isothiocyanate (543) + TX, milbemycin oxime (alternative name) [CCN] + TX, moxidectin (alternative name) [CCN] + TX, Myrothecium verrucaria composition (alternative name) (565) + TX, NC-184 (compound code) + TX, oxamyl (602) + TX, phorate (636) + TX, phosphamidon (639) + TX, phosphocarb [CCN] + TX, sebufos (alternative name) + TX, selamectin (alternative name) [CCN] + TX, spinosad (737) + TX, terbam (alternative name) + TX, terbufos (773) + TX, tetrachlorothiophene (name according to IUPAC / Chemical Abstracts) (1422) + TX, thiafenox (alternative name) + TX, thionazine (1434) + TX, triazophos (820) + TX, triazuron (alternative name) + TX, xylenols [CCN] + TX, YI-5302 (compound code) and zeatin (alternative name) (210) + TX, fluensulfone [318290-98-1] + TX, fluopyram + TX;, a nitrification inhibitor selected from the group of substances consisting of potassium ethylxanthate [CCN] and nitrapyrin (580) + TX; a plant activator selected from the group of substances consisting of acibenzolar (6) + TX, acibenzolar-S-methyl (6) + TX, probenazole (658) and Reynoutria sachalinensis extract (alternative name) (720) + TX; a rodenticide selected from the group of substances consisting of 2-isovalerilindan-1,3-dione (IUPAC name) (1246) + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (IUPAC name) (748) + TX, alphachlorohydrin [CCN] + TX, aluminum phosphide (640) + TX, antu (880) + TX, arsenious oxide (882) + TX, barium carbonate (891) + TX, bistiosemi (912) + TX, brodifacoum (89) + TX, bromadiolone (including alphabromadiolone) + TX, bromethalin (92) + TX, calcium cyanide (444) + TX, chloralose (127) + TX, chlorophacinone (140) + TX, cholecalciferol (alternative name) (850) + TX, coumachlor (1004) + TX, coumafuril (1005) + TX, coumatetralyl (175) + TX, crimidine (1009) + TX, difenacum (246) + TX, difethialone (249) + TX, diphacinone (273) + TX, ergocalciferol (301) + TX,flocoumafen (357) + TX, fluoroacetamide (379) + TX, flupropadine (1183) + TX, flupropadine hydrochloride (1183) + TX, gamma-HCH (430) + TX, HCH (430) + TX, hydrogen cyanide (444) + TX, iodomethane (IUPAC name) (542) + TX, lindane (430) + TX, magnesium phosphide (IUPAC name) (640) + TX, methyl bromide (537) + TX, norbormide (1318) + TX, fosacetim (1336) + TX, phosphine (IUPAC name) (640) + TX, phosphorus [CCN] + TX, pindone (1341) + TX, potassium arsenite [CCN] + TX, pyrinuron (1371) + TX, scylirroside (1390) + TX, sodium arsenite [CCN] + TX, sodium cyanide (444) + TX, sodium fluoroacetate (735) + TX, strychnine (745) + TX, thallium sulfate [CCN] + TX, warfarin (851) and zinc phosphide (640) + TX; a synergistic compound selected from the group of substances consisting of 2-(2-butoxyethoxy)ethyl piperonylate (IUPAC name) (934) + TX, 5-(1,3-benzodioxol-5-yl)-3-hexylcyclohex-2-enone (IUPAC name) (903) + TX, farnesol with nerolidol (alternative name) (324) + TX, MB-599 (development code) (498) + TX, MGK 264 (development code) (296) + TX, piperonyl butoxide (649) + TX, piprotal (1343) + TX, propyl isomer (1358) + TX, S421 (development code) (724) + TX, sesamex (1393) + TX, sesasmoline (1394) and sulfoxide (1406) + TX; an animal repellent selected from the group of substances consisting of anthraquinone (32) + TX, chloralose (127) + TX, copper naphthenate [CCN] + TX, copper oxychloride (171) + TX, diazinon (227) + TX, dicyclopentadiene (chemical name) (1069) + TX, guazatine (422) + TX, guazatine acetates (422) + TX, methiocarb (530) + TX, pyridine-4-amine (IUPAC name) (23) + TX, thiram (804) + TX, trimetacarb (840) + TX, zinc naphthenate [CCN] and ziram (856) + TX; a virucide selected from the group of substances consisting of imanin (alternative name) [CCN] and ribavirin (alternative name) [CCN] + TX; a wound protectant selected from the group of substances consisting of mercury oxide (512) + TX, octylinone (590) and thiophanate-methyl (802) + TX; a biologically active substance selected from 1,1-bis(4-chlorophenyl)-2-ethoxyethanol + TX, 2,4-dichlorophenyl benzenesulfonate + TX, 2-fluoro-N-methyl-N-1-naphthylacetamide + TX, 4-chlorophenyl phenyl sulfone + TX, acetoprol + TX, aldoxycarb + TX, amidithion + TX, amidothioate + TX, amiton + TX, amiton hydrogen oxalate + TX, amitraz + TX, aramite + TX, arsenious oxide + TX, azobenzene + TX, azothoate + TX, benomyl + TX, benoxaphos + TX, benzyl benzoate + TX, bixaphene + TX, brofenvalerate + TX, bromocyclene + TX, bromophos + TX, bromopropylate + TX, buprofezin + TX, butocarboxim + TX, butoxycarboxim + TX, butylpyridaben + TX, calcium polysulfide + TX, campeflor + TX, carbanolate + TX, carbophenothion + TX, cimiazole + TX, quinomethionate + TX, chlorbenside + TX, chlordimeform + TX, chlordimeform hydrochloride + TX, chlorphenetol + TX, chlorfenson + TX, chlorfensulfide + TX, chlorobenzylate + TX, chloromebuform + TX, chloromethioron + TX, chloropropylate + TX, chlorthiophos + TX, cinerin I + TX,cinerin II + TX, cinerins + TX, chlosantel + TX, coumaphos + TX, crotamyton + TX, crotoxyphos + TX, cufraneb + ​​TX, cyanthoate + TX, DCPM + TX, DDT + TX, demephion + TX, demephion-O, TX + demethone + TX, demethone-O + TX, demethone-O-methyl + TX, demethone-S + TX, demethone-S-methyl + TX, demethone-S-methylsulfone + TX, diclofluanide + TX, dichlorvose + TX, diclofluanide + TX, dienoxylone + dimethyl + TX, dimefone + TX TX, dinocap-4 + TX, dinocap-6 + TX, dinoctone + TX, dino-pentone + TX, dinosulfone + TX, dinoterbon + TX, dioxatione + TX, diphenylsulfone + TX, disulfiram + TX, endocti + TX, dophenerapine + TX, dophenrapine + TX eprinomectin + TX, ethoatomethyl + TX, etrimphos + TX, phenazaflor + TX, phenbutatine oxide + TX, phenothiocarb + TX, fenpyrade + TX, fenpyroximate + TX, phenpyrazamine + TX, phenzontri + flubencyl TX, TX + TX, fluenotyl + TX, fluorbenside + TX, FMC 1137 + TX, formathanate + TX, formathanate hydrochloride + TX,formparanate + TX, gamma-HCH + TX, gliodin + TX, halfenprox + TX, hexadecyl cyclopropancarboxylate + TX, isocarbophos + TX, jasmolin I + TX, jasmolin II + TX, iodofenphos + TX, lindanoba + TX, menocar + TX mephospholane + TX, mesulfene + TX, metacryphos + TX, methyl bromide + TX, metholcarb + TX, mexacarbate + TX, milbemycin oxime + TX, mipafox + TX, monocrotophos + TX, morphothion + TX + TX, moxidectin,4-4-led (2-chloro-2-methyl-propyl) -5-[ (6-iodo-3-pyridyl) methoxy]pyridazine-3-one + TX, nifluridide + TX, niccomycins + TX, nitrilacarb + TX, nitrilacarb and zincprop chloride complex, TX omethode + TX oxidisulfoton + TX, pp'-DDT + TX, parathion + TX, permethrin + TX, phenkapton + TX, fosalone + TX, phospholane + TX, phosphamidone + TX, polychloroterpenes + TX, polynactins + TX, proclonol + TX, proclonol + TX, TX, protoate + TX, pyrethrin I + TX, pyrethrin II + TX, pyrethrins + TX, pyridafenthione + TX,pyrimidate + TX, quinalfos + TX, quintiophos + TX, R-1492 + TX, fosglycine + TX, rotenone + TX, escradan + TX, sebufos + TX, selamectin + TX, sofamide + TX, SSI-121, sulfoda + TX, sulfiram TX, sulfur + TX, diflovidazine + TX, tau-fluvalinate + TX, TEPP + TX, terbam + TX, tetradiphone + TX, tetrasul + TX, thiaphenox + TX, thiocarboxyzyme + TX, thiophanox + TX, thiomethone + tunoring + TX, thio + TX, triaratene + TX, triazophos + TX, triazuron + TX, trifenophos + TX, trinactin + TX, vamidothione + TX, vanilliprole + TX, betoxazine + TX, copper dioctanoate + TX, copper dyclone sulfate + diclone + TX, cybu TX, endotal + TX, fentin + TX, quicklime + TX, nabam + TX, quinoclamine + TX, quinonamide + TX, zymazine + TX, triphenylestane acetate + TX, triphenylestane hydroxide + TX, crufomate + TX + TX, piperazine + piperazine fenthion + TX, pyridine-4-amine + TX, strychnine + TX,1-hidroxi-1H-pyridin-2-thiona + TX, 4- (quinoxaline-2-ylamino) bencensulfonamida + TX, sulfato de 8-hidroxyquinolina + TX, bronopol + TX, hidróxido de cobre + TX, cresol + TX, dipyrithione + TX, twelveine + TX, fenaminosulf + TX, formaldehído + TX, hidrargafeno + TX, kasugamicin + TX, hidrated kasugamicin chlorhidrate + TX, bis (dimethyldithiocarbamate) de niquel + TX, nitrapyrina + TX, octilinona + TX, oxolin acid + TX, oxytetracycline + TX, potassium hydroxyquinolinsulfate + TX, probenazol + TX, estreptomycin + TX, sesquisulfato de estreptomycin + TX, tecloftalam + TX, thiomersal + TX, GV de Adoxophyes orana + TX, Agrobacterium radiobacter + TX, Amblyseius spp. + TX, Anagrapha falcifera NPV + TX, Anagrus atomus + TX, Aphelinus abdominalis + TX, Aphidius colemani + TX, Aphidoletes aphidimyza + TX, NPV de Autographa californica + TX, Bacillus sphaericus Neide + TX, Beauveria brongniartii + TX, Chr y soperla carnea + TX, Cr y ptolaemus montrouzieri + TX, Cydia pomonella GV + TX,Dacnusa sibirica + TX, Diglyphus isaea + TX, Encarsia formosa + TX, Eretmocerus eremicus + TX, Heterorhabditis bacteriophora y H. megidis + TX, Hippodamia convergens + TX, Leptomastix dactylopistrai + brassica + TX, Macrosuslo TX, Metaphycus helvolus + TX, Metarhizium anisopliae var. acridum + TX, Metarhizium anisopliae var. anisopliae + TX, NPV of Neodiprion certifer and NPV of N. lecontei + TX, Orius spp. + TX, Paecilomyces fumosoroseus + TX, Phytoseiulus persimilis + TX, Steinernema bibionis + TX, Steinernema carpocapsae + TX, Steinernema feltiae + TX, Steinernema glaseri + TX, Steinernema riobravierne + TX scapterisci + TX, Steinernema spp. + TX, Trichogramma spp. + TX, Typhlodromus occidentalis + TX, Verticillium lecanii + TX, afofolate + TX, bisazir + TX, busulfan + TX, dimatif + TX, hemel + TX, hempa + TX, metepa + TX, methiotepa + TX, afofolate, methyl teron + TX, TX thiohemp + TX,thiotepa + TX, tretamine + TX, uredepa + TX, acetate of (E) -dec-5-en-1-yl with (E) -dec-5-en-1-ol + TX, acetate of (E) -tridec-4-en-1-yl + TX, (E, -ac-2-acate +methylhept4 Z) -tetradec-4, 10-diene-1-ylyl + TX, acetate of (Z) -dodec-7-en-1-yl + TX, (Z) -hexadec-11-enal + TX, acetate of (Z) -hexadec-11-en-1-ylyl + TX, acetate -hexadec-13-en-11-in-1-yl + TX, (Z) -icos-13-en-10-one + TX, (Z) -tetradec-7-en-1-al + TX, (Z) -tetradec-9-en-1-ol + TX, acetate de-dec-9-tet +tete (7E, 9Z) -dodeca-7, 9-diene-1-yl + TX, acetate of (9Z, 11E) -tetradeca-9, 11-diene-1-yl + TX, acetate of (9Z, 12E) -tetradeca-9, 12-TX-methyl-1-ct1-ct 4-methylnonan-5-ol with 4-methylnonan-5-one + TX, alpha-multistriatin + TX, brevicomine + TX, codlelure + TX, codlemona + TX, skinure + TX, disparlure + TX, dodec-8-atote + dode-1,1-ac-ethyl acetate TX, twelve-8 + TX, 10-diene-1-yl acetate + TX, dominicaure + TX,4-methyloctanoate of ethyl + TX, eugenol + TX, frontalin + TX, grandlure + TX, grandlure I + TX, grandlure II + TX, grandlure III + TX, grandlure IV + TX, hexalure + TX, ipsdienol + TX, ipsenol + TX, japonilure + TX, lineatin + TX, litlure + TX, looplure + TX, medlure + TX, megatomoic acid + TX, methyleugenol + TX, muscalure + TX, octadeca-2, 13-dien-1-yl acetate + TX, octadeca-3, 13-dien-1-yl acetate + TX, orfralure + TX, orictalure + TX, ostramone + TX, siglure + TX, sordidine + TX, sulcatol + TX, tetradec-11-en-1-yl acetate + TX, trimedlure + TX, trimedlure A + TX, trimedlure B1 + TX, trimedlure B2 + TX, trimedlure C + TX, trunc-call + TX, 2- (octylthio) ethanol + TX, butopyronoxyl + TX, butoxy (polypropylene glycol) + TX, dibutyl adipate + TX, dibutyl phthalate + TX, dibutyl succinate + TX, diethyltoluamide + TX, dimethyl carbonate + TX, dimethyl phthalate + TX, ethylhexanediol + TX, hexamide + TX, methoquin-butyl + TX, methylneodecanamide + TX, oxamate + TX,picaridin + TX, 1-dichloro-1-nitroethane + TX, 1, 1-dichloro-2, 2-bis (4-ethylphenyl) ethane + TX, 1, 2-dichloropropane with 1, 3-dichloropropene + TX, 1-bromo-2-chloroethane + TX, 2, 2, 2-trichloro-1-(3, 4-dichlorophenyl) ethyl acetate + TX, 2, 2-dichlorovinyl 2-ethylsulfinylethyl methyl phosphate + TX, 2-(1, 3-dithiolan-2-yl)phenyl dimethylcarbamate + TX, 2-(2-butoxyethoxy)ethyl thiocyanate + TX, 2-(4, 5-dimethyl-1, 3-dioxolan-2-yl)phenyl methylcarbamate + TX, 2-(4-chloro-3, 5-xylyloxy)ethanol + TX, diethylphosphate of 2-chlorovinyl + TX, 2-imidazolidone + TX, 2-isovalerilindan-1, 3-dione + TX, methylcarbamate of 2-methyl (prop-2-ynyl) aminophenyl + TX, laurate of 2-thiocyanatoethyl + TX, 3-bromo-1-chloroprop-1-ene + TX, 3-methyl-1-phenylpyrazol-5-yl dimethylcarbamate + TX, methylcarbamate of 4-methyl (prop-2-ynyl) amino-3, 5-xylyl + TX, dimethylcarbamate of 5, 5-dimethyl-3-oxocyclohex-1-enyl + TX, acetione + TX, acrylonitrile + TX, aldrin + TX, halosamide + TX, alixicarb + TX,alpha-ecdysone + TX, aluminum phosphide + TX, aminocarb + TX, anabasine + TX, atidathion + TX, azamethiphos + TX, Bacillus thuringiensis delta endotoxins + TX, barium hexafluorosilicate + TX, barium polysulfide + TX, barthrin + TX, Bayer 22 / 190 + TX, Bayer 22408 + TX, beta-cyfluthrin + TX, beta-cypermethrin + TX, bioethanolomethrin + TX, biopermethrin + TX, bis(2-chloroethyl) ether + TX, borax + TX, bromfenvinphos + TX, bromo-DDT + TX, bufencarb + TX, butacarb + TX, butathiophos + TX, butonate + TX, calcium arsenate + TX, calcium cyanide + TX, carbon disulfide + TX, carbon tetrachloride + TX, hydrochloride de cartap + TX, cevadine + TX, chlorbicyclene + TX, chlordane + TX, chlordecone + TX, chloroform + TX, chloropicrin + TX, chlorfoxim + TX, chlorprazophos + TX, cis-resmethrin + TX, cismethrin + TX, clocitrine + TX, copper acetoarsenite + TX, copper arsenate + TX, copper oleate + TX, cumitoate + TX, cryolite + TX, CS 708 + TX, cyanophenphos + TX, cyanophos + TXcyclethrin + TX, cythioate + TX, d-tetramethrin + TX, DAEP + TX, dazomet + TX, decarbofuran + TX, diamidafos + TX, dicapton + TX, diclofenthion + TX, dicresyl + TX, dicyclanil + TX, dieldrin + TX, 5-methylpyrazol-3-yl diethyl phosphate + TX, dilor + TX, dimefluthrin + TX, dimethan + TX, dimethrin + TX, dimethylvinphos + TX, dimethylan + TX, dinoprop + TX, dinosam + TX, dinoseb + TX, diofenolan + TX, dioxabenzophos + TX, diticrophos + TX, DSP + TX, ecdysterone + TX, EI 1642 + TX, EMPC + TX, EPBP + TX, etaphos + TX, ethiofencarb + TX, ethyl formate + TX, ethylene dibromide + TX, ethylene dichloride + TX, ethylene oxide + TX, EXD + TX, fenchlorfos + TX, fenetacarb + TX, fenitrothion + TX, fenoxacrim + TX, fenpyrithrin + TX, fensulfothion + TX, fenthion-ethyl + TX, flucofurón + TX, fosmetilán + TX, fospirate + TX, fostietán + TX, furatiocarb + TX, furethrin + TX, guazatin + TX, guazatin acetates + TX, sodium tetrathiocarbonate + TX, halfenprox + TX, HCH + TX, HOED + TX,heptachlor + TX, heterophos + TX, HHDN + TX, hydrogen cyanide + TX, hiquincarb + TX, IPSP + TX, isazophos + TX, isobenzan + TX, isodrine + TX, isofenphos + TX, isolane + TX, isoprothiolane + TX, isoxation + TX, juvenile hormone I + TX, juvenile hormone II + TX, juvenile hormone III + TX, kelevan + TX, kinoprene + TX, lead arsenate + TX, leptophos + TX, lirimphos + TX, litidathion + TX, m-cumenyl methylcarbamate + TX, magnesium phosphide + TX, mazidox + TX, mecarfon + TX, menazon + TX, mercurous chloride + TX, mesulfenphos + TX, metam + TX, metam-potassium + TX, metam-sodium + TX, methanesulfonyl fluoride + TX, metocrotophos + TX, methoprene + TX, methothrin + TX, methoxychlor + TX, methyl isothiocyanate + TX, methylchloroform + TX, methylene chloride + TX, methoxadiazone + TX, mirex + TX, naphthalophos + TX, naphthalene + TX, NC-170 + TX, nicotine + TX, nicotine sulfate + TX, nithiazine + TX, nornicotine + TX, O-5-dichloro-4-iodophenyl-O-ethyl ethylphosphonothioate + TX, O phosphorothioate,O-diethyl O-4-methyl2-oxo-2H-chromen-7-yl + TX, O phosphorothioate, O-diethyl O-6-methyl-2-propylpyrimidin-4-yl + TX, O, O, O', O'-tetrapropyl dithiopyrophosphate + TX, oleic acid + TX, para-dichlorobenzene + TX, parathion-methyl + TX, pentachlorophenol + TX, pentachlorophenyl laurate + TX, PH 60-38 + TX, phenkapton + TX, phosphine + TX, phosphine + TX, phoximmethyl + TX, pyrimetaphos + TX, polychlorodicyclopentadiene isomers + TX, potassium arsenite + TX, potassium thiocyanate + TX, precocene I + TX, precocene II + TX, precocene III + TX, pidophos + TX, profluthrin + TX, promecarb + TX, prothiophos + TX, pyrazophos + TX, pyresmethrin + TX, quasia + TX, quinalphosmethyl + TX, quinotion + TX, rafoxanide + TX, resmethrin + TX, rotenone + TX, kadethrin + TX, riania + TX, ryanodine + TX, sabadilla + TX, escradan + TX, sebuphos + TX, SI-0009 + TX, tiapronil + TX, sodium arsenite + TX, sodium cyanide + TX, sodium fluoride + TX, sodium hexafluorosilicate + TX,sodium pentachlorophenoxide + TX, sodium selenate + TX, sodium thiocyanate + TX, sulcofuron + TX, sulcofuron-sodium + TX, sulfuryl fluoride + TX, sulfophos + TX, tar oils + TX, tazimcarb + TX, TDE + TX, tebupirimphos + TX, temephos + TX, teraletrin + TX, tetrachloroethane + TX, ticrophos + TX, thiocyclam + TX, thiocyclam hydrogenoxalate + TX, thionazine + TX, thiosultap + TX, thiosultap-sodium + TX, tralomethrin + TX, transpermethrin + TX, triazamate + TX, trichlorometaphos-3 + TX, trichloronat + TX, trimetacarb + TX, tolprocarb + TX, triclopiricarb + TX, triprene + TX, veratridine + TX, veratrine + TX, XMC + TX, zetamethrin + TX, zinc phosphide + TX, zolapropos + TX, meperfluthrin + TX, tetramethylfluthrin + TX, bis(tributyltin) oxide + TX, bromoacetamide + TX, ferric phosphate + TX, niclosamide-olamine + TX, tributyltin oxide + TX, pyrimorph + TX, trifenmorph + TX, 1,2-dibromo-3-chloropropane + TX, 1,3-dichloropropene + TX, 1,1-dioxide of 3,4-dichlorotetrahydrothiophene + TX, 3-(4-chlorophenyl)-5-methylrhodanine + TX, 5-methyl-6-thioxo-1, 3, 5-thiadiazinan-3-ylacetic acid + TX, 6-isopentenylaminopurine + TX, anisiflupurine + TX, benclothiaz + TX, cytokinins + TX, DCIP + TX, furfural + TX, isamidophos + TX, kinetin + TX, composition of Myrothecium verrucaria + TX, tetrachlorothiophene + TX, xylenols + TX, zeatin + TX, potassium ethylxanthate + TX, acibenzolar + TX, acibenzolar-S-methyl + TX, Reynoutria sachalinensis extract + TX, alpha-chlorohydrin + TX, antu + TX, barium carbonate + TX, bistiosemi + TX, brodifacum + TX, bromadiolone + TX, bromethalin + TX, chlorophacinone + TX, cholecalciferol + TX, coumaclor + TX, coumafuril + TX, coumatetralyl + TX, crimidine + TX, difenacum + TX, difethialone + TX, diphacinone + TX, ergocalciferol + TX, flocoumafene + TX, fluoroacetamide + TX, flupropadine + TX, flupropadine hydrochloride + TX, norbormide + TX, fosacetim + TX, phosphorus + TX, pindone + TX, pyrinuron + TX, scylirroside + TX,sodium fluoroacetate + TX, thallium sulfate + TX, warfarin + TX, 2-(2-butoxyethoxy)ethyl piperonylate + TX, 5-(1,3-benzodioxol-5-yl)-3-hexylcyclohex-2-enone + TX, farnesol with nerolidol + TX, verbutine + TX, MGK 264 + TX, piperonyl butoxide + TX, piprotal + TX, propyl isomer + TX, S421 + TX, sesamex + TX, sesasmoline + TX, sulfoxide + TX, anthraquinone + TX, copper naphthenate + TX, copper oxychloride + TX, dicyclopentadiene + TX, thiram + TX, zinc naphthenate + TX, ziram + TX, imanine + TX, ribavirin + TX, chloroinconazide + TX, mercuric oxide + TX, thiophanate-methyl + TX, azaconazole + TX, bitertanol + TX, bromuconazole + TX, cyproconazole + TX, difenoconazole + TX, diniconazole -+ TX, epoxiconazole + TX, fenbuconazole + TX, fluquinconazole + TX, flusilazol + TX, flutriafol + TX, furametpir + TX, hexaconazole + TX, imazalil + TX, imiben-conazole + TX, ipconazole + TX, metconazole + TX, myclobutanil + TX, paclobutrazol + TX, pefurazoate + TX, penconazole + TX,prothioconazole + TX, pirifenox + TX, prochloraz + TX, propiconazole + TX, pyrisoxazole + TX, -simeconazole + TX, tebuconazole + TX, tetraconazole + TX, triadimefón + TX, triadimenol + TX, triflumizole + TX, triticonazole + TX, ancymidol + TX, fenarimol + TX, nuarimol + TX, bupirimato + TX, dimethirimol + TX, etirimol + TX, dodemorph + TX, fenpropidin + TX, fenpropimorph + TX, spiroxamine + TX, tridemorph + TX, cyprodinil + TX, mepanipyrim + TX, pyrimethanil + TX, fenpiclonil + TX, fludioxonil + TX, benalaxyl + TX, furalaxyl + TX, metalaxyl + TX, R-metalaxyl + TX, ofurace + TX, oxadixyl + TX, carbendazim + TX, debacarb + TX, fuberidazole -+ TX, thiabendazole + TX, clozolinato + TX, diclozolin + TX, miclozolin + TX, procymidone + TX, vinclozolin + TX, boscalid + TX, carboxin + TX, fenfuram + TX, flutolanil + TX, mepronil + TX, oxycarboxin + TX, penthiopyrad + TX, thifluzamide + TX, dodine + TX, iminoctadine + TX, azoxystrobin + TX, dimoxystrobin + TX, enestroburin + TX,phenaminestrobin + TX, flufenoxystrobin + TX, fluoxastrobin + TX, kresoxim-methyl + TX, methominostrobin + TX, trifloxystrobin + TX, orysastrobin + TX, picoxystrobin + TX, pyraclostrobin + TX, pyrametostrobin + TX, pyraoxystrobin + TX, ferbam + TX, mancozeb + TX, maneb + ​​TX, metiram + TX, propineb + ​​TX, zineb + ​​TX, captafol + TX, captan + TX, fluoroimide + TX, folpet + TX, tolylfluanide + TX, bordeaux solution + TX, copper oxide + TX, mancobre + TX, oxin-cobre + TX, nitrotal-isopropyl + TX, edifenphos + TX, iprobenphos + TX, phosdifen + TX, tolclofos-methyl + TX, anilazine + TX, benthiavalicarb + TX, blasticidin-S + TX, chloroneb -+ TX, chlorothalonil + TX, ciflufenamide + TX, cimoxanil + TX, cyclobutrifluram + TX, diclocimet + TX, diclomezin + TX, dichloran + TX, dietofencarb + TX, dimethomorph -+ TX, flumorf + TX, dithianone + TX, etaboxam + TX, etridiazole + TX, famoxadone + TX, phenamidone + TX, fenoxanil + TX, ferimzone + TX, fluazinam + TX, flumethylsulforim + TX,fluopicolide + TX, fluoxithioconazole + TX, flusulfamide + TX, fluxapiroxad + TX, fenhexamide + TX, fosetyl aluminum -+ TX, himexazole + TX, iprovalicarb + TX, ciazofamide + TX, metasulfocarb + TX, metrafenone + TX, pencicurón + TX, phthalide + TX, polyoxins + TX, propamocarb + TX, piribencarb + TX, proquinazid + TX, piroquilon + TX, pyriophenone + TX, quinoxifene + TX, quintocene + TX, thiadinyl + TX, triazoxide + TX, tricyclazole + TX, triforin + TX, validamycin + TX, valifenalate + TX, zoxamide + TX, mandipropamide + TX, flubeneteram + TX, isopyrazam + TX, sedaxan + TX, benzovindiflupir + TX, pidiflumetofen + TX, (3', 4', 5'-trifluoro-biphenyl-2-yl)-amide del ácido 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid + TX, isoflucipram + TX, isothianyl + TX, dipimethytron + TX, 6-ethyl-5, 7-dioxo-pyrrolo[4, 5][1, 4]dithio[1, 2-c]isothiazole-3-carbonitrile + TX, 2- (difluoromethyl)-N-[3-ethyl-1, 1-dimethyl-indan-4-yl]pyridine-3-carboxamide + TX, 4-(2,6-difluorophenyl)-6-methyl-5-phenyl-pyridazine-3-carbonitrile + TX, (R)-3-(difluoromethyl)-1-methyl-N-[1,1,3-trimethyllindan-4-yl]pyrazol-4-carboxamide + TX,4-(2-bromo-4-fluorophenyl)-N-1. (2-chloro-6-fluorophenyl)-2,5-dimethylpyrazol-3-amine + TX, 4-(2-bromo-4-fluorophenyl)-N-(2chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine + TX, fluindapir + TX, cumethoxystrobin (jiaxiangjunzhi) + TX, lvbenmixianan + TX, diclobenthiazox + TX, mandestrobin + TX, 3-(4,4-difluoro-3,4-dihydro-3,3-dimethylisoquinolin-1-yl)quinolone + TX, 2-[2-fluoro-6-[ (8-fluoro-2-methyl-3-quinolyl) oxy]phenyl]propan-2-ol + TX, oxathiapiproline + TX, N-[6-[[ (1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]tert-butyl carbamate + TX, pyraziflumide + TX, . inpirfluxam + TX, trolprocarb + TX, mefentrifluconazole + TX, ipfentrifluconazole + TX, 2-(difluoromethyl)-N-[(3R)-3-ethyl-1,1-dimethyl-indan-4-yl]pyridin-3-carboxamide + TX, N'- 5-dimethyl-4-phenoxy-phenyl)-N-ethyl-N-methyl-formamidine + TX,1.N'-[4-(4, 5-dichlorothiazol-2-yl) oxi-2, 5-dimethyl-fenil]-N-etil-N-metil-formamidina + TX, metansulfonato de [2-[3-[2-[1-[2-[3, 5-bis (difluorometil) pyrazol-1-yl]acetyl]-4-piperidyl]thiazol-4-yl]-4, 5-dihydroisoxazol-5-yl]-3-clorofenilo] + TX, N-[6-[ (Z) -[ (1-metiltetrazol-5-il) -fenil-metilen]amino]oximetil]-2-pyridyl]carbamato de but-3-inilo + TX, N-[[5-[4-(2, 4-dimethylfenil)triazol-2-yl]-2-metil-fenil]metil]carbamato de metilo + TX, 3-chloro-6-metil-5-fenil-4-(2, 4, 6-trifluorofenil) pyridazine + TX, pyridaclomethyl + TX, 3-(difluoromethyl)-1-methyl-N-[1, 1, 3-trimethylindan-4-yl]pyrazole-4-carboxamide + TX, 1-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-methylphenyl]-4-methyltetrazol-5-one + TX, 1-methyl-4-[3-methyl-2-[[2-methyl-4-(3, 4, 5-trimethylpyrazol-1-yl)phenoxy]methyl]phenyl]tetrazol-5-one + TX, aminopyrifeno + TX, ametoctradina + TX, amisulbrom + TX, penflufeno + TX, (Z, 2E)-5-[1-(4-chlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N, 3-dimethyl-pent-3-enamide + TX,florylpicoxamid + TX, fenpicoxamid + TX, metarylpicoxamid + TX, tebufloquine + TX, ipflufenoquine + TX, quinofumelin + TX, isofetamid + TX, ethyl 1-[[4-[[2-(trifluoromethyl)-1,3-dioxolan-2-yl]methoxy]phenyl]methyl]pyrazol-3-carboxylate + TX (can be prepared from the methods described in WO 2020 / 056090), ethyl 1-[[4-[(Z)-2-ethoxy-3,3,3-trifluoroprop-1-enoxy]phenyl]methyl]pyrazol-3-carboxylate + TX (can be prepared from the methods described in WO 2020 / 056090), N-[[4-[1-(4-cyclopropyl-2,6-difluorophenyl) methyl pyrazol-4-yl]-2-methylphenyl]methyl]carbamate + TX (can be prepared from the methods described in WO 2020 / 097012), N-[[4-[1-(2,6-difluoro-4-isopropylphenyl)pyrazol-4-yl]-2-methylphenyl]methyl]carbamate + TX (can be prepared from the methods described in WO 2020 / 097012), 6-chloro-3-(3-cyclopropyl-2-fluorophenoxy)-N-[2-(2,4-dimethylphenyl)-2,2-difluoroethyl]-5-methylpyridazine-4-carboxamide + TX (can be prepared from the methods described in WO 2020 / 109391), 6-chloro-N-[2-(2-chloro-4-methylphenyl)-2,2-difluoroethyl]-3-(3-cyclopropyl-2-fluorophenoxy)-5-methylpyridazine-4-carboxamide + TX (can be prepared from the methods described in WO 2020 / 109391), 6-chloro-3-(3-cyclopropyl-2-fluorophenoxy)-N-[2-(3,4-dimethylphenyl)-2,2-difluoroethyl]-5-methylpyridazine-4-carboxamide + TX (can be prepared from the methods described in WO 2020 / 109391) , N-[2-[2, 4-dichlorophenoxy]phenyl]-3- (difluoromethyl) -1-methyl-pyrazole-4-carboxamide + TX, N-[2-[2-chloro-4- (trifluoromethyl) phenoxy]phenyl]-3- (difluoromethyl) -1-methyl-pyrazole-4-carboxamide + TX, benzothiostrobin + TX, phenamacryl + TX, salt 5-amino-1, 3, 4-thiadiazol-2-thiol zinc (2:1) + TX, fluopyram + TX, flufenoxadiazam + TX, flutianil + TX, fluopimomide + TX, pyrapropoin + TX, picarbutrazox + TX,2-(difluorometil) -N-(3-etil-1, 1-dimethyl-indan-4-yl) pyridin-3-carboxamida + TX, 2-(difluorometil) -N-( (3R)-1, 1, 3-trimetilindan-4-yl) pyridin-3-carboxamida + TX, 4-[[6-[2-(2, 4-difluorofenil)-1, 1-difluoro-2-hidroxi-3-(1, 2, 4-triazol-1-yl) propyl]-3-pyridyl]oxi]benzonitrilo + TX, metiltetraprol + TX, 2-(difluorometil) -N-( (3R) -1, 1, 3-trimetilindan-4-yl) pyridin-3-carboxamida + TX, - (1, 1-dimethyletil) --[4'- (omettrifluorooxy) [1,1'-biphenyl]-4-yl]-5-pyrimidinemethanol + TX, fluoxapiproline + TX, enoxastrobin + TX, (Z) -3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate methyl + TX, (Z) -3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoate methyl + TX, (Z) -2-[5-(3-isopropylpyrazol-1-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoate methyl + TX, (Z) -3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate methyl + TX,(Z) methyl-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate + TX (these compounds can be prepared from the methods described in WO2020 / 079111), (Z) methyl-2-(5-cyclohexyl-2-methylphenoxy)-3-methoxyprop-2-enoate + TX, (Z) methyl-2-(5-cyclopentyl-2-methylphenoxy)-3-methoxyprop-2-enoate + TX (these compounds can be prepared from the methods described in WO2020 / 193387), 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1,2,4-triazol-1-yl) propyl]-3-pyridyl]oxy]benzonitrile + TX, 4-[[6-[2- (2, 4-difluorophenyl) -1, 1-difluoro-2-hydroxy-3- (5-sulfanyl-1, 2, 4-triazol-1-yl) propyl]-3-pyridyl]oxy]benzonitrile + TX, 4-[[6-[2- (2, 4-difluorophenyl)-1, 1-difluoro-2-hydroxy-3- (5-thioxo-4H-1, 2, 4-triazol-1-yl) propyl]-3-pyridyl]oxy]benzonitrile + TX, trinexapac + TX, cumoxystrobin + TX, zhongshengmycin + TX, thiodiazole copper + TX, thiazole zinc + TX, amectotractin + TX, iprodione +TX,seboctilamine + TX; N'-[5-bromo-2-methyl-6-[ (1S) -1-methyl-2-propoxy-ethoxy]-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX, N'-[5-bromo-2-methyl-6-[ (1R) -1-methyl-2-propoxy-ethoxy]-3-pyridyl]-N-ethyl-N-methylformamidine + TX, N'-[5-bromo-2-methyl-6- (1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX, N'-[5-chloro-2-methyl-6- (1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX, N'-[5-bromo-2-methyl-6- (1-methyl-2-propoxy-ethoxy) -3-pyridyl]-N-isopropyl-N-methyl-formamidine + TX (these compounds can be prepared from the methods described in WO2015 / 155075); N'-[5-bromo-2-methyl-6-(2-propoxypropoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX (this compound can be prepared from the methods described in IPCOM000249876D); N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenylethyl)phenyl]-N-methyl-formamidine + TX, N'-[4-(1-cyclopropyl-2,2,2-trifluoro-1-hydroxyethyl)-5-methoxy-2-methylphenyl]-N-isopropyl-N-methylformamidine + TX (these compounds can be prepared from the methods described in WO2018 / 228896); N-ethyl-N'-[5-methoxy-2-methyl-4-[2-trifluoromethyl)oxetan-2-yl]phenyl]-N-methylformamidine + TX, N-ethyl-N'-[5-methoxy-2-methyl-4-[2-trifluoromethyl)tetrahydrofuran-2-yl]phenyl]-N-methylformamidine + TX (these compounds can be prepared from the methods described in WO2019 / 110427); N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoroquinoline-3-carboxamide + TX, N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoroquinoline-3-carboxamide + TX, + TX, N-[ (1S) -1-benzyl-1, 3-dimethylbutyl]-7,8-difluoro-quinoline-3-carboxamida + TX, 8-fluoro-N-[ (1R) -1-[ (3-fluorophenyl) methyl]-1, 3-dimethyl-butyl]quinoline-3-carboxamida + TX, 8-fluoro-N-[ (1S) -1-[ (3-fluorophenyl) methyl]-1, 3-dimethyl-butyl]quinolin-3-carboxamida + TX, N-[ (1R) -1-bencyl-1, 3-dimethyl-butyl]-8-fluoroquinolin-3-carboxamida + TX, N-[ (1S) -1-bencyl-1, 3-dimethyl-butyl]-8-fluoroquinolin-3-carboxamida + TX, N- ( (1R) -1-bencyl-3-chloro-1-methylbut-3-enyl) -8-fluoroquinolin-3-carboxamida + TX, N- ((1S) -1-bencyl-3-chloro-1-methyl-but-3-enyl) -8-fluoroquinolin-3-carboxamida + TX (these components can be prepared starting from the methods described in document WO2017 / 153380) ; 1- (6, 7-dimethylpyrazolo[1, 5-a]pyridin-3-yl)-4, 4, 5-trifluoro-3, 3-dimethyl-isoquinoline + TX, 1- (6, 7-dimethylpyrazolo[1, 5-a]pyridin-3-yl)-4, 4, 6-trifluoro-3, 3-dimethyl-isoquinoline + TX, 4, 4-difluoro-3, 3-dimethyl-1- (6-methylpyrazolo[1, 5-a]pyridin-3-yl) isoquinoline + TX, 4, 4-difluoro-3, 3-dimethyl-1- (7-methylpyrazolo[1,5-a]pyridin-3-yl) isoquinoline + TX, 1- (6-chloro-7-methylpyrazolo[1, 5-a]pyridin-3-yl)-4, 4-difluoro-3, 3-dimethylisoquinoline + TX (these compounds can be prepared from the methods described in WO2017 / 025510); 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethylisoquinoline + TX, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethylisoquinoline + TX, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline + TX, 4,4-difluoro-1-(5-fluoro-4-methylbenzimidazol-1-yl)-3,3-dimethylisoquinoline + TX, 3-(4,4-difluoro-3,3-dimethyl-1-isoquinolyl)-7,8-dihydro-6H-cyclopenta[e]benzimidazole + TX (these compounds can be prepared from the methods described in document WO2016 / 156085); N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropancarboxamide + TX, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide + TX,N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1, 2, 4-oxadiazol-3-yl]phenyl]methyl]propanamide + TX, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1, 2, 4-oxadiazol-3-yl]phenyl]methyl]urea + TX, 1, 3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1, 2, 4-oxadiazol-3-yl]phenyl]methyl]urea + TX, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1, 2, 4-oxadiazol-3-yl]phenyl]methyl]urea + TX, N-[[4-[5-(trifluoromethyl)-1, 2, 4-oxadiazol-3-yl]phenyl]methyl]propanamide + TX, 4, 4-dimethyl-2-[[4-[5- (trifluorometil) -1, 2, 4-oxadiazol-3-yl]fenil]metil]isoxazolidin-3-ona + TX, 5, 5-dimethyl-2-[[4-[5-(trifluorometil)-1, 2, 4-oxadiazol-3-yl]fenil]metil]isoxazolidin-3-ona + TX, 1-[[4-[5-(trifluorometil)-1, 2, 4-oxadiazol-3-yl] 4-oxadiazol-3-il]fenil]metil]pyrazol-4-carboxilato de etilo + TX, N, N-dimethyl-1-[[4-[5-(trifluorometil)-1, 2, 4-oxadiazol-3-yl]fenil]metil]-1, 2, 4-triazol-3-amine + TX. The compounds in this paragraph can be prepared from the methods described in documents WO 2017 / 055473, WO 2017 / 055469,WO 2017 / 093348 and WO 2017 / 118689; 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol + TX (this compound can be prepared from the methods described in WO 2017 / 029179); 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl) propan-2-ol + TX (this compound can be prepared from the methods described in WO 2017 / 029179) ; 3-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxypropyl]imidazol-4-carbonitrile + TX (this compound can be prepared from the methods described in WO 2016 / 156290) ; 3-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluorophenyl)-2-hydroxypropyl]imidazol-4-carbonitrile + TX (this compound can be prepared from the methods described in WO 2016 / 156290) ; 2-amino-6-methylpyridin-3-carboxylate of (4-phenoxyphenyl) methyl + TX (this compound can be prepared from the methods described in WO 2014 / 006945); 2,6-dimethyl-1H,5H-[1,4]dithiyno[2,3-c:5,6-c']dipyrrolo-1,3,5,7(2H,6H)-tetrone + TX (this compound can be prepared from the methods described in WO 2011 / 138281); N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzencarbothioamide + TX; N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide + TX; (Z, 2E)-5-[1-(2,4-dichlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethylpent-3-enamide + TX (this compound can be prepared from the methods described in WO 2018 / 153707); N'-(2-chloro-5-methyl-4-phenoxyphenyl)-N-ethyl-N-methylformamidine + TX; N'-[2-chloro-4-(2-fluorophenoxy)-5-methylphenyl]-N-ethyl-N-methylformamidine + TX (this compound can be prepared from the methods described in WO 2016 / 202742); 2-(difluoromethyl)-N-[(3S)-3-ethyl-1,1-dimethylindan-4-yl]pyridin-3-carboxamide + TX (this compound can be prepared from the methods described in WO 2014 / 095675); (5-methyl-2-pyridyl)-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methanone + TX, (3-methylisoxazol-5-yl)-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methanone + TX (these compounds can be prepared from the methods described in WO 2017 / 220485); 2-oxo-N-propyl-2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide + TX (this compound can be prepared from the methods described in WO 2018 / 065414); ethyl 1-[[5-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2-thienyl]methyl]pyrazol-4-carboxylate + TX (this compound can be prepared from the methods described in WO 2018 / 158365); 2, 2-difluoro-N-methyl-2-[4-[5- (trifluoromethyl) -1, 2, 4-oxadiazol-3-yl]phenyl]acetamide + TX, N-[ (E) -methoxyiminomethyl]-4-[5- (trifluoromethyl) -1, 2, 4-oxadiazol-3-yl]benzamide + TX, N-[ (Z) -methoxyiminomethyl]-4-[5- (trifluoromethyl) -1, 2, 4-oxadiazol-3-yl]benzamide + TX, N-[N-methoxy-C-methylcarbonimidoyl]-4-[5- (trifluoromethyl) -1, 2,4-oxadiazol-3-yl]benzamide + TX (these compounds can be prepared from the methods described in WO 2018 / 202428); microbial agents including: Acinetobacter lwoffii + TX, Acremonium alternatum + TX + TX, Acremonium cephalosporium + TX + TX, Acremonium diospiri + TX, Acremonium obclavatum + TX, Adoxophyes orana granulovirus (AdoxGV) (Capex®) + TX, Agrobacterium radiobacter strain K84 (Galltrol-A®) + TX, Alternaria alternate + TX, Alternaria cassia + TX, Alternaria destruens (Smolder®) + TX, Ampelomyces quisqualis (AQ10®) + TX, Aspergillus flavus AF36 (AF36®) + TX, Aspergillus flavus NRRL 21882 (Aflaguard®) + TX, Aspergillus spp.+ TX, Aureobasidium pullulans + TX, Azospirillum + TX, (MicroAZ® + TX, TAZO B®) + TX, Azotobacter + TX, Azotobacter chroocuccum (Azotomeal®) + TX, Azotobacter cysts (Bionatural Blooming Blossoms®) + TX, Bacillus amiloliquefaciens + TX, Bacillus cereus + TX, Bacillus chitinosporus strain CM-1 + TX, Bacillus chitinosporus strain AQ746 + TX, Bacillus licheniformis strain HB-2 (Biostart™ Rhizoboost®) + TX, Bacillus licheniformis strain 3086 (EcoGuard® + TX, Green Releaf®) + TX, Bacillus circulans + TX, Bacillus firmus strain (BioSafe® + TX, BioNem-WP® + TX, VOTiVO®) + TX, Bacillus firmus strain I-1582 + TX, Bacillus macerans + TX, Bacillus marismortui + TX, Bacillus megaterium + TX, AQ726 strain Bacillus mycoides + TX, Bacillus papillae (Milky Spore Powder®) + TX, Bacillus pumilus spp.+ TX, strain GB34 of Bacillus pumilus (Yield Shield®) + TX, strain AQ717 of Bacillus pumilus + TX, strain QST 2808 of Bacillus pumilus (Sonata® + TX, Ballad Plus®) + TX, Bacillus spahericus (VectoLex®) + TX, Bacillus spp. + TX, strain AQ175 of Bacillus spp. + TX, strain AQ177 of Bacillus spp. + TX, strain AQ178 of Bacillus spp. + TX, Bacillus subtilis strain QST 713 (CEASE® + TX, Serenade® + TX, Rhapsody®) + TX, Bacillus subtilis strain QST 714 (JAZZ®) + TX, Bacillus subtilis strain AQ153 + TX, Bacillus subtilis strain AQ743 + TX, Bacillus subtilis strain QST3002 + TX, Bacillus subtilis strain QST3004 + TX, Bacillus subtilis strain FZB24 var.amyloliquefaciens (Taegro® + TX, Rhizopro®) + TX, Bacillus thuringiensis Cr y 2Ae + TX, Bacillus thuringiensis Cr y 1Ab + TX, Bacillus thuringiensis aizawai GC 91 (Agreeensis®) is thuringisis, TX (BMP123® + TX, Aquabac® + TX, VectoBac®) + TX, Bacillus thuringiensis kurtaki (Javelin® + TX, Deliver® + TX, Cr y Max® + TX, Bonide® + TX, Scutella WP,® + WP + TX, Turilav WP® + TX, Biobit® + TX, Foray®) + TX, Bacillus thuringiensis kurtaki BMP 123 (Baritone®) + TX, Bacillus thuringiensis kurtaki HD-1 (Bioprotec-CAF / 3P®) + TX, strain Acepa BDQs +22 de Bacillus Bacillus thuringiensis + TX, Bacillus thuringiensis var. aizawai (XenTari® + TX, DiPel®) + TX, bacteria spp.(GROWMEND® + TX, GROWSWEET® + TX, Shootup®) + TX, bacteriófago de Clavipacter michiganensis (AgriPhage®) + TX, Bakflor® + TX, Beauveria bassiana (Beaugenic® + TX, Brocaril WP®) + TX, Beauveria bassiana GHA (Mycotrol ES® + TX, Mycotrol O® + TX, BotaniGuard®) + TX, Beauveria brongniartii (Engerlingspilz® + TX, Schweizer Beauveria® + TX, Melocont®) + TX, Beauveria spp. + TX, Botr y tis cineria + TX, Bradyrhizobium japonicum (TerraMax®) + TX, Brevibacillus brevis + TX, Bacillus thuringiensis tenebrionis (Novodor®) + TX, BtBooster + TX, Burkholderia cepacia (Deny® + TX, Intercept® + TX, Blue Circle®) + TX, Burkholderia gladii + TX, Burkholderia gladioli + TX, Burkholderia spp.+ TX, Canadian thistle fungus (CBH Canadian Bioherbicide®) + TX, Candida butyri + TX, Candida famata + TX, Candida fructus + TX, Candida glabrata + TX, Candida guilliermondii + TX, Candida melibiosica + TX, Candida oleophila strain O + TX, Candida parapsilosis + TX, Candida pelliculosa + TX, Candida pulcherrima + TX, Candida reukaufii + TX, Candida saitoana (Bio-Coat® + TX, Biocure®) + TX, Candida sake + TX, Candida spp. + TX, Candida tenius + TX, Cedecea dravisae + TX, Cellulomonas flavigena + TX, Chaetomium cochliodes (Nova-Cide®) + TX, Chaetomium globosum (Nova-Cide®) + TX, Chromobacterium subtsugae strain PRAA4-1T (Grandevo®) + TX, Cladosporium cladosporioides + TX, Cladosporium oxisporum + TX, Cladosporium clorocephalum + TX, Cladosporium spp. + TX, Cladosporium tenuissimum + TX, Clonostachys rosea (EndoFine®) + TX, Colletotrichum acutatum + TX, Coniothyrium minitans (Cotans WG®) + TX, Coniothyrium spp.+ TX, Cr y ptococcus albidus (YIELDPLUS®) + TX, Cr y ptococcus humicola + TX, Cr y ptococcus infirmominiatus + TX, Cr y ptococcus laurentii + TX, Cr y ptophlebia leucotreta granulovirus (Cr y ptex®) + TX, Cupriavidus campinensis + TX, Cydia pomonella granulovirus (CYD-X®) + TX, Cydia pomonella granulovirus (Madex® + TX, Madex Plus® + TX, Madex Max / Carpovirusine®) + TX, Cylindrobasidium laeve (Stumpout®) + TX, Cylindrocladium + TX, Debar y omyces hansenii + TX, Drechslera hawaiinensis + TX, Enterobacter cloacae + TX, Enterobacteriaceae + TX, Entomophtora virulenta (Vektor®) + TX, Epicoccum nigrum + TX, Epicoccum purpurascens + TX, Epicoccum spp. + TX, Filobasidium floriforme + TX, Fusarium acuminatum + TX, Fusarium chlamydosporum + TX, Fusarium oxisporum (Fusaclean® / Biofox C®) + TX, Fusarium proliferatum + TX, Fusarium spp. + TX, Galactomyces geotrichum + TX, Gliocladium catenulatum (Primastop® + TX, Prestop®) + TX, Gliocladium roseum + TX, Gliocladium spp.(SoilGard®) + TX, Gliocladium virens (Soilgard®) + TX, Granulovirus (Granupom®) + TX, Halobacillus halophilus + TX, Halobacillus litoralis + TX, Halobacillus trueperi + TX, Halomonas spp. + TX, Halomonas subglaciescola + TX, Halovibrio variabilis + TX, Hanseniaspora uvarum + TX, nucleopolihedrovirus de Helicoverpa armigera (Helicovex®) + TX, virus de la polyhedrosis nuclear de Helicoverpa zea (Gemstar®) + TX, isoflavona (Mycononete),® + TXonone Kloeckera apiculata + TX, Kloeckera spp.+ TX, Lagenidium giganteum (Laginex®) + TX, Lecanicillium longisporum (Vertiblast®) + TX, Lecanicillium muscarium (Vertikil®) + TX, Lymantria dispar nuclear polyhedrosis virus (Disparvirus®) + TX, Marinococcus halophilus + TX, Meira geulakonigii + TX, Metarhizium anisopliae (Met52®) + TX, Metarhizium anisopliae (Destruxin WP®) + TX, Metschnikowia fruticola (Shemer®) + TX, Metschnikowia pulcherrima + TX, Microdochium dimerum (Antibot®) + TX, Micromonospora coerulea + TX, Microsphaeropsis ochracea + TX, Muscodor albus 620 (Muscudor®) + TX, Muscodor roseus strain A3-5 + TX, Mycorrhizae spp.(AMykor® + TX, Root Maximizer®) + TX, cepa AARC-0255 de Myrothecium verrucaria (DiTera®) + TX, BROS PLUS® + TX, cepa D97 de Ophiostoma piliferum (Silvanex®) + TX, Paecilomyces farinosus + TX, Paecilomyces fumosoroseus (PFR-97® + TX, PreFeRal®) + TX, Paecilomyces linacinus (Biostat WP®) + TX, cepa 251 de Paecilomyces lilacinus (MeloCon WG®) + TX, Paenibacillus polymyxa + TX, Pantoea agglomerans (BlightBan C9-1®) + TX, Pantoea spp. + TX, Pasteuria spp. (Econem®) + TX, Pasteuria nishizawae + TX, Penicillium aurantiogriseum + TX, Penicillium billai (Jumpstart® + TX, TagTeam®) + TX, Penicillium brevicompactum + TX, Penicillium frequentans + TX, Penicillium griseofulvum + TX, Penicillium purpurogenum + TX, Penicillium spp.+ TX, Penicillium viridicatum + TX, Phlebiopsis gigantean (Rotstop®) + TX, phosphate solubilizing bacteria (Phosfomeal®) + TX, Phytophthora cr y ptogea + TX, Phytophthora palmivora (Devine®) + TX, Pichia anomala + TX, Pichia guilermondii + TX, Pichia membranaefaciens + TX, Pichia onychis + TX, Pichia stipites + TX, Pseudomonas aeruginosa + TX, Pseudomonas aureofasciens (Spot-Less Biofungicide®) + TX, Pseudomonas cepacia + TX, Pseudomonas chlororaphis (AtEze®) + TX, Pseudomonas corrugate + TX, Pseudomonas fluorescens strain A506 (BlightBan A506®) + TX, Pseudomonas putida + TX, Pseudomonas reactans + TX, Pseudomonas spp.+ TX, Pseudomonas syringae (Bio-Save®) + TX, Pseudomonas viridiflava + TX, Pseudomons fluorescens (Zequanox®) + TX, Pseudozyma flocculosa strain PF-A22 UL (Sporodex L®) + TX, Puccinia canaliculata + TX, Puccinia thlaspeos (Wood Warrior®) + TX, Pythium paroecandrum + TX, Pythium oligandrum (Polygandron® + TX, Polyversum®) + TX, Pythium periplocum + TX, Rhanella aquatilis + TX, Rhanella spp. + TX, Rhizobia (Dormal® + TX, Vault®) + TX, Rhizoctonia + TX, Rhodococcus globerulus strain AQ719 + TX, Rhodosporidium diobovatum + TX, Rhodosporidium toruloides + TX, Rhodotorula spp. + TX, Rhodotorula glutinis + TX, Rhodotorula graminis + TX, Rhodotorula mucilagnosa + TX, Rhodotorula rubra + TX, Saccharomyces cerevisiae + TX, Salinococcus roseus + TX, Sclerotinia minor + TX, Sclerotinia minor (SARRITOR®) + TX, Scytalidium spp.+ TX, Scytalidium uredinicola + TX, virus de la polihedrosis nuclear de Spodoptera exigua (Spod-X® + TX, Spexit®) + TX, Serratia marcescens + TX, Serratia plymuthica + TX, Serratia spp. + TX, Sordaria fimicola + TX, nucleopolihedrovirus de Spodoptera littoralis (Littovir®) + TX, Sporobolomyces roseus + TX, Stenotrofomonas maltophilia + TX, Streptomyces ahygroscopicus + TX, Streptomyces albaduncus + TX, Streptomyces exfoliates + TX, Streptomyces galbus + TX, Streptomyces griseoplanus + TX, Streptomyces griseoviridis (Mycostop®) + TX, Streptomyces lydicus (Actinovate®) + TX, Streptomyces lydicus WYEC-108 (ActinoGrow®) + TX, Streptomyces violaceus + TX, Tilletiopsis minor + TX, Tilletiopsis spp.+ TX, Trichoderma asperellum (T34 Biocontrol®) + TX, Trichoderma gamsii (Tenet®) + TX, Trichoderma atroviride (Plantmate®) + TX, Trichoderma hamatum TH 382 + TX, Trichoderma harzianum rifai (Mycostar®) + TX, Trichoderma harzianum T-22 (Trianum-P® + TX, PlantShield HC® + TX, RootShield® + TX, Trianum-G®) + TX, Trichoderma harzianum T-39 (Trichodex®) + TX, Trichoderma inhamatum + TX, Trichoderma koningii + TX, Trichoderma spp. LC 52 (Sentinel®) + TX, Trichoderma lignorum + TX, Trichoderma longibrachiatum + TX, Trichoderma polysporum (Binab T®) + TX, Trichoderma taxi + TX, Trichoderma virens + TX, Trichoderma virens (formerly Gliocladium virens GL-21) (SoilGuard®) + TX, Trichoderma viride + TX, Trichoderma viride strain ICC 080 (Remedier®) + TX, Trichosporon pullulans + TX, Trichosporon spp. + TX, Trichothecium spp.+ TX, Trichothecium roseum + TX, Typhula phacorrhiza strain 94670 + TX, Typhula phacorrhiza strain 94671 + TX, Ulocladium atrum + TX, Ulocladium oudemansii (Botr y -Zen®) + TX, Ustilago maydis + TX, various bacteria and complementary micronutrients (Natural II®) + TX, various fungi (Millennium Microbes®) + TX, Verticillium chlamydosporium + TX, Verticillium lecanii (Mycotal® + TX, Vertalec®) + TX, Vip3Aa20 (VIPtera®) + TX, Virgibaclillus marismortui + TX, Xanthomonas campestris pv. Poae (Camperico®) + TX, Xenorhabdus bovienii + TX, Xenorhabdus nematophilus;. Plant extracts including: pine oil (Retenol®) + TX, azadirachtin (Plasma Neem Oil® + TX, AzaGuard® + TX, MeemAzal® + TX, Molt-X® + TX, Botanical IGR (Neemazad® + TX, Neemix®) + TX), rapeseed oil (Lilly Miller Vegol®) + TX, Chenopodium ambrosioides near ambrosioides (Requiem®) + TX, Chr and santhemum extract (Crisant®) + TX, neem oil extract (Trilogy®) + TX, Lamiaceae essential oils (Botania®) + TX, clove, rosemary, peppermint, and thyme oil extracts (Garden insect killer®) + TX, glycine betaine (Greenstim®) + TX, garlic + TX, citronella oil (GreenMatch®) + TX, neem oil + TX, Nepeta cataria (cat's foot oil) + TX, Nepeta catarina + TX, nicotine + TX, oregano oil (MossBuster®) + TX, Pedaliaceae oil (Nematon®) + TX, pyrethrum + TX, Quillaja saponaria (NemaQ®) + TX, Reynoutria sachalinensis (Regalia® + TX, Sakalia®) + TX, rotenone (Eco Roten®) + TX, Rutaceae plant extract (Soleo®) +TX,soybean oil (Ortho ecosense®) + TX, tea tree oil (Timorex Gold®) + TX, thyme oil + TX, AGNIQUE® MMF + TX, BugOil® + TX, blend of rosemary, sesame, spearmint, thyme and cinnamon extracts (EF 300®) + TX, blend of clove, rosemary and spearmint extracts (EF 400®) + TX, blend of garlic, spearmint, clove and peppermint oils (Soil Shot®) + TX, kaolin (Screen®) + TX, brown algae storage glucam (Laminarin®) ;, Pheromones including: Blackheaded Fireworm Pheromone (3M Sprayable Blackheaded Fireworm Pheromone®) + TX, Codling Moth Pheromone (Paramount Dispenser - (CM) / Isomate C-Plus®) + TX, Grapevine Moth Pheromone (3M MEC-GBM Sprayable Pheromone®) + TX, Leafroller Pheromone (3M MEC - LR Sprayable Pheromone®) + TX, Muscamone (Snip7 Fly Bait® + TX, Starbar Premium Fly Bait®) + TX, Oriental Fruit Moth Pheromone (3M Oriental Fruit Moth Sprayable Pheromone®) + TX, Peach Borer Pheromone (Isomate-P®) + TX, Tomato Pinworm Pheromone (3M Sprayable Pheromone®) + TX, Entostat Powder (Palm Extract) (Exosex CM®) + TX, (3E, 8Z, 11Z) -3, 8, 11-Tetradecatrienyl Acetate + TX, (7Z, 11Z, 13E) -7, 11, 13-Hexadecatrienal + TX, (E, Z) -7, 9--dodecadien-1-yl + TX, 2-methyl-1-butanol + TX, calcium acetate + TX, Scenturion® + TX, Biolure® + TX, Check-Mate® + TX, Lavandulyl Senecioate + TX; Macrobiotic agents, including: Aphelinus abdominalis + TX, Aphidius ervi (Aphelinus-System®) + TX, Acerophagus papaya + TX, Adalia bipunctata (Adalia-System®) + TX, Adalia bipunctata (Adaline®) + TX, Adalia bipunctata (Aphidalia®) + TX, Ageniaspis citricola + TX, Ageniaspis fuscicollis + TX, Amblyseius andersoni (Anderline® + TX, Andersoni-System®) + TX, Amblyseius californicus (Ambliline® + TX, Spical®) + TX, Amblyseius cucumeris (Thripex® + TX, Bugline cucumeris®) + TX, Amblyseius fallacis (Fallacis®) + TX, Amblyseius swirskii (Bugline swirskii® + TX, Swirskii-Mite®) + TX, Amblyseius womersleyi (WomerMite®) + TX, Amitus hesperidum + TX, Anagrus atomus + TX, Anagyrus fusciventris + TX, Anagyrus kamali + TX, Anagyrus loecki + TX, Anagyrus pseudococci (Citripar®) + TX, Anicetus beneficis + TX, Anisopteromalus calandrae + TX, Anthocoris nemoralis (Anthocoris-System®) + TX, Aphelinus abdominalis (Apheline® + TX, Aphiline®) + TX, Aphelinus asychis + TX,Aphidius colemani (Aphipar®) + TX, Aphidius ervi (Ervipar®) + TX, Aphidius gifuensis + TX, Aphidius matricariae (Aphipar-M®) + TX, Aphidoletes aphidimyza (Aphidend®) + TX, Aphidoletes aphidimyza (Aphidoline®) + TX, Aphytis lingnanensis + TX, Aphytis melinus + TX, Aprostocetus hagenowii + TX, Atheta coriaria (Staphiline®) + TX, Bombus spp. + TX, Bombus terrestris (Natupol Beehive®) + TX, Bombus terrestris (Beeline® + TX, Tripol®) + TX, Cephalonomia stephanoderis + TX, Chilocorus nigritus + TX, Chr y soperla carnea (Chr y soline®) + TX, Chr y soperla carnea (Chr y sopa®) + TX, Chr y soperla rufilabris + TX, Cirrospilus ingenuus + TX, Cirrospilus quadristriatus + TX, Citrostichus phillocnistoides + TX, Closterocerus chamaeleon + TX, Closterocerus spp. + TX, Coccidoxenoides perminutus (Planopar®) + TX, Coccophagus cowperi + TX, Coccophagus lycimnia + TX, Cotesia flavipes + TX, Cotesia plutellae + TX, Cr y ptolaemus montrouzieri (Cr y ptobug® + TX, Cr y ptoline®) + TX,Cybocephalus nipponicus + TX, Dacnusa sibirica + TX, Dacnusa sibirica (Minusa®) + TX, Diglyphus isaea (Diminex®) + TX, Delphastus catalinae (Delphastus®) + TX, Delphastus pusillus + TX, Diachasmimorpha krausii + TX, Diachasmimorpha longicaudata + TX, Diaparsis jucunda + TX, Diaforencyrtus aligarhensis + TX, Diglyphus isaea + TX, Diglyphus isaea (Miglyphus® + TX, Digline®) + TX, Dacnusa sibirica (DacDigline® + TX, Minex®) + TX, Diversinervus spp. + TX, Encarsia citrina + TX, Encarsia formosa (Encarsia max® + TX, Encarline® + TX, En-Strip®) + TX, Eretmocerus eremicus (Enermix®) + TX, Encarsia guadeloupae + TX, Encarsia haitiensis + TX, Episyrphus balteatus (Syrphidend®) + TX, Eretmoceris sifonini + TX, Eretmocerus californicus + TX, Eretmocerus eremicus (Ercal® + TX, Eretline e®) + TX, Eretmocerus eremicus (Bemimix®) + TX, Eretmocerus hayati + TX, Eretmocerus mundus (Bemipar® + TX, Eretline m®) + TX, Eretmocerus sifonini + TX, Exochomus quadripustulatus + TX,Feltiella acarisuga (Spidend®) + TX, Feltiella acarisuga (Feltiline®) + TX, Fopius arisanus + TX, Fopius ceratitivorus + TX, Formononetina (Wirless Beehome®) + TX, Franklinothrips vespiformis (Vespop®) + TX, Galendromus occidentalis + TX, Goniozus legneri + TX, Habrobracon hebetor + TX, Harmonia axyridis (HarmoBeetle®) + TX, Heterorhabditis spp. (Lawn Patrol®) + TX, Heterorhabditis bacteriofora (NemaShield HB® + TX, Nemaseek® + TX, Terranem-Nam® + TX, Terranem® + TX, Larvanem® + TX, B-Green® + TX, NemAttack ® + TX, Nematop®) + TX, Heterorhabditis megidis (Nemasys H® + TX, BioNem H® + TX, Exhibitline hm® + TX, Larvanem-M®) + TX, Hippodamia convergens + TX, Hypoaspis aculeifer (Aculeifer-System® + TX, Entomite-A®) + TX, Hypoaspis miles (Hypoline m® + TX, Entomite-M®) + TX, Lbalia leucospoides + TX, Lecanoideus floccissimus + TX, Lemophagus errabundus + TX, Leptomastidea abnormis + TX, Leptomastix dactylopii (Leptopar®) + TX, Leptomastix epona + TX, Lindorus lophanthae + TX,Lipolexis oregmae + TX, Lucilia caesar (Natufly®) + TX, Lysiphlebus testaceipes + TX, Macrolophus caliginosus (Mirical-N® + TX, Macroline c® + TX, Mirical®) + TX, Mesoseiulus longipes + TX, Metaphycus flavus + TX, Metaphycus lounsbur yi + TX, Micromus angulatus (Milacewing®) + TX, Microter ys flavus + TX, Muscidifurax raptorellus and Spalangia cameroni (Biopar®) + TX, Neodr y inus typhlocybae + TX, Neoseiulus californicus + TX, Neoseiulus cucumeris (THRYPEX®) + TX, Neoseiulus fallacis + TX, Nesideocoris tenuis (NesidioBug® + TX, Nesibug®) + TX, Ophyra aenescens (Biofly®) + TX, Orius insidiosus (Thripor-I® + TX, Oriline i®) + TX, Orius laevigatus (Thripor-L® + TX, Oriline l®) + TX, Orius majusculus (Oriline m®) + TX, Orius strigicollis (Thripor-S®) + TX, Pauesia juniperorum + TX, Pediobius foveolatus + TX, Phasmarhabditis hermaphrodita (Nemaslug®) + TX, Phymastichus coffea + TX, Phytoseiulus macropilus + TX, Phytoseiulus persimilis (Spidex® + TX, Phytoline p®) + TX,Podisus maculiventris (Podisus®) + TX, Pseudacteon curvatus + TX, Pseudacteon obtusus + TX, Pseudacteon tricuspis + TX, Pseudaphycus maculipennis + TX, Pseudleptomastix mexicana + TX, Psyllaephagus pilosus + TX, Psyttalia concolor (complex) + TX, Quadrastichus spp. + TX, Rhyzobius lophanthae + TX, Rodolia cardinalis + TX, Rumina decollate + TX, Semielacher petiolatus + TX, Sitobion avenae (Ervibank®) + TX, Steinernema carpocapsae (Nematac C® + TX, Millenium® + TX, BioNem C® + TX, NemAttack® + TX, Nemastar® + TX, Capsanem®) + TX, Steinernema feltiae (NemaShield® + TX, Nemasys F® + TX, BioNem F® + TX, Steinernema-System® + TX, NemAttack® + TX, Nemaplus® + TX, Exhibitline sf® + TX, Scia-rid® + TX, Entonem®) + TX, Steinernema kraussei (Nemasys L® + TX, BioNem L® + TX, Exhibitline srb®) + TX, Steinernema riobrave (BioVector® + TX, BioVektor®) + TX, Steinernema scapterisci (Nematac S®) + TX, Steinernema spp. + TX, Steinernematid spp. (Guardian Nematodes®) + TX,Stetorus punctillum (Stetorus®) + TX, Tamarixia radiate + TX, Tetrastichus setifer + TX, Thripobius semiluteus + TX, Tor y mus sinensis + TX, Trichogramma brassicae (Tricholine b®) + TX, Trichogramma brassicae (Tricho-Strip®) + TX, Trichogramma evanescens + TX, Trichogramma minutum + TX, Trichogramma ostriniae + TX, Trichogramma platneri + TX, Trichogramma pretiosum + TX, Xanthopimpla stemmator;, Other biological agents include: abscisic acid + TX, bioSea® + TX, Chondrostereum purpureum (Chontrol Paste®) + TX, Colletotrichum gloeosporioides (Collego®) + TX, copper octanoate (Cueva®) + TX, delta traps (Trapline d®) + TX, Erwinia amylovora (Harpin) (ProAct® + TX, Ni-HIBIT Gold CST®) + TX, fatty acids derived from a natural by-product of extra virgin olive oil (FLIPPER®) + TX, ferriphosphate (Ferramol®) + TX, funnel traps (Trapline y®) + TX, Gallex® + TX, Grower's Secret® + TX, homobrasonolide + TX, iron phosphate (Lilly Miller Worr and Free Ferramol Slug & Snail Bait®) + TX, McPhail trap (Trapline f®) + TX, Microctonus hyperodae + TX, Mycoleptodiscus terrestris (Des-X®) + TX, BioGain® + TX, Aminomite® + TX, Zenox® + TX, pheromone trap (Thripline ams®) + TX, potassium bicarbonate (MilStop®) + TX, potassium salts of fatty acids (Sanova®) + TX, potassium silicate solution (Sil-Matrix®) + TX,potassium iodide + potassium thiocyanate (Enzicur®) + TX, SuffOil-X® + TX, spider venom + TX, Nosema locustae (Semaspore Organic Grasshopper Control®) + TX, sticky traps (Trapline YF® + TX, Rebell Amarillo®) + TX and traps (Takitrapline y + b®) + TX; (1) antibacterial agents selected from the group of: (1.1) bacteria, some examples of which are the R3B strain of Bacillus mojavensis (NCAIM registration no. (P) B001389) (document WO 2013 / 034938) from Certis USA LLC, a subsidiary of Mitsui & Co. + TX; Bacillus pumilus, in particular strain BU F-33, which has NRRL registration no. 50185 (available as part of BASF's CARTISSA® product, EPA Reg. no. 71840-19) + TX; Bacillus subtilis, in particular strain QST713 / AQ713 (available as SERENADE OPTI or SERENADE ASO from Bayer CropScience LP, USA, which has NRRL registration no. B21661, US Patent No. 06, 060, TX015); strain BU1814 of Bacillus subtilis, (available as VELONDIS® PLUS, VELONDIS® FLEX and VELONDIS® EXTRA from BASF SE) + TX; strain FZB24 of Bacillus subtilis var. Amyloliquefaciens with registration no. DSM 10271 (available from Novozymes as TAEGRO® or TAEGRO® ECO (EPA registration no. 70127-5) ) + TX; Bacillus subtilis CX-9060 from Certis USA LLC, a subsidiary of Mitsui & Co. + TX; Bacillus sp., in particular strain D747 (available as DOUBLE NICKEL® from Kumiai Chemical Industr y Co., Ltd.) , which has FERM registration no. BP-8234, US Patent. no. 7, 094, 592 + TX; Paenibacillus sp. strain having registration no. NRRL B-50972 or registration no. NRRL B-67129, WO 2016 / 154297 + TX; Paenibacillus polymyxa, in particular strain AC-1 (eg, TOPSEED® from Green Biotech Company Ltd.) + TX; Pantoea agglomerans, in particular strain E325 (registration no. NRRL B-21856) (available as BLOOMTIME BIOLOGICALTM FD BIOPETICIDE from Northwest Agri Products) + TX; Pseudomonas proradix (eg, PRORADIX® by Sourcon Padena) + TX; water. (1.2) fungi, some examples of which are Aureobasidium pullulans, in particular blastospores of strain DSM14940, blastospores of strains DSM 14941 or mixtures of blastospores of strains DSM14940 and DSM14941 (for example, BOTECTOR® and BLOSSOM PROTECT® from bio-ferm, CH); + TX; Pseudozyma aphidis (as disclosed in document WO2011 / 151819 of Yissum Research Development Company of the Hebrew University of Jerusalem) + TX; Saccharomyces cerevisiae, in particular strains no CNCM 1-3936, no CNCM 1-3937, no CNCM 1-3938 or no CNCM 1-3939 (as described in document WO 2010 / 086790 of Lesaffre et Compagnie, FR) + TX; (2) selected biological fungicides from the group of: (2.1) bacteria, some examples of which are Agrobacterium radiobacter strain K84 (e.g., GALLTROL-A® from AgBioChem, CA) + TX; the K1026 strain of Agrobacterium radiobacter (e.g., NOGALL™ from BASF SE) + TX; strain FZB24 of Bacillus subtilis var. Amyloliquefaciens with registration no. DSM 10271 (available from Novozymes as TAEGRO® or TAEGRO® ECO (EPA registration no. 70127-5) ) + TX; Bacillus amyloliquefaciens, in particular strain D747 (available as Double Nickel™ from Kumiai Chemical Industr y Co., Ltd., which has the registration number FERM BP-8234, US Patent n.o 7, 094), + TX592; strain F727 of Bacillus amyloliquefaciens (also known as strain MBI110) (NRRL registration no. B-50768, document WO 2014 / 028521) (STARGUS® of Marrone Bio Innovations) + TX; strain FZB42 of Bacillus amyloliquefaciens, n.º de registro DSM 23117 (disponible como RHIZOVITAL® de ABiTEP, DE) + TX; aislado B246 de Bacillus amyloliquefaciens (por ejemplo, AVOGREEN™ de University of Pretoria) + TX; Bacillus licheniformis, en particular la cepa SB3086, que tiene el n.º de registro ATCC 55406, documento WO 2003 / 000051 (disponible como ECOGUARD® Biofungicide y GREEN RELEAF™ de Novozymes) + TX + TX; Bacillus licheniformis FMCH001 y Bacillus subtilis FMCH002 (QUARTZO® (WG) y PRESENCE® (WP) de FMC Corporation) + TX; la cepa BAC-9912 de Bacillus metilotrophicus (de Chinese Academy of Sciences' Institute of Applied Ecology) + TX; la cepa R3B de Bacillus mojavensis (n.º de registro NCAIM (P) B001389) (documento WO 2013 / 034938) de Certis USA LLC, una filial de Mitsui & Co. + TX; Bacillus mycoides, aislado, que tiene el n.º de registro B-30890 (disponible como BMJ TGAI® o WG y LifeGard™ de Certis USA LLC, una filial de Mitsui & Co.) + TX; Bacillus pumilus, in particular strain QST2808 (available as SONATA® from Bayer CropScience LP, USA, which has NRRL registration no. B-30087 and is described in US Patent No. 6,245,551) + TX; Bacillus pumilus, in particular strain GB34 (available as Yield Shield® from Bayer AG, DE) + TX; Bacillus pumilus, in particular strain BU F-33, which has NRRL registration no. 50185 (available as part of the product CARTISSA from BASF, EPA Reg. No. 71840-19) + TX; Bacillus subtilis, in particular strain QST713 / AQ713 (available as SERENADE OPTI or SERENADE ASO from Bayer CropScience LP, USA, which has NRRL registration no. B21661 and is described in US Patent no.No. 6,060,051) + TX; Bacillus subtilis Y1336 (available as BIOBAC® WP from Bion-Tech, Taiwan, registered as a biological fungicide in Taiwan with Registration Numbers 4764, 5454, 5096 and 5277) + TX; Bacillus subtilis strain MBI 600 (available as SUBTILEX from BASF SE), which has Registration Number NRRL B-50595, U.S. Patent No. 5,061,495 + TX; Bacillus subtilis strain GB03 (available as Kodiak® from Bayer AG, DE) + TX; Bacillus subtilis strain BU1814, (available as VELONDIS® PLUS, VELONDIS® FLEX and VELONDIS® EXTRA from BASF SE) + TX; Bacillus subtilis CX-9060 from Certis USA LLC, a subsidiary of Mitsui & Co.+TX; Bacillus subtilis strain KTSB (FOLIACTIVE® by Donaghys) + TX; Bacillus subtilis IAB / BS03 (AVIV™ from STK Bio-Ag Technologies, PORTENTO® from Idai Nature) + TX; Bacillus subtilis strain Y1336 (available as BIOBAC® WP from Bion-Tech, Taiwan, registered as a biological fungicide in Taiwan under Registration Numbers 4764, 5454, 5096 and 5277) + TX; Paenibacillus epiphyticus (WO 2016 / 020371) from BASF SE + TX; Paenibacillus polymyxa ssp. plantarum (WO 2016 / 020371) from BASF SE + TX; Paenibacillus sp. strain having NRRL registration number B-50972 or NRRL registration number B-67129, document WO 2016 / 154297 + TX; the AFS009 strain of Pseudomonas chlororaphis, having NRRL registration number B-50897, document WO 2017 / 019448 (e.g., HOWLER™ and ZIO® from AgBiome Innovations, USA).) + TX; Pseudomonas chlororaphis, in particular strain MA342 (e.g., CEDOMON®, CERALL® and CEDRESS® from Bioagri and Koppert) + TX; strain A506 of Pseudomonas fluorescens (e.g., BLIGHTBAN® A506 from NuFarm) + TX; Pseudomonas proradix (e.g., PRORADIX® from Sourcon Padena) + TX; strain K61 of Streptomyces griseoviridis (also known as strain K61 of Streptomyces galbus) (DSM registration no. 7206) (MYCOSTOP® from Verdera, PREFENCE® from BioWorks, cf. Crop Protection 2006, 25, 468-475) + TX; the WYEC108 strain of Streptomyces lydicus (also known as the WYCD108US strain of Streptomyces lydicus) (ACTINO-IRON® and ACTINOVATE® from Novozymes) + TX; and. (2.2) fungi, some examples of which are Ampelomyces quisqualis, in particular strain AQ 10 (e.g., AQ 10® from IntrachemBio Italia) + TX; strain AQ10 of Ampelomyces quisqualis, which has CNCM registration no. 1-807 (e.g., AQ 10® from IntrachemBio Italia) + TX; strain NRRL 21882 of Aspergillus flavus (products known as AFLA-GUARD® from Syngenta / ChemChina) + TX; Aureobasidium pullulans, in particular blastospores of strain DSM14940 + TX; Aureobasidium pullulans, in particular blastospores of strain DSM 14941 + TX; Aureobasidium pullulans, in particular blastospore mixtures of strains DSM14940 and DSM 14941 (e.g., Botector® from bio-ferm, CH) + TX; Chaetomium cupreum (CABI registration no. 353812) (e.g., BIOKUPRUM™ from AgriLife) + TX; Chaetomium globosum (available as RIVADIOM® from Rivale) + TX; Cladosporium cladosporioides, strain H39, which has the no.º de registro CBS122244, US 2010 / 0291039 (de Stichting Dienst Landbouwkundig Onderzoek) + TX; Coniothyrium minitans, en particular la cepa CON / M / 91-8 (n.º de registro DSM9660, por ejemplo, Contans ® de Bayer CropScience Biologics GmbH) + TX; Cr y ptococcus flavescens, cepa 3C (NRRL Y-50378) , (B2.2.99) + TX; Dactylaria candida + TX; Dilofosfora alopecuri (disponible como TWIST FUNGUS®) + TX; Fusarium oxisporum, cepa Fo47 (disponible como FUSACLEAN® de Natural Plant Protection) + TX; Gliocladium catenulatum (synónym: Clonostachys rosea f. catenulate), cepa J1446 (por ejemplo, Prestop ® de Lallemand) + TX; Gliocladium roseum (also known as Clonostachys rosea f rosea), in particular strain 321U de Adjuvants Plus, strain ACM941 as disclosed in Xue (Efficacy of Clonostachys rosea strain ACM941 and fungicide seed treatments for controlling the root tot complex of field pea, Can Jour Plant Sci 83 (3) : 519-524) or cepa IK726 (Jensen DF, et al.Development of a biocontrol agent for plant disease control with special emphasis on the near commercial fungal antagonist Clonostachys rosea strain 'IK726', Australas Plant Pathol. 2007, 36: 95-101) + TX; Lecanicillium lecanii (formerly known as Verticillium lecanii) conidios de la cepa KV01 (por ejemplo Vertalec® de Koppert / Ar y sta) + TX; Metschnikowia fructicola, in particular the cepa NRRL Y-30752, (B2.2.3) + TX; Microsphaeropsis ochracea + TX; Muscodor roseus, especially the A3-5 variety (register no. NRRL 30548) + TX; Penicillium steckii (DSM 27859, WO 2015 / 067800) de BASF SE + TX; Penicillium vermiculatum + TX; cepa VRA 1992 from Phlebiopsis gigantea (ROTSTOP® C from Danstar Ferment) + TX; Pichia anomala, cepa WRL-076 (NRRL Y-30842), Patente de EE. UU. n.º 7579183 + TX; Pseudozyma flocculosa, cepa PF-A22 UL (available as SPORODEX® L from Plant Products Co., CA) + TX; Saccharomyces cerevisiae, in particular the strain LASO2 (de Agro-Levures et Dérivés) , paredes celulares of the strain LAS117 (CEREVISANE® de Lesaffre, ROMOE® de BASF SE) , strains n.º CNCM 1-3936, n.º CNCM 1-3937, n.º CNCM 1-3938, n.º CNCM 1-3939 (document WO 2010 / 086790) de Lesaffre et Compagnie, FR + TX; Simplicillium lanosoniveum + TX; Talaromyces flavus, cepa V117b + TX; Trichoderma asperelloides JM41R (NRRL registry no. B-50759) (TRICHO PLUS® from BASF SE) + TX; Trichoderma asperellum, in particular, the cepa kd (por ejemplo, T-Gro de Andermatt Biocontrol) + TX; Trichoderma asperellum, in particular the type SKT-1, which has the FERM register number P-16510 (for example, ECO-HOPE® from Kumiai Chemical Industry), type T34 (for example, T34 Biocontrol from Biocontrol Technologies SL, ES) or type ICC 012 from Isagro + TX; Trichoderma atroviride, in particular the type SC1 (which has the register number CBS 122089, document WO 2009 / 116106 and Patente de EE. UU. n.No. 8431120 (from BiPA), strain 77B (T77 from Andermatt Biocontrol) or strain LU132 (for example, Sentinel from Agrimm Technologies Limited) + TX; Trichoderma atroviride, strain CNCM 1-1237 (for example, Esquive® WP from Agrauxine, FR) + TX; Trichoderma atroviride, strain No. V08 / 002387 + TX; Trichoderma atroviride, strain NMI No. V08 / 002388 + TX; Trichoderma atroviride, strain NMI No. V08 / 002389 + TX; Trichoderma atroviride, strain NMI No.º V08 / 002390 + TX; Trichoderma atroviride, strain LC52 (e.g. Tenet from Agrimm Technologies Limited) + TX; Trichoderma atroviride, strain ATCC 20476 (IMI 206040) + TX; Trichoderma atroviride, strain T11 (IMI352941 / CECT20498) + TX; Trichoderma atroviride, strain SKT-1 (FERM P-16510), Patent Publication JP (Kokai) 11-253151 A+TX; Trichoderma atroviride, strain SKT-2 (FERM P-16511), Patent Publication JP (Kokai) 11-253151 A+TX; Trichoderma atroviride, strain SKT-3 (FERM P-17021) , Patent Publication JP (Kokai) 11-253151 A + TX; Trichoderma fertile (e.g., BASF's TrichoPlus product) + TX; Trichoderma gamsii (formerly T. viride) , strain ICC080 (IMI CC 392151 CABI, e.g., BioDerma from AGROBIOSOL DE MEXICO, SA DE CV) + TX; Trichoderma gamsii (formerly T. viride) , strain ICC 080 (IMI CC 392151 CABI) (available as BIODERMA® from AGROBIOSOL DE MEXICO, SA DE CV) + TX; Trichoderma harmatum + TX; Trichoderma harmatum, having the n.ATCC registration number 28012 + TX; Trichoderma harzianum strain T-22 (e.g., Trianum-P from Andermatt Biocontrol or Koppert) or SimbT5 strain (from Simbiose Agro) + TX; Trichoderma harzianum + TX; Trichoderma harzianum rifai strain T39 (e.g., Trichodex® from Makhteshim, USA) + TX; Trichoderma harzianum, strain ITEM 908 (e.g., Trianum-P from Koppert) + TX; Trichoderma harzianum, strain TH35 (e.g., Root-Pro from Mycontrol) + TX; Trichoderma harzianum, strain DB 103 (available as T-GRO® 7456 from Dagutat Biolab) + TX; Trichoderma polysporum, strain IMI 206039 (e.g. Binab TF WP from BINAB Bio-Innovation AB, Sweden) + TX; Trichoderma stromaticum, which has registration number Ts3550 (e.g. Tricovab from CEPLAC, Brazil) + TX; Trichoderma virens (also known as Gliocladium virens), particularly strain GL-21 (e.g. SoilGard from Certis, USA) + TX; Trichoderma virens strain G-41, formerly known as Gliocladium virens (n.ATCC registration number 20906) (e.g., ROOTSHIELD® PLUS WP and TURFSHIELD® PLUS WP from BioWorks, USA) + TX; Trichoderma viride, strain Tv1 (e.g., Trianum-P from Koppert) + TX; Trichoderma viride, in particular strain B35 (Pietr et al., 1993, Zesz. Nauk. AR w Szczecinie 161: 125-137) + TX; mixtures of Trichoderma asperellum strain ICC 012 (also known as Trichoderma harzianum ICC012), which has CABI CC IMI registration no. 392716 and Trichoderma gamsii (formerly T. viride) strain ICC 080, which has IMI registration no. 392151 (e.g., BIO-TAM™ from Isagro USA, Inc. and BIODERMA® from Agrobiosol de México, SA de CV) + TX; Ulocladium oudemansii strain U3, which has NM registration no. 99 / 06216 (e.g., BOTRY-ZEN® from Botr and -Zen Ltd, New Zealand and BOTRYSTOP® from BioWorks, Inc.) + TX; Verticillium albo-atrum (formerly V. dahliae), strain WCS850 having no.WCS850 registration number, deposited at the Central Office for Mushroom Cultivation (e.g., DUTCH TRIG® from Tree Care Innovations) + TX; Verticillium chlamydosporium + TX;. (3) biological control agents that have an effect on improving plant growth and / or plant health selected from the group of: (3.1) bacteria, some examples of which are Azospirillum brasilense (e.g., VIGOR® by KALO, Inc.) + TX; Azospirillum lipoferum (e.g., VERTEX-IF™ from TerraMax, Inc.) + TX; Azorhizobium caulinodans, in particular strain ZB-SK-5 + TX; Azotobacter chroococcum , particularly the H23 + TX strain; Azotobacter vinelandii , specifically strain ATCC 12837 + TX; a mixture of Azotobacter vinelandii and Clostridium pasteurianum (available as INVIGORATE® from Agrinos) + TX; Bacillus amyloliquefaciens pm414 (LOLI-PEPTA® from Biofilm Crop ...

Claims

1. A compound of formula (I) where: A1, A2 and A3 are, independently of each other, N or CRY; or A1=A2-A3, taken together, are NR-C (=X0) -N; where X0 is O or S; A4 and A5 are, independently of each other, N or CRY; Q is , where the stepped line represents the connection of Q to the rest of the compound of formula (I); R is hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, or C1-C3 haloalkoxy; R1 is hydrogen, C1-C6 alkyl, C1-C6 cyanoalkyl, C1-C6 aminocarbonyl-alkyl, C1-C6 hydroxycarbonyl-alkyl, C1-C6 nitroalkyl, C1-C6 trimethylsilane-alkyl, C1-C3 alkoxy-C1-C6 alkoxy-C1-C6 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C3-C4 cycloalkyl-C1-C2-alkyl, C3-C4 cycloalkyl-C1-C2-alkyl where the C3-C4 cycloalkyl group is substituted with 1 or 2 halogen atoms, oxethan-3-yl-CH2-, C1-C6 alkylcarbonyl, C1-C6 alkoxycarbonyl, phenyloxycarbonyl, benzyloxycarbonyl,benzyl or benzyl substituted with 1 to 3 substituents selected independently from halogen, C1-C6 alkoxy and C1-C6 haloalkyl; R2a and R2b are each independently selected from hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkylsulfanyl, C1-C3 alkoxy, C1-C3 haloalkoxy, halogen, NO2, SF5, CN, C(O)NH2, C(O)OH, C(S)NH2, C3-C6 cycloalkyl, C3-C6 cycloalkyl substituted with one to three substituents independently selected from Rx, C3-C6 cycloalkylcarbonyl, phenyl, phenyl substituted with one to three substituents independently selected from Rx, heteroaryl, heteroaryl substituted with one to three substituents independently selected from Rx, OR6, piperidin-2-one-1-yl, piperidin-2-one-1-yl substituted with one to two substituents independently selected from Rx, pyridin-2-one-1-yl, pyridin-2-one-1-yl substituted with one to two substituents selected independently of Rx, azetidin-1-yl,azetidin-1-yl substituted with one to two substituents selected independently of Rx, pyrrolidin-1-yl, pyrrolidin-1-yl substituted with one to two substituents selected independently of Rx, C3-C6-C1-C4 cycloalkyl, C3-C6-C1-C4 cycloalkyl substituted with one to two substituents selected independently of Rx, C3-C6-C1-C3 cycloalkyl, C3-C6-C1-C3 cycloalkyl substituted with one to two substituents selected independently of Rx, C1-C5 cyanoalkyl, C1-C5 cyanoalkoxy, C1-C4 alkylsulfanyl, C1-C4 alkylsulfanyl substituted with one to three substituents selected independently of Rx, C1-C4 alkylsulfonyl, C1-C4 alkylsulfonyl substituted with one to three substituents selected independently of Rx of Rx, C1-C4 alkylsulfinyl, and C1-C4 alkylsulfinyl substituted with one to three substituents selected independently of Rx; R3 is C1-C3 alkyl or C1-C3 haloalkyl; R4 is,where the stepped line represents the connection of R4 to Qa or Qb; A14, A24, and A34 are, independently of each other, N or CH; R4c is C1-C3 alkyl, C1-C3 haloalkyl, allyl, propargyl, or C3-C6 cycloalkyl-C1-C4 alkyl; R5 is hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, C1-C3 alkoxy, C3-C4 alkoxy-C(O)-, (C1-C3 alkoxy)2CH-, halogen, CN, NH2C(O)-, amino (i.e., NH2), (C1-C3 alkyl)amino, di(C1-C3 alkyl)amino, hydroxyl, C3-C4 halocycloalkyl, C3-C4 cyanocycloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C1-C4 haloalkylsulfanyl, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylsulfanyl, alkylsulfinyl C1-C4, C1-C4 alkylsulfonyl, C1-C3 alkoxy-C1-C3 alkyl, C1-C3 alkoxy-C1-C3 alkoxy-C1-C3 alkyl, (C1-C3 alkyl)sulfonylamino, (C1-C3 alkyl)sulfonyl (C1-C3 alkyl)amino, (C1-C3 alkyl) NHC (O) , (C1-C3 alkyl) 2NC (O) , (C1-C3 cycloalkyl) NHC (O) , (C1-C3 cycloalkyl) (C1-C3 alkyl) NC (O) ,(C1-C3 alkyl) C (O) (C1-C3 alkyl) N, (C1-C3 alkyl) C (O) NH, (C1-C3 alkyl) C (O) , (C1-C3 alkoxy) C (O) , HC (O) , diphenylmethanimine, C1-C3 haloalkoxy, phenyl, or a 5-membered heteroaromatic ring; or R5 is phenyl substituted with one to three substituents selected from C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C3-C4 cycloalkyl, halogen, CN and hydroxyl; or R5 is a 5-membered heteroaromatic ring substituted with one to three substituents selected from C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C3-C4 cycloalkyl, halogen, CN, and hydroxyl; R5a and R5b are, independently of each other, selected from hydrogen, halogen, CN, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, C1-C3 alkoxy, and C1-C3 haloalkoxy; R6 is phenyl, benzyl, heteroaryl, or C3-C6 cycloalkyl; or R6 is phenyl, benzyl, heteroaryl, or C3-C6 cycloalkyl, each of which, independently of each other,is substituted with one to three substituents selected independently of Rx; Rx is selected independently from halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy, NO2, SF5, CN, C(O)NH2, C(S)NH2, C1-C4 haloalkylsulfanyl, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylsulfanyl, C1-C4 alkylsulfinyl, and C1-C4 alkylsulfonyl; RY is selected from hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, hydroxyl, C1-C3 alkoxy, C1-C3 haloalkoxy, halogen, CN, and cyclopropyl; and RZ is selected from oxo, halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy, and CN; or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer, and N-oxide of the compound of formula I.

2. The compound according to claim 1, wherein - A1 and A3 are N, and A2 is CRY; and RY is hydrogen, chlorine, methyl, trifluoromethyl, or methoxy or - where A1=A2-A3, taken together, are NR-C(=O)-N; and R is hydrogen, methyl, ethyl, 2,2-difluoroethyl, or 2,2,2,-trifluoroethyl.

3. The compound according to claim 1 or claim 2, wherein A4 and A5 are, independently of each other, N or CH; or wherein A4 and A5 are both CH.

4. The compound according to any one of claims 1 to 3, wherein - when R4 is R4a: A14 is N, A24 is N or CH, and A34 is N or CH; or A14 is N, A24 is N or CH, and A34 is CH; or A14 is N, A24 is CH, and A34 is N or CH; or A14 is N, A24 is CH, and A34 is CH; and wherein R4c is methyl, ethyl, propyl, difluoromethyl, trifluoromethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, allyl, propargyl, cyclopropylmethyl, cyclobutylmethyl, 2-cyclopropylethyl, or 3-cyclopropylpropyl.

5. The compound according to any one of claims 1 to 4, wherein: - A14 is N, and, when R4 is R4a, A24 and A34 are CH; and - R4c is methyl or ethyl.

6. The compound according to any one of claims 1 to 5,where X0 is O.

7. The compound according to any one of claims 1 to 6, where R1 is hydrogen, methyl, ethyl, cyanomethyl, methoxymethyl, cyclopropylmethyl, allyl, propargyl, benzyloxycarbonyl, or benzyl.

8. The compound according to any one of claims 1 to 7, wherein R2a is halogen, C1-C3 haloalkyl, C1-C3 haloalkylsulfanyl, C1-C3 haloalkoxy, C3-C6 cycloalkyl optionally substituted with one or two substituents independently selected from C1-C3 haloalkyl, cyano and halogen, C3-C6 cycloalkyl-C1-C4 alkyl optionally substituted with one to three substituents independently selected from C1-C3 haloalkyl, cyano and halogen, C1-C5 cyanoalkyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylsulfinyl, C1-C4 haloalkylsulfinyl, C3-C6 cycloalkylsulfanyl, C3-C6 cycloalkylsulfinyl, or C3-C6 cycloalkylsulfonyl; and where R2b is halogen, C1-C3 haloalkyl, C1-C3 haloalkylsulfanyl,C1-C3 haloalkylsulfonyl, C1-C3 alkoxy, C1-C3 haloalkoxy, or CN.

9. The compound according to any one of claims 1 to 8, wherein R2a and R2b are independently selected from chlorine, bromine, iodine, and trifluoromethyl.

10. The compound according to any one of claims 1 to 9, wherein R3 is methyl.

11. The compound according to any one of claims 1 to 10, wherein: - when Q is Qa: R5 is hydrogen, methyl, trifluoromethoxyl, methoxyl, cyclopropyl, 2,2-difluoroethoxyl, 2,2,2-trifluoroethoxyl, difluoromethoxyl, 2,2,2-trifluoroethyl, chlorine, bromine, methoxyethoxyl, methylcarbonyl, or methoxycarbonyl; and - when Q is Qb: R5a is hydrogen, halogen, CN, C1-C3 alkyl, C1-C3 haloalkyl, C3-C4 cycloalkyl, C1-C3 alkoxy or C1-C3 haloalkoxy; and R5b is hydrogen, halogen, CN, C1-C3 haloalkyl, C3-C4 cycloalkyl,C1-C3 alkoxy or C1-C3 haloalkoxy.

12. A composition comprising a compound as defined in any one of claims 1 to 11, one or more auxiliaries and diluents, and optionally one or more other active ingredients.

13. A method (i) for combating and controlling insects, mites, nematodes, or molluscs, comprising applying to a pest, a pest site, or a plant susceptible to pest attack, an effective quantity as an insecticide, acaricide, nematicide, or molluscicide of a compound as defined in any one of claims 1 to 11 or a composition as defined in claim 12; excluding methods for treating the human or animal body by surgery or therapy; or (ii) for protecting plant propagation material from attack by insects, mites, nematodes, or molluscs, comprising treating the propagation material or the site where the propagation material is planted,with an effective amount of a compound as defined in any one of claims 1 to 11 or a composition as defined in claim 12; or (iii) for controlling parasites in or on an animal in need, comprising administering an effective amount of a compound as defined in any one of claims 1 to 11 or a composition as defined in claim 12, excluding methods for treating the human or animal body by surgery or therapy.

14. A plant propagation material, such as a seed, comprising or adhering thereto a compound as defined in any one of claims 1 to 11 or a composition as defined in claim 12.